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ABSTRACT 
This study was conducted to evaluate the long-term effects 
of soft contact lens extended wear on visual function as 
measured by contrast sensitivity . Contrast sensitivity 
measurements were taken at 6 spatial frequencies on 39 
subj e cts when corrected with spectacle lenses and extended 
wear so f t lenses . The three types of contact lenses used 
(CS I-T, Hydrocurve II-55, Permaflex) represented low (38 %), 
medium (55%), and high (74%) water content s . Measured amounts 
of residual refractive error were corrected using a trial 
frame and lenses and a Clason slide and projector was used to 
obtain a more precise determination of Snellen a c uity. All 
subjects had vision correctable to 20/20 or better. Data were 
taken on nine occa s ions duri n g a five month period to 
investigate the effect of time upon con trast sensi t ivity. 
Two way analysis of variance for repeated measures revealed 
statistically significant decrea se s in cont ~ st sensitivity at 
several of the spatial freq u enc ie s tested, o r a 1 : three lens 
types used. Al t hough a combined eff• of h e corn ea and the 
contact lens was present in some c a.,<:.' s , t he chie f cause for 
this decrease was the cornea. 
KEY WORDS: Contrast sensitivity , spatial frequency, 
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INTRODUCTION 
In 1984 the U.S. Navy conducted a pilot program to 
determine the feasibility of using extended wear soft lenses 
by submarine personnel. 1 This program was instituted to 
facilitate the use of the periscope by eliminating the 
recurrent need to remove spectacles a n d focus the eyepiece. 
It was hoped that the use of contact lenses would increase the 
efficiency and accuracy of periscope use without creating 
additional problems. Extended wear soft lenses were chosen 
for this program to provide maximum readiness of personnel. 
The results of this pilot study indicated that contact 
lens wear did indeed facilitate periscope operation. Although 
not all personnel were able to wear the soft contact lenses, 
those who were successful reported increased efficiency and 
accuracy with periscope use. Questions concerning the longer 
term effects of these lenses on ocular health and visual 
performance are now being considered for these successful 
wearers. 
While in a Navy funded educational program, this study 
was conducted to evaluate the long-term effects soft contact 
lens extended wear on visual capability as measured by 
contrast sensitivity. Contrast sensitivity measurements 
obtained with spectacle correction were compared with those 
obtained with three different soft lenses, representing low 
(38 %), medium (55 %), and high (74 %) water contents . This 
study also attempted to determine which particular aspect of 
the optical system (cornea, contact lens, or a combination) is 
1 
responsible for changes in contrast sensitivity, if changes do 
occur. 
In evaluating visual capability, eye care practitioners 
have relied on measures of Snellen acuity as their standard. 
Patients with 20/20 acuity are generally considered to have 
good vision even though they may have vague complaints about 
their visual performance. Some researchers feel this is a 
common occurrence among contact lens wearers. 2-5 These 
complaints are often manifested more readily under specific 
viewing situations such as driving in the rain or focusing a 
camera at dusk. 6 Consequently, there has been increased 
interest in the u s e of contrast sensitivity measurements to 
help explain these occurrences. 7 r 8 
In discussing contrast sensitivity, it is helpful to 
distinquish this type of evaluation from the more traditional 
Snellen chart . A Snellen chart is a good measure of visual 
acuity (resolution) but not of contrast sensitivity.6, 9 
Resolution on a Snellen chart deals with the discernment of 
variable size letters at maximum contrast: black with sharp 
borders on a white background. 
Contrast sensitivity testing evaluates the eye's response 
to changes in contrast between the object and its background 
as well as the size of the object. Its usefulness becomes 
apparent when we consider those visual conditions, such as 
driving in the rain, which could cause lowered discrimination 
of large objects with poor contrast to a greater degree than 
the ability to discern smaller objects with high contrast. 6 
Several investigators have reported a reduction in 
2 
contrast sensitivity during soft contact lens wear compared to 
that with spectacle lens wear. 10- 12 Inconsistencies have been 
pointed out in the patient samples in these studies, however, 
suggesting that further work is needed in this area. 2' 4 
A recent study by Teitelbaum, et al., examined the effect 
of different polymers of soft lenses of varying water content 
on the contrast sensitivity function (CSF) . 4 They found no 
statistically significant differences in contrast sensitivity 
between the three types of lenses. This study, however, 
entailed only fifteen minutes of lens wear prior to the 
contrast sensitivity measurements. A long-term study 
comparing CSF changes with different lenses has not been 
reported in the literature. 
Kirkpatrick and Roggenkamp, in 1985, studi ed the effects 
of daily wear soft contact lenses on contrast sensitivity. 13 
They were concerned not only with the correlation bet ween 
possible changes in contrast sensitivity and soft contact lens 
wear, but also with the particular aspect of the optical 
system (contact lens or cornea) that may be responsible for 
this effect. The optical component, one of two components 
that comprise the contrast sensitivity function, affects the 
quality of the retinal image . 14 The second is the neural 
component which affects the processing of information within 
the retina and visual pathways. Abnormalities of contrast 
sensitivity in healthy contact lens patients are assumed to be 
a defect within the optical system.13,14 
New aspects considered in this study were the types of 
lenses used, the length of time under study, and the size of 
3 
the subject group . Previous investigators have repeatedly 
expressed a need for longer term studies using large r subject 
groups to more accurately determine the the effects of 
contact lens wear on contrast sensitivity. 
4 
SIGNIFICANCE OF STUDY 
In 1978 Geoffrey Arden was one of the first investigators 
to establish the clinical significance of the contrast 
sensitivity function. 15 He first used this measure to study the 
effects of glaucoma on visual performance. Using 
photographically prepared plates of specific spatial 
frequencies with varying contrast, Arden was able to measure 
contrast sensitivity in a clinical setting. Prior to Arden's 
work, testing was limited to the research laboratory, because 
of the complex apparatus required. Most of this research 
dealt with the verification of its use as a diagnostic tool in 
the detection of ocular pathology . 1 6 Because this is a 
relatively new clinical tool, few studies have been undertaken 
to analyze the effects of contact lens wear on contrast 
sensitivity. The value of such a study becomes apparent when 
we consider the rapidly growing interest and use of extended 
wear lenses . In addition, the question of how different 
lenses affect contrast sensitiivity has not been adequately 
answered. 4 Different lenses possess different structural and 
physical properties such as thickness, permeability, water 
content, base curve and dehydration characteristics, many of 
which are subject to change with time. With the growing 
number of lenses available today, a comparison of their effect 
on contrast sensitivity may have clinical significance . The 
clinical implications may be even more relevant in extended 
wear fittings where the factors that affect soft lens contrast 
sensitivity could be magnified. 4 
Applegate and Massof(1975) were the first researchers to 
5 
consider how contact lens wear affects the optical component 
of the contrast sensitivity function . 12 Kirkpatrick and 
Rogge nkamp, in 1985, were next to consider what aspect of the 
optical system (contact lens or cornea) is responsible for 
possible changes in CSF during soft lens wear. 13 The 
importance of determining the etiology of these changes, if 
any, has been established and will be considered ln this 
study. 
6 
REVIEW OF THE LITERATURE 
Recognizing the limitations of Snellen acuity measurements, 
investigators 17 - 21 have begun encouraging practitioners to 
consider the measurement of contrast sensitivity as an 
additional visual performance test . This technique expands 
visual evaluations from an acuity measurement alone to a more 
extensive appraisal of visual information processing. 
The basic testing component of contrast sensitivity is the 
presentation of sine wave gratings to the patient. 
Comerford(1979) listed several different techniques for 
producing sine wave gratings: laser interference patterns, CRT 
displays, slide project ion, and Arden plates. 9 The most 
preferred technique in recent research appears to be the use 
of cathode ray tube(CRT) displays. 2 
Relatively few studies have been undertaken of contact lens 
wear and its effect on the contrast sensitivity function(CSF). 
The studies that have been performed often appear 
contradictory. 
Applegate and Masso£ were the first to study the effect of 
contact lens wear on the optical component of the CSF. 12 They 
found a decreased sensitivity at the intermediate spatial 
frequencies (2-4 cycles/degree) in subjects wearing early 
series Bausch & Lomb hydrogel lenses (38% water content) as 
compared with spectacles. The test population, however, 
consisted of only three subjects. The residual refractive 
error was not corrected. When the residual error was later 
corrected, there was no significant change in the CSF. 
Woo and Hess(1979) examined three contact lens wearers in 
7 
which only one complained of reduced vision while wearing the 
lenses. 10 The two asymptomatic wearers showed no reduction in 
contrast sensitivity, while the subject who did complain of 
reduced vision showed a marked decrease across the range of 
spatial frequencies . The decrease was greater for the higher 
frequencies . No information regarding visual acuity, lens 
type, or residual refractive error was given. The decrease in 
sensitivity was suggested to be an aberration effect not 
detected by Snellen acuity. 
Bernstein and Brodrick (1981) set out to replicate the 
findings of Applegate and Massof. 22 Nine subjects were tested, 
each corrected to 20/20 acuity or better with Bausch & Lomb 
soft lenses. CSF measurements were taken at two-hour 
interva l s over a single 18 hour period. One eye was fitted 
with a soft lens and the other eye was corrected with 
spectacles to serve as a control. They found no significant 
changes in the CSF for patients wearing the Bausch & Lomb 
lenses. 
Mitra and Lamberts(1981) tested the contrast sensitivity of 
12 subjects wearing B3 and U3 series Bau s ch & Lomb soft 
lenses. 11 Contr a st sensitivi t y was measu r ed wi th their 
spectacle corrections in place a n d then 3 0 to 60 minutes 
following their soft lens fittings. The CSF te s t was repeated 
approximate l y two weeks following t he i n itial fitting. All 
subjects obtained at least 20/20 vi s ion with both glasses and 
contact lenses. Their results agre e d with the conclusion 
reached by Applegate and Massof . 12 Th ey found decreased 
contrast sensitivity over nearly all spatial freque nc ies with 
8 
contact lens wear as compared to spectacle lens wear. 
Kirkpatrick and Roggenkamp(l985) used the Nicolet Optronics 
CS2000 vision testing system to test 19 subjects when 
c o rrected with either spectacles or soft lenses . 13 Visual 
acuity was correctable to 20/20 or better with both spectacles 
and soft lenses, with measured amounts of residual refractive 
error corrected during the testing. Five different soft 
lenses were used but were not analyzed separately (CSI, 
Durasoft II, Hydron, Hydrocurve II, and B&L) . Contrast 
sensitivity testing was done prior to and following contact 
lens fitting. Additional testing was done at one and four 
weeks after this initial testing. They found a lowered CSF 
with soft contact lenses for only the highest spatial 
frequency tested (22. 8 cycles/degree) They concluded that 
the responsibility for this decrease was shared by both the 
contact lens and the cornea. 
Tomlinson and Mann(l985) also used the Nicolet Optronics 
CS2000 to test 10 subjects wearing soft lens and spectacle 
corrections. 3 All subjects were habitual wearers of soft 
contact lenses (38% and 55% water content) and all obtained at 
least 2 0 I 2 0 acuity with both contact lens and spectacle 
correction. They found a statistically significant, superior 
visual function with the lathe-cut soft lenses when compared 
to spectacle correction. However, they felt the difference in 
threshold values obtained with the two forms of visual 
correction was probably not clinically significant as defined 
by a 0.02 log unit difference. 
The most recent research in this area was conducted by 
9 
Teitelbaum, et al. (1985) on 12 subjects adapted to contact 
lens wear. 4 Contrast sensitivities obtained with spectacle 
correct ion were compared with those obtained with three 
hydrogel lenses of different polymer. They concluded that the 
l e ns type did not differentially affect contrast sensitivity 
by a clinically or statistically significant amount. This was 
in the absence of lens induced corneal edema, lens deposits, 
or structural and physical changes of the lens. They stated, 
however, that for longer wearing periods, especially with 
extended wear lenses, where these factors may be present, the 
CSF may be affected. 
The published research to date has not resolved the 
question of how soft contact lenses affect contrast 
sensitivity. Possible reasons for conflicting results include 
a failure to take residual astigmatism into account, 
differences in experimental design and instrumentation, 
failure to use appropriate statistical analysis, the use of 
different contact lenses, and generalizing from small numbers 
of subjects. 4 , 13 
10 
HYPOTHESIS 
This study considered the hypothesis that contrast 
sensitivity, for a group of newly fit extended wear soft 
contact lens patients, would show a significant decrease, with 
time, when compared to prefit contrast sensitivities with 
spectacles. If CSF decreased over time, responsibility for 
the decrease could be attributed to either the contact lens, 
the cornea, or a combination of the contact lens and the 
cornea. Contrast sensitivity measurements were taken with 
both spectacle correction and contact lens correction during 
each visit to analyze these possibilities. They are 
represented diagrammatically in Figure 1 . 
Figure lA represents the first possibility. It shows a 
significant decrease in contrast sensitivity with contact 
lenses, but no significant change with spectacles. In this 
case the contact lens would be responsible for the decrease. 
The second possibility is represented in figure lB. It 
shows an equally significant decrease in contrast sensitivity 
when both contact lenses and spectacles are worn. In this 
case the cornea is considered responsible for the decrease. 
The third possibility indicates a combined effect from both 
the contact lens and the cornea. Figure lC shows a 
significant decrease in contrast sensitivity with spectacles 
and a greater decrease with contact lenses. The decrease 
during spectacle lens wear is attributed to the cornea, while 
incremental decrease between the spectacle lens and contact 
lens is attributed to the contact lens . 
Measurements of CSF with contact lenses and spectacles 
were, therefore, made at each progress evaluation during the 
11 
course of the study. The hypothesis was accepted if there was 
a significant decrease in contras t sensitivity for any of the 
spatial frequencies tested when contact lenses were worn. It 
was rej e cted i f a significant decrease did not occur. 
Adequate and appropriate statistical analysis of t he data 
was used to determine the significance of any changes in 
contrast sensi tivity. The use of a statistically significant 
subject group, a long-term testing period, and appropriate 
analysis of the data, was an effort to avoid some of the 
limitations found in past research . These limi tations, at 
least in part, were considered as possible explanations for 
conflicting results in prior studies . 
12 
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Figure lB: Decrease in contrast sensitivity due to the cornea. 
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FIGURE lC: Decrease in contrast sensitivity due to the cornea an d 
t he contact lens. 
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SUBJECTS 
Thirty-nine subjects (twenty-five females and fourteen 
males) were selected for this study following the screening of 
approximately one hundred subjects. All subjects were 
selected to meet the criteria needed for three concurrent 
studies. In addition to contrast sensitivity measurements, 
the subjects and their lenses were evaluated for permeability 
changes of their lenses 23 , corneal thickness changes 24 , and 
endothelial cell studies 24 • All contrast sensitivity 
measurements were taken prior to these tests. 
An age range of 18 to 35 years was chosen to avoid problems 
with presbyopia and age related effects on contrast 
sensitivity. 25 , 26 This range also served to limit the field of 
study and match the primary population that would be included 
in a military contact lens program. Refractive errors were 
limited to a range from -1.00 to -8.00 diopters . This range 
was chosen to reduce the effects of high refractive error on 
contrast sensitivity27 and still meet our military population 
requirements. Only three subjects had errors in excess of 
-5.50 diopters and all refractive errors were spherical or had 
an astigmatic component of 0. 7 5 diopters or less. Visual 
acuities were correctable to 20/20 or better with spectacle 
and contact lens corrections. All subjects had clear media in 
both eyes and were free from active ocular infections or 
inflammations . No histories of significant ocular surgery, 
trauma or pathology were present . Additional subject criteria 
included good tear break-up time (greater than 10 seconds) and 
good personal hygiene. Table 1 contains mor E' specific 
14 
information about patient age and visual acuity as well as 
spectacle and contact lens prescriptions for the initial 
subject population. 
Four control subjects, that met the subject criteria 
outlined above, were utilized in this investigation. More 
specific information concerning this control group is included 
in Appendix F. 
15 
Table 1: Data Describing the Initial Subject Population 
Snellen Acuity 
C/L + Over-
SUBJECT AGE EYE SPECTACLE RX LENS POVVER B.C. DIAMETER Refraction 
-- -
1 26 CD -4.75 sph HCII -4.50 8.8 14.5 20/18 
OS -4.50-0.25x01 0 PF -4.25 8.7 14.4 20/20 
2 28 CD -1.25 sph PF -1.25 8.7 14.4 20/15 
a> -1.00 sph HCII -1.00 9.1 14.5 20/15 
3 18 CD -2.00-050x075 HCII -2.00 8.8 14.5 20/18 
a> -2.25-0.25x1 05 PF -2.25 8.7 14.4 20/20 
4 29 . CD -1.00-0.25x01 0 HCII -1.00 8.8 14.5 20/18 
a> -1.25 sph PF -1.00 8.7 14.4 20/18 
...to. 
0') 
5 27 CD -1.25 sph Hell -1.25 8.8 14.5 20/17 
00 -1.25 sph CSI-T -1.25 8.6 13.8 20/17 
6 31 CD -2.75 sph HCII -3.00 8.5 14 20/13 
a> -2. 75-0.25x008 PF -2.75 8.7 14.4 20/13 
7 22 CD -2.00 sph CSI-T -2.00 8.6 13.8 20/20 
a> -2.00 sph HCII -2.00 8.8 14.5 20/18 
' 
8 21 CD -5. 75-0.25x065 HCII -5.75 8.8 14.5 20/14 
a> -5.00-0.25x090 PF -5.25 8.7 14.4 20/14 
9 28 CD -1.50-0.25x007 HCII -2.00 8.8 14.5 20/18 
a> -1 . 75-0 .25x003 CSI-T -1.75 8.9 14.8 20/18 
10 19 CD -3.25-0.25x180 CSI-T -3.50 8.9 14.8 20/17 
00 -3.75 sph HCII -3.75 8.8 14.5 20/17 
Table 1: Data Describing the Initial Subject Population 
Snellen Acuity 
C/L + Over-
SUBJECT AGE EVE SPECTACLE RX LENS POWER B.C. DIAMETER Refraction 
11 31 CD -1.75 sph CSI-T -2.00 8.6 13.8 20/15 
cs -2.50 sph HCII -2.50 8.8 14.5 20/15 
12 30 CD -4.75 sph PF -4.50 8.7 14.4 20/17 
OS -5.50 sph HCII -5.50 8.8 14.5 20/17 
13 26 CD -2.50-0.25x01 0 HOI -2.75 8.8 14.5 20/15 
cs -3.00-0.25x180 PF -3.00 8.7 14.4 20/15 
14 29 CD -2.25 sph PF -2.25 8.7 14.4 20/18 
cs -2.00 sph HCII -2.00 8.8 14.5 20/17 
....... 15 25 CD -1.50 sph HCII -1.50 9.1 14.5 20/18 
........ cs -1.00 sph PF -1.00 8.9 14.4 20118 
16 31 CD -3.25sph CSI-T -3.25 8.6 14.8 20/17 
cs -3.25-0.25x035 PF -3.25 8.7 14.4 20/18 
17 32 CD -3.25-0.25x005 HCII -3.25 8.8 14.5 20/20 
cs -3.25-0.25x01 0 PF -3.25 8.7 14.4 20/18 
18 24 CD -5.75-0.25x180 HOI -6.00 9.1 14.5 20/17 
cs -6.50-0 .50x005 CSI-T -7.00 9.35 14.8 20/17 
19 34 CD -2.25 sph CSI-T -2.25 8.6 13.8 20/18 
cs -1.50 sph HOI -1.50 8.8 14.5 20/18 
20 26 CD -3.50-0.25x075 HOI -3.75 8.5 14 20/20 
cs -4.00-0.25x120 PF -3.75 8.7 14.4 20/20 
Table 1: Data Describing the Initial Subject Population 
Snellen Acuity 
C/l + Over 
SUBJECT AGE EVE SPECTACLE RX LENS PO'WER B.C. DIAMETER Refraction 
21 26 <D -2.00-0.25x090 HOI -2.25 8.8 14.5 20/17 
cs -3.00-0.25x085 CSI-T -3.25 8.6 13.8 20/17 
22 22 <D -2.25-0.50x1 00 HOI -2.50 8.5 14 20/17 
cs -3.50 sph PF -3.50 8.7 14.4 20/17 
23 29 <D -1.25-0.25x090 HOI -2.00 8.8 14.5 20/20 
03 -1.50 sph CSI-T -1.50 8.6 14.8 20/20 
24 21 <D -4.25-0.25x090 HOI -4.50 8.8 14.5 20/17 
cs -4.00-0.25x090 PF -4.00 8.7 14.4 20/17 
~ 25 31 <D -1.25-0.25x150 Hal -1.50 8.8 14.5 20/17 (X) 
cs -1.50-0.25x030 PF -1.75 8.7 14.4 20/17 
26 26 <D -1.75 sph Hal -1.75 8.8 14.5 20/20 
cs -1.50 sph PF -1.50 8.7 14.4 20/17 
27 30 <D -1.75 sph CSI-T -1.75 8.6 13.8 20/17 
cs -1.50 sph HCII -1.50 8.8 14.5 20/17 
28 20 <D -1.25 sph HCII -1.25 8.8 14.5 20/17 
cs -1.75-0.25x175 CSI-T -2.00 8.6 13.8 20117 
29 34 CD -3.00 sph PF -3.00 8.7 14.4 20/18 
cs -3.00 sph Hal -3.00 8.8 14.5 20/18 
30 31 CD -3.75 sph CSI-T -4.00 8.9 14.8 20/15 
cs -4.00-0.50x180 Hal -4.25 8.8 14.5 20/15 
Table 1: Data Describing the Initial Subject Population 
Snellen Acuity 
C/L + Over 
SUBJECT AGE EYE SPECTACLE RX LENS POWER B.C. DIAMETER Refraction 
31 31 CD -4.25-0.25x017 Hell -4.25 9.1 14.5 20/17 
a> -3.00 sph CSI-T -3.00 8.6 13.8 20/17 
32 27 CD -3.50-0.75x180 HCII -3.50 8.8 14.5 20/17 
a> -3.50-0.75x014 CSI-T -3.75 8.6 14.8 20/17 
33 34 CD -7.25 sph HCII -7.00 8.8 14.5 20/14 
a> -7 .00-0.50x015 PF -6.50 8.7 14.4 20/14 
34 35 CD -2.75 sph HCII -2.75 8.8 14.5 20/18 
a> -2.50 sph CSI-T -2.50 8.6 13.8 20/18 
_,. 
35 24 CD -1.25-0.50x070 HCII -1.50 8.8 14.5 20/18 <.0 
a> -1.25-0.50x090 PF -1.50 8.7 14.4 20/18 
36 28 CD -3.25 sph HCII -3.25 8.8 14.5 20/17 
a> -2.75 sph CSI-T -2.75 8.6 13.8 20/18 
37 18 CD -1.25 sph HCII -1.25 8.8 14.5 20/18 
a> -1.50 sph CSI-T -1.50 8.6 13.8 20/15 
38 27 CD -1.50 sph PF -1.50 8.7 14.4 20/20 
a> -2.25 sph HCII -2.25 ' 9.1 14.5 20/18 
39 26 CD -4.25-0.25x020 HCII -4.25 9.1 14.5 20/18 
a> -3. 75-0.50x165 CSI-T -3.75 8.9 14.8 20/18 
METHODS AND MATERIAL 
The Nicolet Optoronics CS-2000 Contrast Sensitivity Testing 
System was used for this study. 2 8 It became available for 
clinical use in 1981, eliminating many of the drawbacks of the 
Arden plates. 6 It consists of an observer response box, a 
microcomputer control console with keyboard and printer, and a 
display monitor (Figure 2) . It has a built-in calibration 
system, limiting the need for external photometric calibration 
and ensuring standard testing conditions from session to 
session. It can also be photometrically calibrated prior to 
testing, if desired. 
Stationary, flickering, or drifting sine wave grating 
targets can be generated by the CS-2000. This can be done at 
various levels of contrast, spatial frequency, and mean 
luminance. The preprogrammed memory of the CS-2000 allows 
multiple techniques for test administration. 
1 imi t s test method was used for this study: 
The ascending 
the contrast 
between the light and dark bars is raised until the subject is 
just able to detect the grating. This measures the 
relationship between contrast sensitivity and spatial 
frequency using a sinusoidal luminance profile. 
The observer response box allows a subject to signal when a 
pattern is first detected. This can be done by either (1) 
pressing a button in response to the increasing contrast of 
the grating pattern or (2)turning a knob, increasing the 
contrast until it is just visible. 
first response method. 
This study utilized the 
All subjects were evaluated at the standard 3 meter test 
20 
The CS 2000 System Includes a Contrast Sensltlvlty Display Monitor • Control 
Console with Keyboard, and an Observer Response Box. 
Figure 2. The ·Nico1et Optronics CS-2000 Contrast Sensitivity Testing System 
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d i s t a n c e .  T h i s  d i s t a n c e  s e r v e s  t o  s t a n d a r d i z e  t e s t i n g  
c o n d i t i o n s ,  a l l o w i n g  f o r  m o r e  m e a n i n g f u l  c o m p a r i s o n s  o f  t h e  
r e s u l t s .  A t  t h e  3  m e t e r  t e s t  d i s t a n c e  t h e  d i s p l a y  m o n i t o r  
s u b t e n d s  a  v i s u a l  a n g l e  o f  4 . 3  d e g r e e s  h o r i z o n t a l l y  a n d  5 . 4  
d e g r e e s  v e r t i c a l l y .  P r o p e r  a d j u s t m e n t  o f  t h e  m o n i t o r  i s  
n e c e s s a r y  t o  m i n i m i z e  t h e  r a s t e r  c r e a t i n g  a s  h o m o g e n e o u s  a  
f i e l d  a s  p o s s i b l e .  
A  f r o s t e d  w h i t e  p l a s t i c  s u r r o u n d  w a s  u s e d  o n  t h e  m o n i t o r  t o  
p r o v i d e  u n i f o r m i t y  o f  p e r i p h e r a l  a n d  c e n t r a l  f i e l d s  ( F i g u r e  
3 )  .  T h i s  s u r r o u n d  a l s o  a l l o w e d  a  m o r e  c o m f o r t a b l e  t r a n s i t i o n  
b e t w e e n  t h e  b r i g h t  m o n i t o r  a n d  t h e  n o n - i l l u m i n a t e d  r o o m .  
F i g u r e  3 .  S u b j e c t  v i e w  o f  m o n i t o r  w i t h  f r o s t e d  s u r r o u n d  
T o  i n c r e a s e  f l e x i b i l i t y ,  t h e  C S - 2 0 0 0  i n c o r p o r a t e s  t h r e e  
m e t h o d s  o f  c a l i b r a t i o n . 2 8  
T h e  s t a n d a r d  ( d e f a u l t )  m e t h o d  s e t s  
t h e  d i s p l a y  m o n i t o r  f o r  1 0 0  c a n d e l a s  p e r  s q u a r e  m e t e r  a v e r a g e  
2 2  
luminance, and 0. 50 peak contrast measured at the screen 
center. This is a semi-automatic calibration method, designed 
to keep the instrument set for proper contrast and luminance 
values over time. 
The photometric method allows for the use of an external 
photometer to calibrate the CS-2000 to specified luminance and 
contrast values. Verification that the display behaves in a 
linear fashion at these settings is also possible. 
The third, non-standard method of calibration, was used for 
this study. The display is initially set for the desired 
contrast and luminance values using the photometric method of 
calibration. It is then reset to these non-standard values 
through the use of the non-standard calibration option. 
Appendix A outlines the instructions for performing the 
contrast sensitivity testing program using the non-standard 
method of calibration. 
A Tektronix J-16 Photometer with a J6523-2 10 narrow angle 
luminance probe was used to verify the established luminance 
settings. The mean luminance, based on 5 measurements, was 
7 7. 4 candela/meter2 at the beginning of the study and 77 . 6 
candela/meter2 at the end of the study. Two measurements taken 
to evaluate the screen surround gave an mean luminance reading 
of 25.5 candela/meter2 at the beginning of the study and 26 
candela/meter2 at the end of the study. There was no change in 
the ambient luminance of the screen surround which measured 
0.1 candela/meter2 (Appendix B) 
The CS-2000 testing program was tailored to this study by 
using the non-standard test options. To facilitate their use, 
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these options have been grouped into three general categories : 
setup, method, and stimuli. 28 The standard setup option was 
used for all testing. This was recommended by the 
manufacturer and configured the CS-2000 using default values 
for test distance (m), screen size (em), line rate, and peak 
contrast. The testing distance was 3 meters, the screen size 
was 22. Scm (width of the display monitor), the line rate was 
392, and the peak contrast was 0.5. 
The non-standard method option was used to specify which of 
the four test methods was to be used. A preview of each 
stimulus pattern was given, using a preview time of five 
seconds and a preview contrast of 0.2. Following the preview 
stimulus, each test stimulus was repeated three times. This 
was a non-standard method, replacing the default value of 
four. 
The number of stimulus trials was set at six using the 
non-standard stimuli option. 
single stationary sinusoidal 
follows: 6.0, 1.2, 4.0, 11.4, 
Each trial was presented as a 
grating in random order as 
and 16.0 cycle s/de gree (Figure 
4) . Each test trial was started at .002 contrast level. A 
trial was repeated if the standard deviation (determined by 
the instrument) was greater than 0.1. 
Prior to contrast sensitivity testing, each subject was 
given a visual examination in which Snellen visual acuities 
were determined using his or her best spectacle correction. A 
Clason acuity slide and projector was used to provide a more 
precise determi nation of visual acuity (Figure 5) . 
24 
0.7 Cycles/Degree 1.2 Cycles/Degree 4.0 Cycles/Degree 
6.0 Cycles/Degree 11.4 Cycles/Degree 16.0 Cycles/Degree 
Figure 4. Spatial Frequencies Used to Determine Contrast Sensitivity 
Function (CSF) 
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F i g u r e  5 .  C l a s o n  P r o j e c t o r  
C o n t r a s t  s e n s i t i v i t y  w a s  m e a s u r e d  m o n o c u l a r l y  w i t h  
s p e c t a c l e  c o r r e c t i o n  t o  e s t a b l i s h  b a s e l i n e  d a t a  a n d  a  t r i a l  
f r a m e  a n d  l e n s e s  w e r e  u s e d  w h e n e v e r  t h e  s u b j e c t ' s  s p e c t a c l e s  
d i d  n o t  m a t c h  t h e i r  b e s t  s p e c t a c l e  c o r r e c t i o n .  
E a c h  s u b j e c t ,  w i t h  o n e  e x c e p t i o n ,  w a s  t h e n  f i t  w i t h  a  
H y d r o c u r v e  I I - 5 5  ( B a r n e s - H i n d / H y d r o c u r v e )  e x t e n d e d  w e a r  s o f t  
l e n s  o n  o n e  e y e  a n d  e i t h e r  
a  
C S I - T ( S y n t e x )  
o r  
P e r m a f l e x ( C o o p e r v i s i o n )  e x t e n d e d  w e a r  s o f t  l e n s  o n  t h e  o t h e r  
e y e  ( T a b l e  2 ) .  
T h i s  s e l e c t i o n  p r o v i d e d  a  m e d i u m  w a t e r  c o n t e n t  
l e n s  a n d  a  h i g h  o r  l o w  w a t e r  c o n t e n t  l e n s  f o r  e a c h  s u b j e c t  t o  
m i n i m i z e  s u b j e c t  a w a r e n e s s  o f  a  d i f f e r e n c e  b e t w e e n  t h e  l e n s e s .  
T h e  e x c e p t i o n  r e q u i r e d  t h e  u s e  o f  C S I - T  a n d  P e r m a f l e x  l e n s e s  
o n  o n e  s u b j e c t  t o  a c h i e v e  a  p r o p e r  f i t .  
S u b j e c t s  w e r e  n o t  
2 6  
informed that they were wearing two different lens type s 
("single-blind" paradigm). 
CONTACT LENS TABLE 
LENS MANUFACTURER POLYMER WATER CONTENT 
CSI-T Syntex crofilcon A 38.5% 
Hydro curve II 55 Barnes Hind bufilcon A 55.0% 
Permaflex Coopervision surfilcon A 74.0% 
Tab le II: Contact Lens Data 
Contrast sensitivity was again determined for each subject 
following a 30 minute adaptation period. All residual 
re fractive errors were corrected using a trial frame and 
lenses . The complete schedule of testing for the contact lens 
dispensing day, given in Appendix C, indicates the order of 
all data collection for the three concurrent studies using 
this subject group. During dispensing, subjects were 
ins tructed in the proper methods of insertion, removal, and 
care of their lenses. A printed instruction form, Caring for 
Your Extended Wear Contact Lenses, was given to each subject. 
Eight additional testing sessions, over a five month 
period, followed the initial testing. They were scheduled at 
weekly intervals during the first month and at monthly 
intervals thereafter. Subjects were instructed to wear their 
lenses for seven days on an extended wear basis and to awaken 
a minimum of three hours prior to testing. All subjects 
removed their lenses every seventh night for overnight 
cleaning, dis infect ion, and storage. The instruct ions and 
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contact lens care regimen given to each subject is outlined in 
Appendix D. 
The comprehensive followup examinations included: 
1 . visual acuity and subjective refraction at 20 feet 
2. contrast sensitivity testing 
3. auto refraction and auto keratometry 
4. slit lamp biomicroscopy 
5. manual ophthalmometry 
6. endothelial cell count and photodocumentation 
7. corneal thickness determination 
8. photokeratoscopy (Corneascope) 
9. intraocular pressure (AO Non-Contact Tonometer) 
10. binocular stereopsis (Keystone Aviator Series) 
These tests and the order of their administration are given 
on the Contact Lens Followup Form (Appendix C) . 
At the end of study each subject was refitted with a n e w 
pair of soft contact lenses based upon eye health, lens 
performance, and subject preference. Eye health and contact 
lens status was discussed with each subject a n d a copy of 
their contact lens specifications was reviewed and d i spensed 
(Appendix C) 
The four subjects comprising the control group were on the 
same schedule established for the test subjects. Their nine 
contrast sensitivity measurements during the 150 day study 
were utilized to determine the consistency and reliability of 
the instruments and procedures used in this investigation. 
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TREATMENT OF DATA 
The purpose of this study was to determine whether soft 
contact lens extended wear resulted in a significant decrease 
in contrast sensitivity, with time, when compared to prefit 
contrast sensitivities with spectacles. The statistical 
analysis had to consider the following conditions: (1) three 
different contact lens types (2) six spatial frequencies (3) 
and two testing situations (contact lenses and spectacles). 
Nine separate testing periods also had to be considered. A 
two-way analysis of variance for repeated measures was used to 
analyze the data. 29 , 30 Brennan3 1 and Coffey32 agreed that this 
was the appropriate method for data treatment. Eighteen 
separate analyses were run to study the three different lens 
types at the six spatial frequencies tested (Appendix E) . The 
Northwest Analytical Statistical Package (NWA StatPak) 33 and an 
Apple Macintosh computer were used for these analyses. 
A .05 level of significance was used to determine whether 
the hypothesis for the study was considered statistically 
significant. This significance level states that there is 
only a five percent probability of obtaining the observed 
decrease in contrast sensitivity by random factors alone. 29 If 
the results did not show a decrease at the .05 level, then 
they were considered not significant and the hypothesis were 
rejected. 
In the statistical analyses, contrast sensitivi ty data with 
contact lenses were compared to that with spectacle lenses to 
reveal one of the three possibilities stated in the second 
part of the hypothesis . 
29 
(1) A significant decrease in contrast sensitivity 
occurring when contact lenses were worn as compared to that 
measured when spectacles were worn, would suggest that the 
decrease was due to the contact lens. This is represented in 
the Lens column of the significance study (Tables IV, v, and 
VI). A probability less than . 05 indicates a significant 
difference occurred between contact lens correction and 
spectacle lens correction. Referral to the mean tables or CSF 
graphs establishes which contrast sensitivity values were 
lower: contact lens or spectacle. 
(2) A significant decrease in contrast sensitivity found 
through the course of the study when both contact lenses and 
spectacles were worn, would suggest the cornea was responsible 
for the decrease. This is represented by the Time column in 
the significance study. This column compares the nine 
contrast sensitivity measurements taken while corrected with 
contact lenses, using the prefit spectacle contrast 
sensitivity measurements as the baseline. 
(3) A significant difference in contrast sensitivity found 
between the two testing situations (contact lens and 
spectacles) and a significant decrease in contrast sensitivity 
for both during the course of the study, would suggest that 
the decrease was attributed to both the cornea and the contact 
lens. This determination can be found in the Interaction 
column of the significance study. 
The two-way analysis of variance produced an F-ratio which 
indicated the probability of random occurrence of the results. 
The calculated F-ratio, at the appropriate degrees of freedom 
(df) for the grouped being tested, was compared to values in 
30 
the F-table. The results were considered significant if there 
was less than a five percent probability (P<.05) of obtaining 
a calculated F by random factors alone.30 
31 
RESULTS 
The 9 testing intervals over the 150 day study resulted in 
18 separate contrast sensitivity tests for each subject: nine 
with spectacle correction and nine with contact lens 
correction. These measurements were in addition to the 
baseline measurement administered prior to contact lens 
fitting. 
Statistical analyses of the data for subjects wearing the 
three contact lens types are represented in Tables IV,V, and 
VI. These analyses were run for each of the six spatial 
frequencies and resulted in the three F-ratios mentioned in 
the Treatment of Data section. Two graphical representations 
using the mean contrast sensitivity values in Tables VII 
through XII help illustrate any changes found in the data. 
Figures 6, 7, and 8 are contrast sensitivity functions in 
which mean contrast sensitivity was plotted as a function of 
spatial frequency. The baseline (prefit) CSF for subjects 
fitted with each of the three types of lenses is compared to 
the CSF during contact lens wear at day 0 and day 150. The 
CSF at day 150 during spectacle correction is also 
represented. 
To demonstrate changes in contrast sensitivity as a 
function of time it was necessary to plot the six spatial 
frequencies separately. A graphical representation of each 
spatial frequency ( 0 . 7' 1. 2' 4 . 0, 6 . 0' 11.4, 16.0 
cycles/degree) over time can be seen in Figures 9 through 14. 
They compare the mean contrast sensitivites of subjects 
wearing CSI-T, Hydrocurve II, and Permaflex lenses for the 
nine testing intervals. The mean contrast sensitivities for 
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the control group are also represented for comparison. 
The results of the statistical analysis for the subjects 
wearing CSI-T lenses (Table IV) were as follows: 
1. Significant decreases in contrast sensitivity, through 
time, were found at 1.2, 4.0, 6.0, and 11.4 cycles/degree. 
2. A significant decrease in contrast sensitivity, while 
wearing CSI-T lenses (compared to spectacle lenses), occurred 
at 4.0 cycles/degree. At this spatial frequency, therefore, a 
decrease in contrast sensitivity can be attributed to the 
contact lens. For the remaining spatial frequencies that 
showed a decrease in contrast sensitivity with time (1.2, 6.0, 
and 11.4 cycles/degree) the cause is attributed to the cornea. 
3. Of the 4 spatial frequencies that showed a decrease in 
contrast sensitivity through time, only 1. 2 cycles/degree 
showed a significant combined effect of the contact lens and 
the cornea. 
The results of the statistical analysis for the subjects 
wearing Hydrocurve II lenses {Table V) were as follows: 
1. A significant decrease in contrast sensitivity occurred 
at all frequencies tested, through time, during contact lens 
wear . 
(2) There was no significant difference in contrast 
sensitivity between contact lens wear and spectacle lens wear 
(after contact lens removal) . The significant decreases ln 
contrast sensitivity found above are, therefore, attributable 
to the cornea. 
(3) There was a combined effect of the contact lens and the 
cornea at 1 .2 and 4.0 cycles/degree. 
The results of the statistical analysis for the subjects 
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wearing Permaflex lenses (Table VI} were as follows: 
(1) A significant decrease in contrast sensitivity occurred 
at all frequencies tested accept 0.7 cycles/degree, through 
time, during contact lens wear. 
(2) There was no significant difference in contrast 
sensitivity between contact lens wear and spectacle lens wear. 
The significant decreases in contrast sensitivity found at all 
6 spatial frequencies were, therefore, attributable to the 
cornea. 
(3} There was no combined effect of the contact lens and 
the cornea at any of the spatial frequencies tested. 
The statistical analysis was performed on the data 
collected from 21 of the original 39 subjects. Lenses that 
had to be replaced because of loss or damage and data 
collected from subjects who did not complete the study were 
not included. Of the 26 subjects able to complete the full 
150 days, 15 required a single lens replacement and 4 required 
replacement of both lenses. Only 33 of the original 78 lenses 
were worn throughout the study without replacement and, 
therefore, comprised the final analysis . Of these lenses, 18 
were Hydrocurve II, 8 were CSI-T, and 7 were Permaflex. 
33% of the initial subject population did not complete the 
150 day study. There were 2 subjects who failed to return for 
their scheduled appointments. One of these subjects did not 
return after his initial examination and contact lens fitting 
and the other dropped out after 60 days because of family 
problems. Another subject joined the u . s. Army and had to 
leave the area and one subject was discontinued because of 
excessive lens use, losing or damaging six lenses during the 
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first four months of the study. 
Two subjects had to be discontinued because of pregnancy, 
a criteria established at the beginning of the study. 
Discomfort was experienced by 2 additional subjects during the 
first 14 days of extended wear. Folds in Descemet's membrane 
were revealed during the biomicroscopic examination. Both of 
these subjects also experienced conjunctival injection and 
excessive tearing. They were successfully fit with daily wear 
soft lenses and released from the study. 
Lastly, 6 subjects developed a viral-like syndrome during 
the first three months of contact lens extended wear and were 
unable to complete the study. All 6 subjects experienced a 
watery discharge and discomfort with contact lens wear 
associated with follicular conjunctivitis and subepithelial 
corneal infiltrates . Four of the subjects presented with 
palpable preauricular lymph nodes on the affected side. The 
condition was bilateral in 2 of the subjects but affected the 
second eye only after contact lens wear had been discontinued. 
The eventual diagnosis was epidemic keratoconjunctivitis and 
in all cases the problem resolved following one month of 
contact lens removal. Of the 6 subj e cts that developed this 
problem, 5 were wearing the high water content lens(Permaflex) 
and 1 was wearing the low water content lens(CSI-T). Table 
III is a summary of the subjects who did not complete the 
study. 
Subject compliance to the complete con t act lens care 
regimen (Appendix D) was excellent. A questionnaire answered 
by all subjects at t h e end of the study indicated no 
difficulties were experienced by any of the subjects in 
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following the instructions for the wearing and caring of their 
lenses. 
Biomicroscopic examination revealed no neovascularization in 
any of the subjects through the course of the investigation. 
These examinations did, however, show increased limbal 
vascular engorgement in many cases, unaccompanied by 
subjective symptoms. 
SUBJECTS WHO DID NOT COMPLETE STUDY 
REASON SUBJECTS 
1. Left the area 1 
2. Excess lens replacement 1 
3. No Show 2 
4. Pregnancy 2 
5. Discomfort 2 
6. Viral-like syndrome 6* 







*one of the pregnant subjects is included in this count 
**adjusted for subject duplication 














Spatial Frequency (cycles/degree) 
·•- Baseline-Day 0 (Spec) 
·0- CSF Day 0 (CL) 
·•- CSF Day 150 (Spec) 
·C- CSF Day 150 (CL} 
Figure 6. Graph of contrast sensitivity function(CSF) for subjects 
wearing CSI-T lenses. Mean contrast sensitivity is 
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0.7C/D 1.2C/D 4.0C/D 6.0C/D 11.4C/D 16.0C/D 
Spatial Frequency (cycles/degree) 
Figure 7. Graph of contrast sensitivity function(CSF) for subjects 
wearing Hydrocurve II-55 lenses. Mean contrast sensitivity 



















0.7C/D 1.2 C/D 4.0 C/D 6.0 C/D 11.4 C/D 16.0 C/D 
Spatial Frequency 
·•- Baseline Day 0 (Spec) 
·0- CSF Day 0 (CL) 
·•- CSF Day 150 (Spec) 
·C- CSF Day 150 (CL) 
Figure 8. Graph of contrast sensitivity function(CSF) for subjects 
wearing Permaflex lenses. Mean contrast sensitivity is 
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Figure 9. Graph of contrast sensitivity plotted as a function of 
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·O- Hydrocurve 11 
·•- CS1-T 
·C- Permaflex 
Figure 10. Graph of contrast sensitivity plotted as a function of 
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·O- Hydrocurve II 
·• - CSI-T 
·O- Permaflex 
Figure 11 . Graph of contrast sensitivity plotted as a function of 
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Figure 12. Graph of contrast sensitivity plotted as a function of 
time for 6.0 cycles/degree. 
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Figure 13. Graph of contrast sensitivity plotted as a function of 
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Figure 14. Graph of contrast sensitivity plotted as a function of 
time for 16.0 cycles/degree. 
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Table IV: Significance study: Two Way Analysis of Variance for Repeated 
Measures {Appendix E). Data taken with CSI·T extended wear soft 
lenses (residual refractive error corrected}. N = 8 eyes. 
SPATIAL FREQUENCY LENS TIME INTERACTION 
(Cycles/Degree) (Spec vs CL) (Lens vs Time) 
F (1 ,7) = 0.005 F (9,63} = 0.963 F (9,63) =1.131 
0.7 C/D P>.05 p>.05 I p>.05 
F (1 ,7) = 0.106 F (9,63} = 5.191 F (9,63} = 2.252 
1.2 C/D p>.05 P<.01 P<.05 
F (1 ,7) = 8.851 F (9,63) ... 2.831 F (9,63) -= 0.744 
4.0 C/D P<.05 P<.01 p>.05 
F (1 ,7} = 1.856 F (9,63) = 2.295 F (9,63) = 1.133 
6.0 C/D p>.05 P<.OS P>.05 
F (1,7) = 1.772 F (9,63} = 3.517 F (9,63) = 0.909 
11.4 C/D p>.05 P<.01 p>.05 
F (1 ,7) = 4.087 F (9,63} = 1.215 F (9,63) = 0.813 
16.0 C/D P>.05 p>.05 P>.05 
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Table V: Significance study: Two Way Analysis of Variance for Repeated 
Measures (Appendix E). Data taken with HC II extended wear 
soft lenses (residual refractive error corrected). N = 18 eyes. 
SPATIAL FREQUENCY LENS TIME INTERACTION 
(Cycles/Degree) (Spec vs CL) (Lens vs Time) 
F (1 ,17) = 4.403 F (9, 153) = 2.394 F (9,153) = 0.705 
0.7 C/0 p>.05 J><.05 p>.05 
F (1 ,17) = 2.174 F (9, 153) == 8.727 F (9,153) = 2.217 
1.2 C/0 p>.05 J)<.01 J)<.05 
F (1, 17) = 1.611 F (9,153) == 11.993 F (9, 153) = 2.408 
4.0 C/0 p>.05 P<.01 P<.05 
. 
F (1 ,17) = 0.005 F (9,153) = 7.350 F (9,153) = 0.722 
6.0 C/D p>.05 J)<.01 P>.05 
F (1 ,17) = 0.094 F (9, 153) = 5.979 F (9, 153) = 3.251 
11.4 C/D p>.05 J)<.01 J)<.01 
F (1 ,17) == 0.049 F (9, 153} = 3.904 F (9, 153} = 2.393 
16.0 C/D p>.05 p<.01 J)<.05 
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Table VI: Significance study: Two Way Analysis of Variance for Repeated 
Measures (Appendix E). Data taken with Permaflex extended wear 
soft lenses (residual refractive error corrected). N = 7 eyes. 
SPATIAL FREQUENCV LENS TIME INTERACTION 
(Cycles/Degree} (Spec vs CL) (Lens vs Time) 
F (1 ,6) = 2.609 F (9,54) = 0.682 F (9,54) =0.905 
0.7 C/0 p>.05 p>.05 P>.05 
F (1 ,6) = 1.992 F (9,54) = 4.466 F (9,54) = 1.338 
1.2 C/0 p>.05 P<-05 P>.05 
F (1,6) = 0.111 F (9,54} = 2.492 F (9,54) .. 0.466 
4.0 C/0 p>.05 P<.05 p>.05 
F (1 ,6) = 0.005 F (9,54) = 2.197 F (9,54) = 0.926 
6.0 C/0 P>.05 P<.05 P>.05 
F (1 ,6) = 1 .607 F (9,54) = 2.71 F (9,54) = 1.505 
11.4 C/O P>.05 P<.05 p>.05 
F (1 ,6) = 3.476 F (9,54) = 2.669 F (9,54) == 0.969 




Table VII: Mean contrast sensitivity (±1 standard deviation) with CSI-T extended wear soft lenses (residual 
refractive error corrected). N = 8 eyes (lenses that completed the 150 day study without replacement). 
CONTRAST SENSITIVITY 
SPATIAL FREQUENCY SPECTACLES EXTENDED WEAR SOFT CONTACT LENSES 
(CYCLES/DEGREE) BASEUNE DISPENSING DAY 7 DAY 14 DAY 21 DAY 28 
0.7 C/0 23.8 ± 4.8 22.3 ± 6.3 23.3 ± 5.9 20.2 ± 7.1 20.5 ± 8.8 18.9 ± 8.6 
1.2 C/D 39.3 ± 11.3 32.6 ± 10.9 35.2 ± 15.5 30.9 ± 10.0 27.6 ± 10.6 27.4 ± 11.4 
4.0 C/0 85.7 ± 20.8 74.3 ± 15.1 67.3 ± 24.7 57.2 ± 26.4 53.1 ± 12.0 56.5 ± 14.6 
6.0 C/D 59.8 ± 18.1 59.4 ± 17.9 48.8 ± 16.3 46.2 ± 16.2 39.7 ± 14.6 45.3 ± 13.0 
11.4 C/0 38.0 ± 7.7 33.1 ± 9.4 31.1 ± 15.2 25.7 ± 11 .0 23.0 ± 8.1 19.3 ± 7.0 
16.0 C/D 19.4 ± 5.8 16.1 ± 4.9 14.7 ± 6.4 14.2 ± 5.1 11.2 ± 5.5 11 .5 ± 5.6 
(CYCLES/DEGREE) BASEUNE DAY 60 DAY 90 DAY120 DAY150 
0.7 C/0 23.8 ± 4.8 23.0 ± 9.6 23.5 ± 9.5 27.2 ± 9.9 24.1 ± 10.8 
1.2 C/D 39.3 ± 11.3 31.0±8.2 34.5 ± 10.3 40.1 ± 8.4 31.5 ± 9.1 
4.0 C!D 85.7 ± 20.8 60.7 ± 19.3 64.9 ± 21.5 72.8 ± 14.4 61.6 ± 14.7 
6.0 CID 59.8 ± 18.1 45.4 ± 9.8 51.1 ± 10.0 56.5 ± 14.0 55.8 ± 15.0 
11.4 C/D 38.0 ± 7.7 24.7 ± 8.6 24.6 ± 8.6 27.1 ± 7.7 27.5 ± 12.9 
16.0 C/0 19.4 ± 5.8 14.2 ± 3.1 15.3 ± 7.7 15A_± 4.9 14.6 ± 9.2 
01 
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Table VIII: Mean contrast sensitivity (±1 standard deviation) with HC II extended wear soft lenses (residual 
refractive error corrected). N = 18 eyes ( lenses that completed the 150 day study without replacement). 
CONTRAST SENSITIVITY 
SPATIAL FREQUENCY SPECTACLES EXTENDED WEAR SOFT CONTACT LENSES 
(CYCLES/DEGREE) BASEUNE DISPENSING DAY 7 DAY 14 DAY 21 DAY 28 
-----0.7 C/0 22.8 ±6.4 21.6 ± 7.8 20.9 ± 7.4 21.3 ± 9.0 19.9 ± 9.8 18.1 ± 6.5 
1.2 C/0 39.3 ± 9.1 34.0 ± 7.7 32.5 ± 10.0 28.6 ± 9.8 28.1 ± 12.5 25.8 ± 8.6 
4.0 C/0 90.7 ± 20.8 75.3 ± 19.2 70.9 ± 22.6 61.3 ± 22.6 61.5 ± 23.7 59.2 ± 22.7 
6.0 C/0 60.2 ± 19.0 57.9 ± 14.0 48.7 ± 12.4 46.0 ± 14.8 50.3 ± 14.2 43.5 ± 13.8 
. 
11.4 C/O 34.8 ± 12.7 28.9 ± 12.0 33.9 ± 19.1 23.2 ± 10.0 26.1 ± 12.7 23.3 ± 7.2 
16.0 C/O 18.1 ± 7.2 16.2 ± 6.1 17.9 ± 7.1 14.1 ± 5.5 13.1 ± 5.3 13.3 ± 5.0 
(CYCLES/DEGREE) BASEUNE DAY 60 DAY 90 DAY120 DAY150 
----- ------0.7 C/0 22.8 ±6.4 20.4 ± 7.3 21.9 ± 7.9 22.6 ± 10.0 21.3 ± 6.7 
1.2 C/0 39.3 ± 9.1 30.1 ± 8.5 30.3 ± 8.0 32.4 ± 9.7 30.6 ± 7.8 
4.0 C/0 90.7 ± 20.8 64.5 ± 20.4 64.1 ± 18.1 65.3 ± 14.6 62.6 ± 13.1 
6.0 C/0 60.2 ± 19.0 46.4 ± 14.2 48.5 ± 12.2 47.9 ± 10.5 49.1 ± 12.5 
11.4 C/0 34.8 ± 12.7 24.8 ±9.6 27.5 ± 8.6 26.2 ± 7.2 22.5 ± 8.2 
16.0 C/0 18.1 ± 7.2 14.3 ± 6.0 14.8 ± 6.3 12.5 ± 4.6 11.7 ± 4.2 
(11 
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Table IX: Mean contrast sensitivity (±1 standard deviation) with Permaflex extended wear soft lenses (residual 
refractive error corrected). N = 7 eyes ( lenses that completed the 150 day study without replacement). 
CONTRAST SENSITIVITY 
SPATIAL FREQUENCY SPECTACLES EXTENDED WEAR SOFT CONTACT LENSES 
(CYCLES/DEGREE) BASEUNE DISPENSING DAY 7 DAY 14 DAY 21 DAY 28 
- ---- - ---0.7 C/0 22.8 ±7.6 21.4 ± 5.6 20.4 ± 8.2 19.6±8.2 18.5 ± 9.4 19.3 ± 6.2 
1.2 C/0 40.7 ± 8.4 38.0 ± 8.5 35.1 ± 11.3 32.0 ± 13.0 24.4 ± 6.6 25.0 ± 7.0 
4.0 C/0 88.9 ± 17.4 86.2 ± 22.2 79.7 ± 17.3 64.9 ± 24.4 63.7 ± 23.1 62.6 ± 21.3 
6.0 C/0 64.8 ± 15.5 60.9 ± 10.3 55.5 ± 7.1 46.7 ± 13.1 51.7 ± 16.8 47.5 ± 12.8 
11.4 C/0 42.6±14.1 27.5 ± 10.1 28.4 ± 7.1 28.4 ± 16.4 28.0±11 .6 27.6 ± 12.7 
16.0 C/0 21.5 ± 8.0 15.6 ± 8.0 15.6 ± 7.5 12.7±5.4 14.9 ± 4.0 12.9±4.1 
(CYCLES/DEGREE) BASEUNE DAY 60 DAY 90 DAY120 OAY150 
-----
~ 
-----0.7 C/0 22.8 ±7.6 19.5 ± 9.6 20.5 ± 6.9 23.2 ± 8.6 22.2 ± 6.2 
1.2 C/0 40.7 ± 8.4 27.3 ± 7.5 31.4 ± 9.8 29.9 ± 7.9 30.2 ± 7.0 
4.0 C/0 88.9 ± 17.4 66.5 ± 23.1 69.0 ± 24.0 66.7±21.4 75.8 ± 18.2 
6.0 C/0 64.8 ± 15.5 55.7 ± 17.9 50.2 ± 10.3 57.1 ± 20.1 54.3;!: 8.6 
11.4 C/0 42.6 ± 14.1 28.8 ± 13.6 28.3 ± 9.3 26.8 ± 9.7 30.9±10.1 





Table X: Mean contrast sensitivity (±1 standard deviation) with spectacle correction after CSI-T removal. 
N = 8 eyes (lenses that completed the 150 day study without replacement). 
SPATIAL FREQUENCY SPECTACLES 
(CYCLES/DEGREE) BASELINE DAY 7 DAY 14 DAY 21 DAY 28 
----- ------ ------- ------ -------0.7 C/0 23.8 ± 4.8 21.0 ± 5.1 21.8 ± 9.4 20.0 ± 8.7 22.2 ± 4.4 
1.2 C/0 39.3 ± 11.3 32.7 ± 7.9 30.0 ± 8.2 29.0 ± 12.0 27.9 ± 7.3 
4.0 C/0 85.7 ± 20.8 68.0 ± 23.4 65.7 ± 22.5 70.0 ± 30.1 65.9 ± 21.9 
6.0 C/0 59.8±18.1 52.6 ± 17.3 45.8 ± 12.0 54.9 ± 23.1 51.4±17.4 
11.4 C/0 38.0 ± 7.7 28.8 ± 11.2 26.7 ± 8.8 27.9 ± 11.3 24.6 ± 8.4 
16.0 C/0 19.4 ± 5.8 16.6 ± 7.2 15.4 ± 7.8 17.8 ± 7.1 13.9 ± 8.0 
(CYCLES/DEGREE) . DAY 60 DAY 90 DAY120 DAY150 
------ -------0.7 C/0 22.4± 4.9 25.2 ± 8.6 22.7 ± 7.2 21.6 ± 7.6 
1.2 C/0 29.3 ± 7.4 37.0 ± 7.7 33.0 ± 8.0 35.2 ± 7.2 
4.0 C/0 67.1 ± 20.6 74.6 ± 19.7 73.9 ± 18.6 69.2 ± 14.4 
6.0 C/0 • 53.1 ± 8.0 54.4 ± 13.6 55.4 ± 13.7 54.0 ± 8.6 
11.4 C/0 29.8 ± 8.3 29.8 ± 12.4 27.5 ± 9.1 26.5 ± 9.7 
16.0 C/0 14.8 ± 2.8 17.2 ± 5.4 16.6 ± 6.0 17.5±7.9 
(11 
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Table XI: Mean contrast sensitivity (±1 standard deviation) with spectacle correction after HC II removal. 
N = 18 eyes (lenses that completed the 150 day study without replacement). 
SPATIAL FREQUENCY SPECTACLES 
(CYCLES/DEGREE) BASELINE DAY 7 DAY 14 DAY 21 DAY 28 
----- ------0.7 C/D 22.8 ± 6.4 20.8 ± 7.1 18.7 ± 8.0 19.2±10.1 17.0 ± 5.7 
1.2 C/D 39.3 ± 9.1 30.9 ± 9.5 29.2 ± 10.9 26.9 ± 10.4 26.8 ± 10.5 
4.0 C/D 90.7 ± 20.8 68.9 ± 23.7 62.7 ± 20.7 58.1 ± 18.2 58.2 ± 14.0 
6.0 C/D 60.2 ± 19.0 46.9 ± 11.3 46.5 ± 10.0 45.4 ± 15.3 42.5 ± 13.7 
11.4 C/D 34.8 ± 12.7 26.2 ± 11.1 26.1 ± 8.1 22.5 ± 6.8 21.9 ± 7.2 
16.0 C/D 18.1 ± 7.2 13.6 ± 5.2 15.1 ± 5.2 12.7 ± 5.2 12.2±4.2 
(CYCLES/DEGREE) DAY 60 DAY 90 DAY120 DAY150 
----- ------ ------
0.7 C/D 18.5 ± 7.0 21.6 ± 9.4 21.1 ±8.2 20.9 ± 7.0 
1.2 C/D 28.3 ± 9.4 31.6 ± 11.4 31.7 ± 8.6 34.6 ± 9.5 
4.0 C/D 58.7 ± 19.0 70.2 ± 26.0 69.3 ± 20.5 71.2 ± 22.1 
6.0 C/D 43.8 ± 13.3 48.8 ± 18.1 51.4 ± 20.0 52.8 ± 20.6 
11.4 C/D 26.5 ± 11.2 27.5 ± 10.6 27.2 ± 12.0 28.5 ± 13.1 
16.0 C/D 13.5 ± 6.2 15.6 ± 8.6 13.5 ± 5.5 15.1 ± 5.5 




Table XII: Mean contrast sensitivity {±1 standard deviation) with spectacle correction after Permaflex removal. 
N = 7 eyes (lenses that completed the 150 day study without replacement). 
SPATIAL FREQUENCY SPECTACLES 
(CYCLES/DEGREE) BASELINE DAY 7 DAY 14 DAY 21 DAY 28 
-----0.7 C/D 22.8 ± 7.6 21.3 ± 10.7 18.6 ± 7.0 . 19.0 ± 10.1 20.3 ± 9.3 
1.2 C/D 40.7 ± 8.4 35.3 ± 13.2 30.0 ± 12.5 27.1 ±9.0 29.0 ± 10.4 
4.0 C/D 88.9 ± 17.4 71.3 ± 25.3 73.2 ± 31.9 62.0 ± 21.5 68.5 ± 29.9 
6.0 C/D 64.8 ± 15.5 53.3 ± 16.7 58.5 ± 23.1 51.2 ± 20.6 45.0±11.7 
11.4 C/D 42.6 ± 14.1 32.3 ± 13.5 31.5 ± 13.9 31.0 ± 6.2 31.6 ±10.4 
16.0 C/D 21.5 ± 8.0 16.2 ± 5.3 17.1± 6.5 16.9 ± 4.5 15.1 ± 6.0 
(CYCLES/DEGREE) DAY 60 DAY 90 DAY120 DAY150 
------- -------- -----0.7 C!D 18.3 ± 6.5 20.5 ± 7.8 18.5 ± 4.1 19.5 ± 5.6 
1.2 C/D 34.3 ± 12.8 28.6 ± 10.2 31.7 ± 10.6 34.0 ± 13.4 
. 4.0 C/D 76.1 ± 28.5 65.9 ± 32.1 66.8 ± 14.7 79.0 ± 38.9 
6.0 CID 56.9 ±24.6 49.3 ± 21.0 49.1 ± 11.2 54.6 ± 20.5 
11.4 C/D 34.8 ± 13.0 27.6 ± 11.0 28.6 ± 8.6 28.8 ± 9.2 
16.0 C/D 19.2 ± 7.3 14.9± 9.3 14.8 ± 4.3 16.3 ± 5.7 
CONCLUSIONS AND DISCUSSION 
This study utilized contrast sensitivity measurements to 
investigate the effects of extended wear soft contact lenses 
on visual performance. Would a group of such contact lens 
patients show a significant decrease in contrast sensitivity 
with time? If so, was such a decrease due to the cornea, the 
contact lens, or a combined effect of the cornea and contact 
lens? 
The answers to these questions are based on the results of 
the statistical analyses of the data. Contrast sensitivity 
was significantly decreased during soft contact lens extended 
wear at 1.2, 4.0, 6.0, and 11.4 cycles/degree. All three 
lens types used in this study showed lowered contrast 
sensitivities at these spatial frequencies. In addition, two 
lens types (Hydrocurve and Permaflex) showed a significant 
decrease at 16 cycles/degree and one lens type (Hydrocurve) 
showed a decrease at 0.7 cyc les/degree. Although a combined 
effect of the cornea and the contact lens was present in some 
cases, the chief cause of this decrease was the cornea. 
All three lenses showed very similar changes in contrast 
sensitivity with time for the six spatial frequencies tested, 
indicating that contrast sensitivity is not dependent on the 
lens type. This is graphically demonstrated in Figures 9 
through 14. Patient complaints of visual performance, 
therefore, may be independent of the lens type. 
In contrast to some reports, there was no significantly 
greater decrease in contrast sensitivity at the higher spatial 
frequencies ( 16 cycles/ degree) than for the middle or low 
spatial frequencies. This is attributed to the fact that 
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great care was taken to correct all residual refractive errors 
during contact lens testing. 
Decreases in contrast sensitivity were accompanied by 
subjective comments that a decrease in visual performance had 
occurred. Such comments included seeing road signs, watching 
television, and reading the Snellen chart. This decrease, 
however, was not apparent in recorded Snellen acuity or 
stereopsis testing. Contrast sensitivity measurements, 
therefore, may provide additional information about visual 
performance in soft contact lens extended wear patients not 
revealed with traditional measurements. 
The consistency and reliability of the instruments and 
procedures used in this study were verified by the control 
group contrast sensitivity results. 
responses during the 150 day study 
through 14. These subjects did 
The consistency of their 
is illustrated in Figures 9 
show a small but gradual 
increase in contrast sensitivity at several spatial 
frequencies, indicating a possible learning effect with time. 
These increases, however, were not statistically sigificant . 
The length of investigation and the size of the subject 
population were two unique aspects of this study. Previous 
studies of Woo and Hess, 10 Applegate and Massorf, 12 Bernstein 
and Broderick, 22 and Tomlinson and Mann 3 used subject 
populations ranging from 3 to 12 s ubjects and testing periods 
ranging from 18 hours to 2 weeks. The much longer 
investigational period and larger subject population used in 
this study were an effort to address past criticism concerning 
short testing periods and small subject groups . 
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The use of extended wear soft contact lenses is also unique 
to this type of research. The rapidly growing interest and 
use of extended wear lenses prompted their use in this study. 
Considering the sustained wearing periods of these lenses, the 
factors that affect soft lens contrast sensitivity may be 
magnified. One such factor is deposit fo rmation. Mitra and 
Lamberts 11 reported a decrease in contrast sensitivity 
following 2 weeks of soft contact lens wear and attributed 
this decrease to deposit formation. In addition, the three 
different lens types used have different struct ural and 
physical properties which may be subject to change with time . 
These aspects could explain why decreases in contrast 
sensitivity occurring during this reseach were not found in 
past studies. 3' 4, l3, 22 
The subject population used in the investigation should not 
be considered a typical random sample of the general 
population. Prior to selection, each potential subject was 
given a thorough examination to determine their suitability 
for soft lens extended wear. Over 100 subjects were in itially 
examined of which only 39 were selected for the study. 
A total of 26 of the initial 39 subjects were able to 
complete this 150 day investigation with their extended wear 
lenses. Only 9 of these 26 subjects, however, were allowed to 
r e main on an extended wear schedule after the study was 
concluded. This was based on observations of increased limba l 
vascular engorgement, conjunctival injection, and superficial 
corneal epithelial punctate staining. These clinical signs 
were often accompanied by subjective complaints of mild lens 
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discomfort. Eye health as well as microscopic and macroscopic 
changes to the cornea and its surrounds are important 
considerat i ons when determining the success of soft contact 
lens extended wear. Although sophisticated methods of 
measuring the effects of these lenses may not show 
statistically significant change, a practitioner's clinical 
evaluation should give him or her cause for concern. 
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TESTING PROGRAM 
Instructions for performing contrast sensitivity test: 
TYPE RTN (RETURN) after responding to each command. 
1. Turn on computer and monitor (allow for 15 minute warmup). 
2 . (PROMPTER) <: TYPE N (for Non-Standard Calibration routine) . 
3. MESSAGE ?: Patient name 
OD or OS; Status (contact lenses or spectacles) 
Date; Examiner's name 
4 . STANDARD TEST ? Y/N: N 
5 . TEST OR CALIBRATE ?: C 
6. CAL.METHOD ? (SNP): N (NON-STANDARD) 
7. SLOPE= -0.792 
8. INTERCEPT= 187 
9. <RETURN> TO SCAN: Place the hand control/electric eye 
on platform in front of monitor. 
PRESS RTN 
10 . EXIT: Y 
11. TEST OR 
12 . STANDARD 
CALIBRATE 
SETUP ? : 
Adjust monitor controls until 
calibration is indicated three 
consecutive times. 
? : T 
y 
13. STANDARD METHOD ? : N 
14. METHOD (BVAI) ?: I (INCREASING) 
15. # REPEATS ? : 3 
16. PREVIEW (Y/N) ? : y 
17. PREVIEW TIME <5> ? : RTN (DEFAULT) 
18. PREVIEW CONTRAST ?: . 2 
19. FULL SCALE TIME ?: RTN 
20. PRINT ALL DATA ?: RTN 
21. STANDARD STIMULI ?: N 
22 . # STIMULI ?: 6 
23 . S. TYPE ? <SMCFI>: S (STATIONARY) 
24 . GRATING/BAR/USER ?: G 
25 . SPECIFY CONTRAST?: Y 
SPAT. FREO. CONTRAST 
1- 6.0 .002 
2- 1.2 .002 
3- 4.0 .002 
4- 11.4 .002 
5- 0.7 .002 
6- 16.0 .002 
26. <RTN> TO START: Instruct patient to indicate when they 
first identify a grating pattern on the 
monitor by pressing button on hand 
control. 
2 beeps before PREVIEW pattern 
1 beep before TRIAL pattern 
PRESS RTN 
27. PROBE <N/Y>: Y (YES) if any STD. DEV. (STANDARD DEVIATION) 
is greater than .100 
28. REPEAT TEST <Y/N> ?: Y for other eye 
29. MESSAGE: Indicate as above 
30. <RTN> TO START: RTN 
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I. Photometric measurement of Nicolet Optronics CS-2000 
monitor display. 
A. A Tektronix J-16 Photometer with J6523-2 10 narrow angle 
luminance probe was used to verify the established luminance 
settings at the start and the end of this study. Five 
measurements of the screen, two measurements of the screen 
surround, and two measurements of the ambient luminance 
were taken to make this verification. They are shown below. 
The luminance measurements in parenthesis were taken at the 
end of the study. 
B. Start of the study: August 19, 1985 
The mean luminances of the screen and the screen surround 
were 77.4 and 25.5 candela/meter2 respectively. The average 
ambient luminance was 0.1 candela/meter2 . 
The end of the study: March 6, 1986 
The mean luminances of the screen and the screen surround 
were 77.6 and 26 candela/meter2 respectively. The average 
ambient luminance was unchanged. 
Units of Measurement= nits (candela/meter2 ) 





CONTACT LENS FITTING FORM 
NAME----------- I. D. NUMBER'-----------





PUPIL SIZE __ _ 
OS 
CORNEAL DIAMETER __ _ 
PALPEBRAL FISSURE __ _ TEAR BUT __ _ 
DIAGNOSTIC FITTING 
TRIAL 1 LENS- OD __________ TRIAL 2 LENS- OD ______ _ 
OS OS ______ _ 
COVERAGE 
TRIAL 1 OD 
OS 
TRIAL 2 OD 
OS 
CENTER MOVEMENT OVER K OVER RET OVER REF 
SLIT LAMP---------------------
FINAL CONTACT LENS PRESCRIPTION 
OD 
OS 
BASE CURVE DIAMETER POWER MANUFACTURE 
SAM FORM 1, REVISED 3 JUN 85 
CQ\JTACT LENS FOL.LONUP FORM 
PATIENT NAME'------------ I.D. NUMBER ___ _ 
DATE VISIT 0- DISP. DAYS 
DISCUSSION _________________ _ 
_ CLASON VA - Spec. - OD =::20"---1 __ OS ~20~1 __ ou =-::20=-/ __ _ 
C.L.- OD ~20"-/ ___ OS 20/ OU ~20"-/ __ _ 
OVER REFRACTION -OD ------ os _____ _ 
CSF- SEE ATTACHED 
_ AUTO REFRACTION (WITH LENS) - SEE ATTACHED NUMBER __ 
_ AUTO "K" (WITH LENS) -SEE ATTACHED NUMBER;..____ 
_ SLIT LAMP - Injection_ Nee-Vascularization_ Iritis_ Edema_ Staining_ 
OD - DK!L L OK HUM TEMP 
BOTILE 
OS - DK/L L OK HUM TEMP 
00 - DK/L L OK HUM TEMP 
EYE 
OS - DK!L L OK HUM TEMP 
ENDO PHOTO- PER SQ MM -FIXATION OD ' OS 
PACHOMETRY 
_ AUTO REFRACTION (WITHOUT LENS) -SEE A TI ACHED NUMBER __ 
_ AUTO "K" (WITHOUT LENS) - SEE ATTACHED NUMBER __ 
CORNEASCOPE- PHOTO A TI ACHED 
B&L "K" -OD @ 
------
___ @ __ _ 
OS @ __ _ ___ @ __ _ 
lOP- NCT- OD ___ _ OS ___ _ 
NOTES- CONSENT FORM SIGNED 
ANTERIOR SEG PHOTO OU 
DEPTH PERCEPTION TEST 
CL INSTRUCTION 
NEXT APPOINTMENT ________ _ 
SAM FORM 2, REVISED 8 AUG 85 
CQ\JTACT LENS FOLLOJVUP FORM 
PATIENT NAME. __________ I.D. NUMBER'-----
DATE _______ VISIT ______ DAYS 
DISCUSSION __________________ _ 
_ CLASON VA - C.L. - OD =.;20""'"'/ ___ 0S =20"""'/ ___ 0U =20;::;.:..1 __ _ 
Spec. - oo =-=20=::..!..,/ ___ os 201 ou =-=20=::..!.../ __ _ 
OVER REFRACTION- OD _______ OS ______ _ 
CSF- SEE ATTACHED 
_ AUTO REFRACTION (WITH LENS) - SEE ATTACHED NUMBER __ 
_ AUTO "K" (WITH LENS) -SEE ATTACHED NUMBER'----
_ SLIT LAMP - Injection_ Nee-Vascularization_ Iritis_ Edema_ Staining_ 
OD- DKIL __ 











___ PERSQMM -FIXATION OD __ • OS __ 
_ AUTO REFRACTION (WITHOUT LENS)- SEE ATTACHED NUMBER __ 
_ AUTO "K'' (WITHOUT LENS) - SEE A TI ACHED NUMBER __ 
CORNEASCOPE-PHOTOATTACHED 
B&L "K" - OD @ @ 
---------
OS @___ @ __ _ 
lOP- NCT- OD ___ _ OS ___ _ 
NOTES- ___________________ ___ 
NEXT APPOINTMENT ________ _ 
SAM FORM 2, REVISED 8 AUG 85 
PERRORMANCEDEPTHPERCEPTIONTEST 
KEYSTONE DIAGNOSTIC SERIES- A VIA TORS UNIT 
NAME. ___________ I.D. NUMBER. ____ _ 
BASELINE (PRE-CONTACT LENS WEAR) 
SLIDE# _______ _ 
PERCENT STEREOPSIS __ _ 
SECONDS OF ARC ___ _ 
EXAMINER'--------
DATE ______________ _ 
FINAL (POST -CONTACT LENS WEAR) 
SLIDE# ______ _ 
PERCENT STEREOPSIS __ 
SECONDS OF ARC ___ _ 
EXAMINER _____ _ 
DATE ______________ _ 
COMMENTS ________________________________ ___ 
SAM FORM 3, REVISED 5 AUG 85 
lP AC~f~C lUJlNJijV[E~~ijlfY 
COLllEGlE OF ~OM~V 
2043 COLLEGE WAY 
FOREST GROVE, OR 97116 
EXTENDED WEAR CONTACT LENS RESEARCH 
CONTACT LENS INFORMATIQ\J 
PATIENT ____________________________ __ 
Original "K" 0.0 .. _________ Latest "K" 0.0 .. _______ _ 
Date ____ O.S .. ______ Date ____ O.S. ______ _ 
Spectacle Rx 0.0. _____ Latest Refraction O.D. ________ _ 
Date. ____ O.S. ______ Date. ____ O.S. _____ _ 
CURRENT SOFT LENS SPECIFICATIONS 
Date Prescri bedi ______ Ma nufacturer ______ __ 
Bese Power Diemeter VA 
O.D. 20/ 
O.S. 20/ 
PRESCRIPTION IS VALID FOR SIX MONTHS FROM DATE PRESCRIBED 
SAMFORM6 
EXTENDED WEAR CONTACT LENS 
PATIENT QUESTIONARIE 
1. Do you feel that you received adequate and professional care 
during the research period? YES __ NO __ COMMENT_ 
2. Are there any changes you would suggest in future research 
projects of this nature? YES __ NO __ COMMENT __ _ 
3. Do you plan to remain an extended wear contact lens 
wearer? YES __ NO __ COMMENT _______ _ 
4. Would you be interested in participating in another research 
project? YES __ NO __ COMMENT _______ _ 
5. Did you have any problems in following the instructions given 
during the research period? YES __ NO __ COMMENT __ 
6. Did you have a preference between your right and Jeft lenses 
during the study with ... 
a. Vision - Right __ Left __ No Difference. __ 
b. Comfort - Right Left __ No Difference. __ 
c. Ease of Hand1ing- Right __ Lett __ No Difference __ 
Comments. ________________ _ 
SAM FORM? 
~AC~f~C lUHNl~VlE~S~UV 
OOUJEGE Of ~~BlRTV 
2043 COLLEGE WAY 
FOREST GROVE, OR 97116 
EXTENDED WEAR CONTACT LENS RESEARCH 
CONTACT LENS INFORMATlQ\J 
PATIENT _____________ _ 
1. Recommend you continue to follow the contact lens care procedures 
that where prescribed at the beginning of this study. 
2. Recommend you have continuing follow-up examinations at 90 day 
(3 months) to 180 day (6 months) inteNals. 
3. Recommend you wear your contact lenses in the following manner: 
I have read and understand the above. I have received a new pair of contact 





CONTACT LENS REGIMEN AND INSTRUCTIONS 
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CARING FOR YOUR EXTENDEDWEARCQr\[ACT LENSES 
We want you to follow the steps listed below, always starting with the right 
lens first: 
1. Set up all of the items you will need to clean and disinfect your extended 
wear lenses (Piiagel, extenzyme cleaner, Septicon disinfection system, and 
Blairex deionizer). 
2. Wash your hands with a pure soap that does not contain additives. Rinse 
thoroughly. 
3. Remove your lenses and clean them with Pliagel (see directions supplied 
with the package). This removes inorganic material from the lens surface. 
4. Rinse your lenses off with non-thimerosal saline (Biairex system for making 
normal saline) to completely remove cleaner. 
5. Place the lenses in the Septicon lens baskets and soak in the extenzyme 
cleaner for 15-20 minutes using the Lensept cup #1. This removes organic 
material (protein complex from your tears etc.) from the lens. 
6. Replace the extenzyme cleaner with fresh saline and shake for 15 seconds. 
7. Replace saline with Lensept solution and soak lenses for 10 minutes. 
8. Fill Rinse cup #2 with saline solution. Remove the lens basket from cup #1 
and place into cup #2. The lenses must be left in cup #2 for 6 hours to 
neutralize the Lensept disinfection solution. 
9. After the 6 hour neutralizing cycle, remove the Septicon lens baskets from 
the Rinse cup #2. Replace the solution with fresh saline solution and allow 
the lenses to soak in it for another 3 minutes before placing the lenses back 
on the eyes. 
FOLLOW-UP CARE FOR EXTENDED WEAR CONTACT LENS PATIENTS 
Patients wearing contact lenses for extended periods of time require 
additional professional follow-up care to more closely monitor how their 
lenses are fitting. For this reason and for the purposes of this research 
project, the following schedule of follow-up evaluations will be followed: 
*After 24 hours of extended wear, 
*After 4 days of extended wear, 
*After 1 week of extended wear and then weekly for three weeks, 
*After each month of extended wear for the remainder of the 5 months of the 
study. 
Your eyes should always "FEEL GOOD, LOOK GOOD AND SEE GOOD." If your eyes 
bother you at anytime, or if you have any questions or concerns, we want to be 
the first to know. You can always reach one of our research staff 24 hours a 
day, 7 days a week. Office 357-6151 ext. 2453, Dr. Tim Allen 357-3953, Dr. 
David Marrs 357-4026, Dr. Gary Slater 357-8378. 
PACIFIC UNIVERSITY 
COLLEGE OF OPTOMETRY CLINICS 
Extended Wear Lens Care and Handling 
Proper care is necessary for successful wear, normal lens life, and good eye health. You will be provided with products 
to dean, disinfect and store your extended wear lenses. Use them as instructed. 
Your lens cleaner is 
Your lens disinfectant is 
Your soaking solution is 
Your rinsing solution is 
Eyedrops to use before sleep and upon waking 
Pliagel and EXTENZYME Soflens 
Septicon Lenseet solution 
Normal saline (Blairex Si:stem 
Normal saline 
Normal saline or Clerz 2 
erotein cleaner 
and salt tablets) 
NOTE: These products have been prescribed specifically for your lenses and eyes. Do not change or substitute brands 
unless you check with us first. Usc of improper solutions may result in lens damage or eye irritation. 
SPECIAL INSTRUCTIONS: ____________________________________________ _ 
Please note that although certain brands of lenses may be FDA ~pproved for 7, 14, or even 30 days of wear, the 
adaptability of your eyes is the key factor in determining wearing time. Trust us to recommend a schedule 
suited to your individual needs. And remember, like any medical device contact lenses must be monitored on a 
regular basis. Professional follow-up care is the most important element in successful long term lens wear. 
IN THE BEGINNING IT IS NORMAL IF: REMOVE AND DO NOT SLEEP IN YOUR LENSES IF: 
1) Your lenses itch or feel funny. 1) You develop unusual pain or redness. 
2) One lens is more noticeable than the other. 2) You develop unusually cloudy or foggy vision. 
3) Your vision seems fu1.zier than with glasses. 3) You experience a decrease in vision that does not clear up. 
4) One eye sees better than the other. 4) You suspect something is wrong. 
5) You have trouble handling your lenses. 
WEARING SCHEDULE 




c:> HMI Viclr.sbur&, MS 1984 EWIS 
Instructions for the Care a11d H.an~l~ng of Extended ~'ear Lenses 
1)WASH UP 
Hr·lore ha ndlin g your l~nses, ; wa$h 
h,mcb, rirN· \•veil, and dry with a lint 
lr<'e toweL finger nails should be short 
,1nd .qvtOHlh-·-lO--i!-void. damaging the . 




Rc rnm e len:;; .fwm. the .ca:.e. and r.inse it. 
vvt•ii. fp a\o id pm sible mix-ups. take 
thP ri~h! fen<. fir<.t each ·time: -
3 INSPECTION 
PL'• f• the;. lens· o n. your forefinger t~ 
insp·(·ct it for deanliness and .. determine 
it it'c, right side out. 
If tl ,.·. lem is in thv correct fhJs it ion, the 
,.,Jt:~.., wiii ;;pp<-~l r airno~t str aight up. 
\··, t 11 i~l\ ~··;i<·d, lt:t k·r!::. c::f~:e·) \\' iH flar r· 
, ,. 1 <-h• hth. ·1 hi·, ,, 0ite" difi icult to 
<Jd• :;mH· un1:l yilu h.:lve had a litt le 
.I· ~ \ .p,··r :.!;..ht·' {f~<Jf 1hc lid} tc~ 
I l 1d ·!~:.- b~ F u!! !t:l bounrn 









I .. ----I 
H,\1' ,., , , .. ·,•· ; \\ l~ 
-. with thf' f:'ye you are not putting the 
'lens on d) PlacE:' the len·s on the central 
corn('a, not to the side e) Do not blink 




One or two drop~ of lens lubricant are 
recci'rnmended li your lenses feel dry or 
it ' l:•)tJrr\ vision ,O<.."CUr<; whik• wearing. 
E.yedrop~ may afso bE' helpiul prior to 
retn0v2 l if yot:J'"IetJse<. •ft:>f•l d ry or sticky. 
\'\'a~h h,mds before remova l. Slide the 
edg\o oi your lens dov,·n onto the white 
par I d \·our eye (sdera). Then gently 
-s rmr>czc the kns brt\'~f'n vour thumb 
c>nd imt'fintcer to remove. . 
- ._ .. 
'G 
~ 
Yl1~n . cc•ntacb must be cleaned after 
v.cwin;..: Place the lens in your palm , 
put J r!rop or t\\0 of ciE'iming solution 
nn · it ar 1d rub in a ·stra i~ht bad, and 
tort h mo! ion. 
h-•(,~ -;-" _ .., , . )':' · "~ \'1 "' " i:_, r' "'~~ ov~rnig~:. 
:,'·ir \~!. c;-:_~c ~'--~ 11 \.".;~f, hof. tap ~~n€'r 
,,··i -, r( t;!; v:;'"t·~ frt·::.h ~-ni·_lli:,,-, 
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ANALYSIS OF VARIANCE 
An analysis of variance is used for testing the hypothesis that two 
or more independent samples were drawn from populations having the 
same mean. It makes four assumptions: 
(1) the samples are independent random samples 
(2) the samples are from normally distributed populations 
(3) the populations are equally variable 
(4) the samples have the same means 
When a hypothesis is rejected using an analysis of variance, it is 
assumed that it is the inequality of the means that has been 
violated. The analysis of variance is much more sensitive to 
violation of the assumption of equal means than to violation of the 
assumptions of normality or of homogeneous variances. 2 6 
sum of the squares within groups ~w 
degrees of freedom (N-k) 
mean square within (MSw) 
MSw reflects variation within each sample around its sample mean. 
sum of the squares between groups ~b 
degrees of freedom (k-1) 
mean square between (MSb) 
MSb reflects variation of the sample means from the general mean. 
with df=k-1, N-k 
The F-ratio thus calculated may be compared to the F-table (at the 
desired level of significance) to determine whether MSb is 
significantly larger than MSw. This procedure, known as the 
analysis of variance, provides a test of the hypothesis of equal 
means. 
CSI-T 
--> PROG&NWA StatPakl3tANOVA2R2 FJLE1CS vs TlMEICSl<B,CL,S>.7SP DATEa 
PAGE 1 
SlJ1 SQUARES DEG FREEDCtt MEAN SQUARE F-TEST RATIO 
----------- ----------- ----------- ------------
FACTOR A 2.007813 1 2.007813 5.372394E-02 
ERROR 261.6094 7 37.37277 
FACTOR B 369.5781 9 41.06424 . .9626528 
ERROR 2687.414 63 42.65737 
A X B 197.8594 9 21.98438 1.131137 
ERROR 1224.445 63 19.43564 
--> PROG:NWA StatPakl3rANOUA2R2 FILE:CS us TIME:CSI<B,CL,S>1.2SP DATE: 
PAGE 1 
Slt1 SQUARES DEG FREEDIJ1 MEAN SQUARE F-TEST RATIO 
----------- ----------- ----------- ------------
FACTOR A 2.53125 1 2.5312~ .1062395 
ERROR 166.7813 7 23.82589 
FACTOR B 2132.281 9 236.9201 5.191303 
ERROR 2875.188 63 45.6379 
A )( B 508.1563 9 56.46181 2.25284 
ERROR 1578.938 63 25.0625 
--> PROG:NWA StatPaki3:ANOVA2R2 FILE:CS vs TIME:CSI<8,CL,S>4.0SP DATE: , 
PAGE 1 
SIJ'1 SQUARES DEG FREEDOM MEAN SQUARE F-TEST RATI 0 _______ .., ___ 
----------- ----------- ------------
FACTOR A 2059.875 1 2059.875 8.851179 
ERROR 1629.063 7 232.7232 
FACTOR B 10151.88 9 1127.986 2.83163 
ERROR 25096.19 63 398.3522 
A )(' B 1024.75 9 113.8611 .7438238 





--> PROGaNWA StatPakl3aANOVA2R2 FILEaCS vs TIMEaCSI<B,CL,S>6.0SP DATEa 
PAGE 1 
SlJ1 SQUARES DEG FREED(J1 MEAN SQUARE F-TEST RATIO 
----------- ----------- ----------- ------------
FACTOR A 439.6563 1 439.6563 1.856278 
ERROR 1657.938 7 236.8482 
FACTOR B 3574.094 9 397.1215 . 2.294855 
ERROR 10902.06 63 173.0486 
A )( B 986.4375 9 109.6042 1.132883 
ERROR 6095.125 63 96.74802 
--> PROG:NWA StatPaki3:ANOVA2R2 FILE:CS vs TJME:CSI<B,CL,S>11.4SP DATE: 
PAGE 1 
SlJ1 SQUARES DEG FREED(J1 MEAN SQUARE F-TEST RATIO 
----------- ----------- ----------- ------------
FACTOR A 224.6016 1 224.6016 1.771708 
ERROR 887.3984 7 126.7712 
FACTOR B 3326.617 9 369.6241 3.517293 
ERROR 6620.523 63 105.0877 
A )( B 319.1875 9 35.46528 .9091262 
ERROR 2457.648 63 39.01029 
--> PROG:NWA StatPaki3:ANOVA2R2 FJLE:CS us TIME:CSI<B,CL,S)16SP DATE: 
PAGE 1 
Slt1 SQUARES DEG FREEDCt1 MEAN SQUARE F-TEST RAT I 0 
----------- ----------- ----------- ------------
FACTOR A .197.8125 1 197.8125 4.087167 
ERROR 338.7~91 7 48.39844 
FACTOR B 494 9 54.88889 1.214755 
ERROR 2846.664 63 45.18514 
A X B 123.0273 9 13.6697 .8130979 




--> PROGaNWA StatPaki31ANOVA2R2 FlLEaCS us llHEaPF<B,CL,S>.7SP DATE1 
PAGE l 
Sll1 SQUARES DEG FREEDct1 H~ SQUARE F-TEST RATIO 
----------- ----------- ----------- ------------
FACTOR A 11.28906 1 11.28906 2.608696 
ERROR 25.96484 6 4.327474 
FACTOR B 227.0039 9 25.22266. ' ·- .6822656 
ERROR 1996.324 54 36.96897 
A X B 114.2148 9 12.69054 .9045835 
ERROR 757.5742 54 14.02915 
--> PROG:NWA StatPakM3:ANOVA2R2 FJLE:CS us TIME:PR<B,CL,S>1.2SP DATE:08-29-l904 
PAGE 1 
Slt1 SQUARES DEG FREED(J1 MEAN SQUARE F-TEST RATJ 0 
----------- ----------- ----------- ------------
FACTOR A 106.0469 1 106.0469 1.991978 
ERROR 319.4219 6 53.23698 
FACTOR B 2964.359 9 329.3733 4.466271 
ERROR 3982.328 54 73.74682 
A X B 278.8594 9 30.98438 1.337639 
ERROR 1250.828 54 23.16348 
--> PROG:NWA StatPaki3:ANOVA2R2 FJLE:CS vs TIME:PF<B,CL,S>4.0SP DATE:08-29-l904 
PAGE 1 
SlJ'1 SQUARES DEG FREEDIJ-1 MEAN SQUARE F-TEST RATI 0 
----------- ----------- ----------- ------------
FACTOR A 97.5 1 97.5 .1110254 
ERROR 5269.063 6 878.1771 
FACTOR B 10276.44 9 1141.826 2.491962 
ERROR 24743 54 458.2037 
A X B 940.875 9 104.5417 .4658902 





--> PROGaNWA StatPakM3aANOVA2R2 FlLEaCS vs TlMErPF<B,CL,S>6.0SP DATEa 
PAGE I 
SlJ1 SQUARES DEG FREEDtl1 MEAN SQUARE F-TEST RATIO 
----------- ---------·-- ----------- ------------
FACTOR A 3.03125 I 3.03125 5.078401E-03 
ERROR 3581.344 6 596.8906 
FACTOR B 3979.719 9 442.191 2.196951 
ERROR 10868.84 54 201.2749 
A )( B 807.0625 9 89.67361 .9263216 
ERROR 5227.531 54 96.80614 
) 
--> PROG:NWA St~tP~kM3:ANOVA2R2 FILE:CS vs TIME:PF<B,CL,S>11.4SP DATE: 
PAGE 1 
SlJ1 SQUARES DEG FREEDOM MEAN SQUARE F-TEST RATI 0 
----------- -----------
----------- ------------
FACTOR A 404.7656 1 404.7656 1.607326 
ERROR 1510.953 6 251.8255 
FACTOR B 2494.266 9 277.1406 2.710146 
ERROR 5522.063 54 102.2604 
A X B 720.1875 9 80.02084 1.505135 
ERROR 2870.922 54 53.16522 
--> PROG:NWA StatPakM3:ANOVA2R2 FILE:CS vs TIME:PF<B,CL,S>16SP DATE~ 
PAGE 1 
SIJ1 SQUARES DEG FREEDOM MEAN SQUARE F-TEST RATIO 
----------- ----------- ----------- ------------
FACTOR A 198.7188 1 198.7188 3.47609 
ERROR 343.0039 6 57.16732 
FACTOR B 724.7891 9 80.53212 2.668952 
ERROR 1629.379 54 30.17368 
A X B 124.5625 9 13.84028 .9686807 
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CONTRAST SENSfnVITYWfTH CONTACT LENSES 
Status I a.. I Pt#~ ~ lm I Age~ 
I HCII lc/L Rx '--l-_4._50 __ ___.1 B.C.,8.80 I Dlal14.5 r Spec Rx l-4.75 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 62.1 34.4 83.2 31.9 17.9 12.9 
DAY 7 36.9 26.3 58.9 12.7 12.7 7.5 
DAY 14 34.7 27.1 59.3 12.4 16.5 10.3 
DAY 21 57.5 74.7 61.7 14.2 20.6 13.7 





















status I a_ I Pt#~ ~los I Age~ 










6.0 1.2 4.0 11.4 .7 16 
56.7 26.9 70.8 39.5 16.1 29.1 
53.3 22.0 67.1 29.1 19.1 18.2 
62.1 28.0 70.8 31.9 18.6 19.2 
63.6 105.5 96.2 20.9 25.9 14.6 











VA CtLI I 
VA C/LI I 
CON1RAST SENSilMTYWITH CONTACT LENSES 
Status ( Cl. I Ptl~ ~ lm I Age@O 
I PF l ctL Rxl ~-_1._25 __ ___.1 B.c.~ Dla(14.4 I spec Rx f-1.25 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 62.1 36.6 100.0 24.5 17.8 25.3 
DAY 7 61.7 43.0 85.1 24.0 14.9 21.2 
DAY 14 50.5 27.3 46.4 19.1 14.9 12.7 
DAY 21 59.3 20.9 50.9 19.5 10.0 12.3 
DAY 28 47.5 18.6 65.6 22.0 21.9 13.0 
DAY 60 77.0 30.0 87.1 33.6 16.7 16.0 
DAY 90 60.3 35.8 80.0 36.6 23.8 16.6 
DAY 120 94.0 37.2 108.0 33.1 22.9 15.1 
DAY 150 ~8.7 42.3 110.5 37.2 26.9 17.2 
VAC/L 15 
Y,A C/L 15 







Status ( a._ I Pt# ~ ~ ( CS I Age @0 
j HCII l c/L Rx '-1-_1._0_0 __ __,I B.C.~ Dlal14.5 I Spec Rx j-1.00 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 61.7 28.8 78.8 39.5 16.7 24.6 
DAY 7 47.5 14.9 66.6 30.2 11.7 14.8 
DAY 14 39.5 19.5 45.4 19.6 10.1 18.2 
DAY 21 51.3 23.6 95.5 24.5 15.4 11.7 
DAY 28 49.4 18.5 60.7 30.0 20.0 15.6 
DAY 60 41.4 30.4 78.2 36.3 22.4 19.3 
. 
DAY 90 49.4 31.6 83.2 27.5 24.2 27.8 
DAY 120 37.2 ,37.4 67.6 19.8 54.5 20.1 
DAY 150 51.7 39.5 63.1 25.3 33.9 14.7 
VA C/L l15 
VA C/L 15 
VAC/L 15 
VAC/L 13 
VA C/L 14 
VAC/L 14 
15 VA CIL 
VAC/L~ 
VAC/L~ 
CONTRAST SENSillVI1YWITH CONTACT LENSES 
Status I 0.. I Pt# §:] ~ I CD I Age~ 
I HCII lc/L Rx '--l-2_._oo __ ~l B.C.~ Dlal14.5 1  Spec Rx l-2.00-050x075 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 58.9 46.8 75.3 58.0 54.5 35.0 
DAY 7 62.6 55.0 68.1 86.4 33.6 22.9 
DAY 14 53.3 32.4 69.7 31.1 47.1 23.6 
DAY 21 43.7 34.9 41.4 33.4 30.2 16.5 
DAY 28 30.9 22.0 35.5 23.1 22.2 19.3 
DAY 60 38.0 36.6 39.5 29.5 25.3 17.8 
DAY 90 36.0 36.6 50.9 26.5 20.7 14.0 
DAY 120 46.8 42.0 62.6 38.6 42.3 23.1 
DAY 150 52.5 33.9 64.1 21.7 25.5 24.4 
VA C/L 
VA C/L 















Status I a.. I Pt#§J ~ Ia> I Age~ 
I PF lc/L Rx 1'---2_._25 __ ~1 B.c.@IJ Dtal14.4 J Spec Rx l-2.25-0.25x1 05 l 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 99.2 51.3 95.5 60.3 75.9 38.3 
DAY 7 61.7 45.7 63.6 42.7 27.1 33.1 
DAY 14 42.3 27.8 50.9 43.3 31.9 23.8 
DAY 21 41.4 26.9 47.1 28.8 18.8 13.5 
DAY 28 42.0 32.4 55.0 31.9 16.6 17.2 
DAY 60 38.6 29.7 47.5 28.6 23.8 20.0 
DAY 90 53.3 26.9 52.9 27.3 25.1 18.5 
DAY 120 77.0 46.1 103.9 43.0 35.8 29.3 
DAY 150 40.4 33.4 54.1 42.0 27.1 22.2 
VACIL 20 
VA C/L 17 
VAC/L 17 
VAC/l 17 
' VA C/L 17 
VAC/L I 17 
I 18 VA C/L 
VACtLQD 
VA C/Lr.:ICJ 
CONTRAST SENSmvllYWJTH CONTACT LENSES 
Status I a.. J Pt#~ ~ (m l Age~, 
I HCII I elL Rx IL--_1._00 __ _____.1 B.C.~ Dia l' 14.5 I Spec Rx l-1.00-0.25x01 0 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 44.3 31.6 52.9 16.7 20.6 9.8 
DAY 7 34.1 29.7 53.7 25.7 21.1 16.5 
DAY 14 38.0 36.6 65.6 28.4 25.5 24.5 
DAY 21 47.9 39.2 86.4 34.4 38.6 17.2 
DAY 28 49.7 31.9 70.8 23.1 27.5 13.9 
DAY 60 46.4 42.7 49.0 22.7 25.3 8.1 
DAY 90 53.7 29.7 67.1 33.1 28.4 19.1 







VA C/L 20 
VAC/L 17 
18 VA C/L 
VAC/L~ 
VACILCJ 
status Ia.. I Pt#~ ~ lcs I Age~ 
I PF lctL Rx l _-_1._oo __ __.l e.c.0 Dla j 14.4 1. Spec Rx l-1.25 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 55.8 31.1 67.6 25.7 18.9 10.8 
DAY 7 50.9 31.4 63.1 27.5 36.3 17.4 
DAY 14 44.3 29.3 76.4 33.1 23.8 13.3 
DAY 21 51.3 36.6 68.1 34.9 21.5 21.9 
DAY 28 59.3 26.7 60.3 17.8 24.5 14.0 
DAY 60 53.7 38.3 71.3 34.9 28.6 15.7 
DAY 90 45.7 30.9 68.7 29.1 21.5 13.8 
DAY 120 55.8 32.1 65.1 19.2 21.9 16.7 
DAY 150 
VAC/L 1S 
VA C/L ' 18 
VA C/L 18 
VAC/L 17 
VA C/L 15 
VAC/L 17 I 
17 VA C/l 
VAC/L~ 
VACtLCJ 
CONTRAST SENSmvnYWTTH CONTACT LENSES 
Status I Q. ( Ptt ~ ([] I <D I Age ~ 
I HCII lc/L Rxl ~ -_1._25 __ ___.11 B.C.~ Dlal14.5 I, Spec Rx l-1.25 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 66.1 51.7 111.3 32.1 27.8 14.7 
DAY 7 64.1 49.4 91.9 29.3 26.9 13.6 
DAY 14 50.9 32.6 69.7 20.6 24.2 11.6 
DAY 21 53.7 36.0 82.5 33.1 28.8 15.0 
DAY 28 55.8 35.2 70.3 27.1 23.1 13.9 
DAY 60 66.1 38.9 78.2 27.5 20.1 15.5 
DAY 90 73.0 38.0 93.3 23.4 31.1 14.0 
DAY 120 57.1 46.1 82.5 23.6 26.5 12.5 

















Status ~ Q. I Pt# ~ ([] I CS ] ~ge ~ 
I CSI-T lc/L Rxl ...._ - 1._25 __ ___.1 B.C.~ Dla ( 13.8 I Spec Rx 1-1.25 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 72.4 45.7 78.2 42.7 29.3 18.6 
DAY 7 69.2 43.0 78.8 34.4 28.2 15.0 
DAY 14 52.1 45.7 67.6 22.0 13.9 9.2 
DAY 21 37.4 28.8 62.6 30.0 18.8 10.2 
DAY 28 55.0 30.0 54.5 19.6 18.5 7.2 
DAY 60 50.1 31.9 73.6 38.9 23.1 12.1 
DAY 90 60.7 43.7 89.8 28.2 27.3 16.7 
DAY 120 72.4 39.5 61.2 22.0 29.5 14.7 
' 
DAY 150 55.8 31.1 71.3 23.6 24.4 10.6 
VA C/L 17 
I====='. 
VA C/L 15 
I===~ 
VA C/L 14 
to====l 
VA C/L 14 
'==== VAC/L~ 
VAC/L~ 
VA C/LI15 I 
VAC/L~ 
VAC/L~ 
CONTRAST SENSI11VIlYWnH CONTACT LENSES 
Status I a.. l Pt#~ ~ lm I Age @I] 
I HCII lctL Rxl ._ -_3_.o_o __ __.l B.C.~ Dlal14.0 I Spec Rx l-2.75 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 45.0 30.0 73.0 37.2 9.1 18.6 
DAY 7 47.1 22.6 80.0 25.1 10.9 9.4 
DAY 14 57.1 28.4 89.1 28.6 14.0 17.9 
DAY 21 55.0 26.5 66.1 30.0 10.6 12.9 
DAY 28 54.1 28.2 67.1 35.8 13.8 16.9 






VA C/L i 15 
1 
VAC/L 13 





Status I Cl.. I Pt# ~ ~ I CB I Age @I] 
I PF lctL Rx L...l-_2._75 __ __.1 B.c.@2J Dlal14.4 I Spec Rx l-2.75-0.25x008 l 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 64.6 26.3 69.7 42.3 12.1 17.4 
DAY 7 48.6 29.1 87.8 38.6 16.9 24.5 
DAY 14 52.9 24.4 91.9 33.6 17.9 16.7 
DAY 21 67.1 24.5 79.4 29.3 12.3 13.7 
DAY 28 54.1 25.1 67.6 35.2 13.8 18.1 




VA C/L 13 
I====. 
VA C/L 14 
~-======~ 
VA C/L 14 
I===={ 
VA C/L 13 
~=~ VAC/L~ 
VAC/L~ 
VA C/LI I 
VACtLC:=J 
VACtLC:=J 
CONTRAST SENSrTIVITYWITH CONTACT LENSES 
Status I Q_ I Pt#~ ~ lm I Age§] 
I CSI-T lctL Rx l ._-_2._oo __ ____.f B.c.~ Dta l 13.8 I Spec Rx l-2.00 sph 
6.0 1.2 4.0 11 .4 .7 16 
DAY 0 32.4 21.9 56.7 18.9 13.9 11.7 
DAY 7 26.7 31.4 41.4 13.0 17.8 5.6 
DAY 14 23.4 19.2 20.1 7.6 12.7 7.6 
DAY 21 19.8 18.6 37.4 10.6 10.2 4.5 
DAY 28 26.9 15.1 42.7 11.4 12.9 5.1 
DAY 60 27.1 23.1 36.9 13.2 11.6 12.9 
DAY 90 31.9 20.9 36.3 15.8 14.7 8.1 
DAY 120 36.3 34.1 62.1 15.6 15.0 13.0 















18 VA C!L 
VACIL~ 
VAC/L~ 
Status fa_ l Pt#~ ~ lcs I Age~ 
I HCII !ctL Rxl ..._ -_2._oo __ ___,l B.C.~ Dlaj14.5 I Spec Rx 1-2.00 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 55.4 37.7 85.1 16.3 13.2 15.3 
DAY 7 38.6 28.4 50.5 21.5 17.0 11.8 
DAY 14 29.7 17.1 30.7 9.1 13.5 7.9 
DAY 21 26.5 16.0 30.9 12.5 7.2 13.7 
DAY 28 16.3 15.6 22.2 11.5 9.9 7.8 
DAY 60 25.5 23.6 35.5 14.6 13.8 10.0 
DAY 90 30.7 22.2 50.1 16.0 13.3 7.4 
DAY 120 34.4 ,25.7 58.0 23.3 14.9 12.1 
DAY 150 26.1 18.3 65.6 22.7 13.1 13.0 
VAC/L 18 
VA C/L 18 
VA C/L 18 
VAC/L 18 
VA C/L 18 
VAC/L 18 
18 VA C/L 
VAC/L~ 
VAC/L~ 
CONTRAST SENSmvrTYWITH CONTACT lENSES 
Status I 0... I Ptl ~ [0 I Q) I Age @I] 
I HCII felL Rx &....1-5_._75 _ ___.( B.c.~ DJaj14.5 I spec Rx f-5.75-0.25x065 I 
6.0 1.2 4.0 11.4 . 7 16 
DAY 0 33.9 25.5 52.1 9.3 26.3 6.2 
DAY 7 46.8 27.3 67.1 23.8 24.7 17.2 
DAY 14 47.1 32.4 65.1 17.2 31.4 13.8 
DAY 21 45.7 20.0 52.1 36.6 15.4 10.9 
DAY 28 38.0 25.3 44.3 29.3 17.5 9.6 
DAY 60 47.9 30.9 68.1 24.7 29.7 11.3 
DAY 90 42.7 27.3 54.5 25.7 17.6 11.6 
DAY 120 45.0 26.7 65.1 34.4 16.1 8.6 
DAY 150 36.3 26.9 61.2 24.7 21.1 14.2 
VAC/L 14 
VA C/L 18 
VAC/L 18 
VA C/L 17 
VAC/L 17 
VAC/L 15 
17 VA C/L 
VAC/L~ 
VACIL~ 
Status I 0... I Ptl ~ [0 I CE I Age @I] 
I PF l c/L Rxj '--_5._25 __ ___.1 B.c.~ Dlal14.4 I spec Rx j-5.00-0.25x090 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 48.2 29.7 44.0 24.4 24.4 19.5 
DAY 7 21.1 20.7 39.5 16.6 21.7 9.1 
DAY 14 57.5 21.5 47.5 22.9 17.4 12.3 
DAY 21 52.5 19.5 50.9 19.6 19.8 11.1 
DAY 28 35.2 21.7 61.7 22.6 15.8 13.9 
DAY 60 43.7 23.6 45.4 25.9 19.1 19.2 
DAY 90 56.7 40.4 71.3 17.8 15.1 15.7 
DAY 120 54.1 26.3 81.3 28.2 22.6 13.1 
DAY 150 56.2 41.1 53.3 41.1 24.5 14.0 
VAC/L 14 
VA C/L 17 




18 VA C/L 
VAC/L~ 
VACIL~ 
OONTRAST SENSmvrTYWITH CONTACT LENSES 
Status Ia.. I Pt#~ ~ lm I Age~ 
( HCII l c/L Rx l _-2_._oo __ ___.l B.C.~ Dlal14.5 I Spec Rx l-1.50-0.25x007 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 54.5 24.0 67.6 28.2 17.2 13.1 
DAY 7 64.6 44.7 74.7 31.6 21.1 8.8 
DAY 14 53.3 34.9 57.5 26.1 15.3 12.3 
DAY 21 51.3 33.1 65.6 28.8 18.3 15.1 
DAY 28 43.0 29.3 58.4 30.7 18.5 14.6 
DAY 60 36.6 21.1 46.1 26.7 15.4 10.1 
DAY 90 54.5 33.4 58.4 24.4 19.2 13.1 
DAY 120 56.2 32.9 94.8 49.7 24.5 20.7 















17 VA C/L 
VAC/LEJ 
VAC/L~ 
Status I a. I Pt#~ ~ lrn I Age~ 
I 
I CSI-T l c/L Rx L-l-_1._75 __ ----il  B.C.~ Dlal14.8 I Spec Rx l-1.75-0.25x003 j 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 53.7 19.2 68.1 36.6 13.8 18.6 
DAY 7 52.9 23.8 67.6 30.2 20.9 13.5 
DAY 14 43.7 29.3 47.9 22.0 15.8 14.6 
DAY 21 44.7 21.4 74.1 30.7 19.8 13.4 
DAY 28 45.4 18.8 55.0 21.9 12.0 8.3 
DAY 60 41.7 20.4 47.9 22.6 15.4 12.1 
DAY 90 53.7 36.3 56.7 31.9 18.3 12.2 
DAY 120 46.8 34.9 60.3 30.9 22.7 13.6 
DAY 150 46.4 25.9 44.0 20.1 18.6 13.3 
VA C/L 118 
VAC/L 17 
VA C/L 17 
VAC/L 1 17 
VA C/L 18 
VAC/L 18 
17 VA C/L 
VACtLEJ, 
VAC/LEJ 
OONTRAST SENSlllVITYWTTH CONTACT LENSES 
Status J a_ I Pt# [I§] ~ I CD I Age QIJ 
I 
j CSI-T lc/L Rxl ._-_3._50 __ __..1 B.C.~ Dlal14.8 I Spec Rx l-3.25-0.25x180 I 
6.0 1.2 4.0 11.4 . 7 16 
DAY 0 34.9 22.9 58.9 20.9 16.6 14.5 
DAY 7 30.0 22.4 46.4 28.0 16.7 19.2 
DAY 14 22.6 19.3 35.5 20.1 14.1 13.9 
DAY 21 14.0 13.6 17.9 13.5 11.4 9.4 
DAY 28 16.7 12.9 25.9 16.6 13.4 10.7 
DAY 60 25.9 20.0 33.9 14.7 17.8 15.5 




















Status I 0... I Pt# §] ~ I CS I Age QIJ 
I HCII lctL Rxl .._-_3._75 __ ___,1 B.C.~ Dlal14.5 I Spec Rx 1-3.75 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 42.3 21.4 50.9 24.9 20.4 17.1 
( 
DAY 7 35.2 19.6 52.9 20.6 22.7 15.7 
DAY 14 26.1 15.1 30.2 16.7 12.7 13.3 
DAY 21 17.5 13.5 22.0 15.1 11.7 11.3 
DAY 28 24.9 14.8 54.1 24.4 12.5 10.4 
DAY 60 38.0 27.3 42.3 23.1 18.2 15.7 


















VA Ctlj I 
VA C/L1 1 
OONTRAST SENSilMTYWilH CONTACT LENSES 
Status I a. I Pt#~ ~ lm I Age @I] 
(csi-T l ctLRxl .._-_2._oo __ ___.ls.c.~ DtaJ13.8 l specRxl-1.75sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 80.0 40.4 110.5 42.0 16.7 17.9 
DAY 7 72.4 38.6 117.5 32.9 18.2 22.4 
DAY 14 51.3 39.2 105.5 17.9 23.1 16.2 
DAY 21 66.8 38.0 90.5 16.5 26.3 12.4 
DAY 28 51.3 27.8 82.5 12.1 24.2 11.1 
DAY 60 42.7 37.2 86.4 12.9 27.3 8.7 
DAY 90 67.1 38.6 91.9 31.6 23.4 16.2 
DAY 120 78.8 31.4 89.1 29.5 37.4 24.4 
















Status I Q. I Pt# .~ ~ j 03 I Age @I] 
I HCII ' C/L Rxl ..... -_2._5_0 __ __.I B.c.@IJ Dtaj14.5 I Spec Rx l-2.50 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 68.1 34.4 113.9 33.1 17.9 14.8 
DAY 7 59.8 31.9 94.8 39.2 21.5 20.0 
DAY 14 81.9 28.4 77.6 42.7 23.6 24.4 
DAY 21 68.7 31.1 113.1 42.0 32.6 17.8 
DAY 28 64.1 30.4 113.1 32.4 21.9 11.6 
DAY 60 62.1 32.4 105.5 37.2 27.5 11.0 
DAY 90 65.6 35.2 89.8 21.4 27.1 6.4 
DAY 120 60.7 .46.1 71.3 21.4 23.3 14.9 
DAY 150 70.8 27.1 82.5 27.3 24.2 16.7 
I 
VAC/L 1S 
VA C/L 15 




18 VA C/L 
VAC/L~ 
VAC/L~ 
CONTRAST SENSillVITYWrTH CONTACT LENSES 
Status I a. I Pt# IT!IJ ~ I ro I Age ~ 
j HCII l C/L Rxl L.. -_2._75 __ __.) e. c.~ Dla l 14.5 I Spec Rx l-2.50-0.25x01 0 i 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 60.7 50.5 95.5 34.9 25.5 23.8 
DAY 7 51.7 50.5 106.3 50.5 31.9 26.7 
DAY 14 51.7 46.4 85.8 19.1 37.4 24.4 
DAY 21 61.2 39.5 71.3 27.8 22.6 9.3 
DAY 28 44.4 39.6 87.1 27.0 26.9 22.8 
DAY 60 41.1 43.0 62.1 16.5 27.3 13.2 
DAY 90 51.7 43.7 61.7 31.9 27.1 13.5 
DAY 120 45.0 42.3 78.8 24.7 26.3 8.1 

















Status I 0.. I Pt# IT!IJ ~ I CE I Age ~ 
I PF I C/L Rx 1 ..... ~3_._oo __ __.l e.c.@2J Draj14.4 I Spec Rx j-3.00-0.25x180 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 73.6 33.4 121.2 46.1 24.0 21.9 
DAY 7 58.0 51.3 111.3 35.2 37.2 29.1 
DAY 14 50.1 43.7 91.2 32.4 28.8 19.6 
DAY 21 60.3 28.2 67.1 27.8 22.2 14.7 
DAY 28 51.6 26.9 54.3 27.9 25.3 13.8 
DAY 60 51.3 25.9 51.3 21.7 19.3 13.4 
DAY 90 39.2 32.4 66.7 24.0 18.9 12.9 
DAY 120 58.9 30.7 62.6 26.5 30.2 7.6 
DAY 150 46.4 25.9 69.7 30.4 27.5 14.2 
VAC/L 15 
VA C/L 1 14 
VAC/L 15 
VAC/L 17 
VA C/L 17 
VAC/L I 18 
17 VA C/L 
VAC/L~ 
VAC/L~ 
CONTRAST SENSmVIlY WllH CONTACT LENSES 
Status II a.. I Pt# ~ rD. I m I Age~ 
I PF jctL Rxl L-2_._25 __ ___.1 e.c.0 Dla l 14.4 I Spec Rx 1-2.25 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 36.5 27.6 45.3 20.8 16.5 18.3 VAC/L 18 
DAY 7 43.3 30.3 52.9 29.5 19.5 20.9 VAC/L 17 
DAY 14 50.9 32.9 96.2 29.1 18.3 22.0 VA C/L 17 
DAY 21 44.0 26.7 89.8 33.6 25.1 23.6 VAC/L 17 
DAY 28 30.4 37.5 n.o 25.9 30.9 20.9 VA C/L 17 
DAY 60 VAC/L 





Status j a.. I Ptl ~ {D I 03 I. Age~ 










6.0 1.2 4.0 11.4 .7 16 
52.1 28.2 85.1 33.9 15.8 18.2 
66.1 29.5 74.7 20.7 17.9 17.9 
39.2 35.8 62.6 14.3 20.3 17.0 
49.7 35.8 68.1 26.7 33.6 20.4 








VA ctq 1 
VA C/q I 
CONTRAST SENSillVITYWffii cc:>t-ITACT LENSES 
Status I a. I Pt#~ ~ lm I Age~ 
I HCII lc/L Rx l.._-_1._50 __ ____.11 B.C.~ Dta f 14.5 I Spec Rx f-1.50 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 68.7 29.5 81.9 36.6 15.5 19.2 
DAY 7 53.7 23.4 56.7 31.6 13.7 19.2 
DAY 14 46.1 16.9 38.6 26.5 11.5 12.2 
DAY 21 49.7 15.4 36.0 26.3 11.4 19.6 
DAY 28 38.9 15.1 35.5 25.3 10.5 16.5 
DAY 60 46.1 17.0 47.5 28.8 10.4 20.7 
DAY 90 44.3 14.5 34.9 29.5 11.6 16.0 
DAY 120 45.0 20.9 42.3 26.7 13.1 12.9 
















Status Ia. I Pt#~ ~ I1CS I Age~ 
I PF lc/L Rxl .._ -_1._00 __ _.11 e.c.~l Dtaj14.4 I Spec Rx 1-1.00 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 66.1 21.5 66.6 25.3 17.6 14.8 
DAY 7 63.1 19.8 66.1 31.4 11.9 15.0 
DAY 14 28.8 15.4 38.6 20.9 10.2 10.3 
DAY 21 31.4 13.0 35.5 32.9 11.0 15.6 
DAY 28 24.7 13.5 30.4 17.6 10.6 10.0 
DAY 60 32.9 16.0 42.3 21.5 10.1 9.2 
DAY 90 37.2 12.4 21.7 18.5 8.3 9.3 
DAY 120 31.6 15.5 35.5 17.4 11.7 10.6 















VA C!lf 14 I 
VA C/LI15 I 
CONTRAST SENSmvnYWITH CONTACT LENSES 
Status I a. I Ptt§J ~ lm ~ Age§] 
I HCII fc/L Rx ..... l-6_._oo ____ fe.c.~ Dlal14.5 I spec Rx l-5.75-0.25x180 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 40.7 23.3 45.7 24.0 14.1 17.8 
DAY 7 44.0 22.7 45.0 19.2 18.8 7.2 
DAY 14 28.4 17.6 39.5 16.7 11.7 12.0 
DAY 21 33.1 18.1 35.2 19.5 11.7 6.7 
DAY 28 34.7 15.7 33.4 15.7 13.1 7.5 
DAY 60 19.2 16.9 31.4 12.2 8.3 9.6 
DAY 90 40.4 19.6 58.9 24.5 12.5 9.7 
DAY 120 30.0 17.5 37.2 30.9 12.3 12.0 













20 VA C!L 
VAC!L~ 
VAC/L~ 
Status r a_ I Pt# §] ~ I cs I Age§] 
I CSJ-T lctL Rx ~~-7._0_0 __ __.I e.c.l9.35 I Dlal14.8 ~ Spec Rx l-6.50-0.50x005 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 24.5 23.8 40.7 18.6 15.6 4.5 
DAY 7 21.7 23.6 35.2 8.6 13.9 8.8 
DAY 14 28.8 14.5 28.2 18.1 11.7 5.5 
DAY 21 16.1 14.5 28.0 8.1 10.9 5.0 
DAY 28 22.6 16.6 25.7 12.9 11.2 9.3 
DAY 60 17.6 13.0 23.1 8.9 10.4 5.1 
DAY 90 12.7 17.6 28.0 10.4 10.2 7.9 
DAY 120 13.3 20.1 33.4 16.7 15.3 18.8 
' 
DAY 150 21.9 15.3 24.0 14.7 13.9 10.8 
VAC/L 17 
VA C/L 25 
VA C/L 17 
VAC/L 20 
VA C/L 20 
VAC/L 120 
125 VA CIL 
VAC/L~ 
VAC/L~ 
CONTRAST SENSmVIlYWITH CONTACT LENSES 
Status I Cl. I Ptl @D ~ I CD I Age @IJ 
I CSI-T l c/L Rx ..._l-2_._25 __ ___.1 B.C.~ Dla l 13.8 I Spec Rx 1-2.25 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 62.1 34.1 92.6 28.8 19.2 8.5 
DAY 7 50.5 32.6 81.3 18.8 23.4 11.0 
DAY 14 66.1 40.1 94.8 34.4 27.1 15.3 
DAY 21 63.6 38.0 54.1 25.1 25.3 9.0 
DAY 28 38.9 28.0 49.7 9.2 13.4 5.8 
DAY 60 54.5 30.4 81.9 24.4 20.4 9.4 
DAY 90 47.1 35.8 68.7 14.3 16.6 6.1 
DAY 120 58.0 31.9 68.7 23.1 18.1 13.1 
DAY 150 44.3 29.5 57.5 19.6 17.0 7.0 
VAC/L 18 
y_A C/L 20 







Status 1 a... I Pt# @D ~ I CS I Age @IJ 










6.0 1.2 4.0 11.4 .7 16 
70.4 27.3 81.3 16.6 27.3 12.1 
52.1 34.4 68.7 15.6 18.3 11.5 
60.3 38.3 79.4 29.5 24.4 11.3 
55.8 41.1 53.3 17.6 26.3 7.3 
38.0 22.6 81.3 19.8 16.9 12.7 
43.3 32.4 66.1 21.4 17.5 6.1 
51.7 31.6 68.7 33.9 17.1 13.5 
42.3 28.8 58.9 14.3 14.3 6.7 
49.4 26.3 63.1 8.8 14.5 6.1 
VA C/L 18 
1-====='1 
VA C/L 20 
F====t 
VA C/L 20 
F====f 
VA C/L 20 
~=~ 





OONTRAST SENSillVIlY WfTH CONTACT LENSES 
Status I Cl. I Pt#~ [C) lm I Age~ 
I HCII lc/L Rx l .._-_3._7_5 __ _,1 B.C.~ Dta(1 14.0 I Spec Rx (-3.50-0.25x075 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 54.5 26.3 53.7 23.4 16.2 11.3 
DAY 7 71.9 38.9 94.8 39.5 20.7 20.0 
DAY 14 58.9 25.1 65.6 28.8 17.5 18.1 
DAY 21 57.1 24.0 60.7 24.0 16.2 13.3 
DAY 28 46.4 19.3 52.5 20.6 12.9 11.3 
DAY 60 63.6 30.7 78.8 12.2 19.1 9.2 
DAY 90 33.9 28.8 35.2 18.9 20.9 7.5 
DAY 120 35.8 29.5 50.5 15.5 24.2 5.3 















VA Cllj 18 I 
VA CIL(18 I 
Status ~ Cl. I Pt# ~ [C)( CS I Age~ 
I PF I C/L Rx( L--_3._75 __ ___,1 B.c.0 Dlal14.4 I Spec Rx (-4.00-0.25x120 I 
.6.0 1.2 4.0 11.4 .7 16 
DAY 0 47.1 29.5 44.0 16.0 19.3 3.3 
DAY 7 46.4 30.4 85.8 32.6 17.2 10.2 
DAY 14 49.7 25.5 61.7 20.0 17.6 10.2 
DAY 21 26.1 21.4 50.9 12.0 16.5 6.1 
DAY 28 58.0 22.4 67.6 22.4 16.7 5.6 
DAY 60 40.1 32.4 72.4 17.2 20.0 8.0 
DAY 90 63.1 31.9 85.1 20.7 20.6 7.1 
DAY 120 58.9 34.9 67.1 26.1 17.2 13.3 
DAY 150 42.1 31.1 44.7 16.3 19.3 7.1 
VA C/L 20 
I===='. 
VA C/L 20 
~=====-~ 
VA C/L 20 
1===-==f 






VA Ctl(18 'I 
VA Ctl(18 I 
CC>NTRAST SENSmvTTYWJlH CONTACT LENSES 
Status I Cl. I Ptt#~ ~ len I Age~ 
I HCII l'c/L Rx l.._-2_._25 ____ 1 B.C.~ Dlal14.5 I Spec Rx l-2.00-0.25x090 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 86.4 39.5 102.3 34.1 27.1 24.0 
DAY 7 80.0 40.1 118.4 56.2 21.9 27.5 
DAY 14 63.6 39.8 107.2 45.4 26.7 21.9 
DAY 21 55.4 27.3 71.3 38.3 14.9 19.2 
DAY 28 74.1 27.1 83.2 35.8 19.6 20.1 
DAY 60 44.0 29.1 62.1 31.6 21.4 25.3 
DAY 90 72.4 35.5 97.0 38.3 25.7 24.0 
DAY 120 59.8 24.9 87.8 27.5 27.5 10.9 
DAY 150 75.3 40.1 68.7 42.7 26.3 11.0 
VAC/L 17 
YAC/L 15 




I 13 VA C/L 
VACtLEJ 
VAC/l~ 
Status I Cl. I Ptl# @D ~ I CS I Age~. 
I CSI-T lc/L Rx L...l-_3._25 __ ___.1 B.C.~ Dlaj13.8 I Spec Rx l-3.00-0.25x085 j 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 86.4 36.6 81.9 40.1 22.4 23.4 VA C/L 17 
DAY 7 65.6 39.5 94.8 47.1 26.1 27.8 VA C/L 14 
DAY 14 70.3 22.4 91.9 41.1 23.3 21.5 VA C/L 15 
DAY 21 48.6 18.9 60.3 27.3 14.3 12.3 VA Ctlj 15 
DAY 28 68.7 24.2 86.4 32.1 15.1 14.2 VA C/L 14 
DAY 60 58.0 28.2 91.2 33.6 17.2 17.0 VAC/L 15 
DAY 90 63.1 30.4 96.1 38.9 19.5 31.4 VAC/L 13 
DAY 120 69.7 41.4 91.2 41.1 28.6 27.1 VA Ctlj 15 I 
DAY 150 83.8 29.3 90.5 54.5 24.2 36.0 vA ctLI15 I 
OONTRAST SENSillVrTY WITH CONTACT LENSES 
Status I a.. I Pttl2EJ [0 I m I Age~ 
I HCII I C/L Rx ..... l-2_._50 _____ 1 B.C.~ Dlal14.0 ~ Spec Rx l-2.25-0.50x1 00 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 74.1 43.3 106.3 30.1 17.6 28.4 
DAY 7 44.0 26.1 62.6 16.9 14.3 7;6 
DAY 14 56.7 29.7 49.4 17.6 16.5 13.7 
DAY 21 45.4 34.4 58.9 27.3 19.5 13.9 
DAY 28 56.7 28.8 60.7 24.7 15.8 16.5 
DAY 60 71.3 51.3 74.1 27.3 24.0 13.6 
DAY 90 74.1 44.3 103.1 27.1 32.1 13.9 
DAY 120 70.8 55.8 116.6 40.4 34.4 22.0 














17 VA C/L 
VAC/L~ 
VAC/L~ 
Status I a.. I Pt# l2EJ [CJ I CB I Age~ 










6.0 1.2 4.0 11.4 .7 16 
57.5 28.4 100.8 30.7 14.9 16.1 
36.6 18.2 45.4 21.4 12.7 13.2 
45.4 22.9 36.3 11.6 13.3 14.0 
38.0 21.1 43.0 12.0 14.6 7.4 
45.7 30.9 55.8 28.0 15.5 7.1 
51.3 34.9 94.8 30.9 24.0 16.1 
61.7 47.5 107.9 25.7 22.2 6.8 
53.3 50.1 100.0 16.6 29.7 12.0 
44.7 35.8 69.7 12.8 16.5 5.5 
VA C/L 117 
t====~ 
VA C/L 17 
l=====t. 
VA C/L 17 
~-===~ 
VA C/L 18 
~=~ 





OONTRAST SENSillVIlYWfTH CONTACT LENSES 
Status ~ a_ I PU#~ ~ lm I Age~ 
I HCII I C/L Rxl ~ -_2._0_0 --~~ B.C.~ Dla l14.5 l Spec Rx 1-1 .25-0 .25x090 I 
6.0 1.2 4.0 11.4 . 7 16 
DAY 0 28.8 20.9 25.9 6.0 14.0 4.8 
DAY 7 55.8 35.2 55.0 27.5 22.7 17.9 
DAY 14 27.8 20.7 41.1 21.2 14.9 12.5 
DAY 21 25.3 21.4 36.3 10.2 12.0 12.0 
DAY 28 26.7 19.8 33.4 16.7 14.7 9.7 
DAY 60 32.9 24.9 44.3 20.6 18.6 16.2 
DAY 90 34.9 26.5 43.3 17.4 17.0 7.2 
DAY 120 44.3 30.7 50.9 25.1 18.6 12.4 















VA ctlj 18 1 
VA C/Ll20 I 
Status I a_ I Pt#~ ~ lcs I Age~ 
I CSI-T jc/L Rx L...l-_1._5_0 __ __.1 B.C.~ Dlal14.8 I Spec Rx f-1.50 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 17.1 20.1 43.3 14.3 12.7 5.0 
DAY 7 23.3 22.6 31.6 15.6 14.8 8.8 
DAY 14 29.3 14.7 32.4 15.5 11.1 12.8 
DAY 21 23.3 17.6 29.7 13.2 12.4 11.9 
DAY 28 20.7 18.5 27.3 11.9 15.0 8.1 
DAY 60 22.4 21.9 47.1 16.3 15.8 16.1 
DAY 90 24.7 23.9 47.9 20.3 17.8 8.4 
DAY 120 40.7 24.4 58.0 26.7 19.6 19.2 
DAY 150 36.6 24.4 51.7 22.4 28.6 11.3 
VA C/L 20 
VA C/L 20 
VA C/L 18 
VAC/L 17 
VA C/L 20 
VAC/L 20 
20 VA C/L 
VACIL~ 
VAC/L~ 
CONTRAST SENSI11VITY WllH CONTACT LENSES 
Status I Cl. I Pt# @I] ~ f Q) I Age @I] 
I HCII jctL Rx L-j-4_._50 __ _..1 e.c.@IJ Dla l 14.5 I Spec Rx l-4.25-0.25x090 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 39.8 28.4 51.3 14.9 14.7 21.7 
DAY 7 16.6 21.2 34.1 9.3 12 . .5 5.3 
DAY 14 38.9 31.1 33.1 8.6 17.6 11.2 
DAY 21 21.9 22.4 31.1 9.1 15.7 7.2 
DAY 28 21.2 20.3 32.4 6.2 17.4 5.6 




VA C/L 17 
VA C/L 22 
VAC/L 20 
VAC/L 17 





Status I Cl. I Pt# @D ~ I\ CS I Age @I] 
I PF l c/L Rxl .__ -4_._oo __ ____.l B.c. @I] Dlal14.4 · I Spec Rx l-4.00-0.25x090 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 38.6 16.0 49.0 29.3 14.9 16.0 
DAY 7 34.7 22.7 52.5 13.8 17.0 12.8 
DAY 14 35.2 17.0 42.7 20.0 14.1 13.7 
DAY 21 27.3 14.9 36.6 14.2 14.3 7.0 
DAY 28 18.5 17.5 18.9 13.5 14.2 10.6 


















VA C/L'F=I =====w 
CONTRAST SENSITMTY WITH CONTACT LENSES 
Status I a.. I Ptl~ u lm r Age~ 
I HCII fc/L Rx '-j-_1._50 __ ___,1 e.c.0 Dla l 14.5 1  Spec Rx l-1.25-0.25x150 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 58.4 32.9 98.5 35.5 12.6 21.4 
DAY 7 52.5 27.5 74.1 38.0 20.1 16.2 
DAY 14 54.5 27.5 72.4 40.4 17.4 27.3 
DAY 21 48.6 18.2 59.8 20.4 16.3 15.6 
DAY 28 54.5 26.1 68.1 32.9 15.3 17.9 





VA C/L 18 
VA C/L I 15 
VAC/L 15 





Status Ia.. I Pt#~ U lcs I Age~ 
I PF lc/L Rx '-j-_1._75 __ ___..1 B.c.@IJ Dla l 14.4 I Spec Rx l-1.50-0.25x030 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 31.4 24.5 58.9 17.6 18.6 9.4 
DAY 7 31.4 20.7 47.5 17.5 15.0 8.2 
DAY 14 34.1 22.4 49.0 13.1 16.2 8.8 
DAY 21 44.3 25.1 60.3 24.5 17.4 12.4 
DAY 28 40.1 21.4 56.2 25.7 14.8 15.4 





VA C/L 17 
VA C/L 18 
VA C/L 15 





CONTRAST SENSrrMlYWITH CONTACT LENSES 




I HCII lc/L Rx ~(-_1._75 _ ___.1 B.C.~ Dtaj14.5 I Spec Rx l-1.75 sph 
6.0 1.2 4.0 11.4 .7 16 
' 
DAY 0 42.3 36.6 51.7 24.5 12.3 9.2 
DAY 7 43.0 26.9 51.7 14.8 16.2 7.8 
DAY 14 50.5 30.4 66.6 18.5 20.1 11.0 
DAY 21 70.8 29.7 74.1 23.1 15.5 16.5 
DAY 28 36.6 28.6 68.7 27.5 13.3 15.5 
DAY 60 62.6 27.8 67.1 32.9 15.5 16.0 
DAY 90 61 .2 29.3 70.3 30.2 17.2 20.8 
DAY 120 51.3 25.5 71.9 26.9 16.1 10.4 













17 VA C/L 
VAC/L~ 
VAC/L~ 
Status I 0... I Pt#~ ~ jcs I Age~ 
l PF lc/L Rx ~1·_1._50 _ ___.1 B.c.0 Dta(14.4 I Spec Rx ( -1.50 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 58.9 42.7 89.8 26.7 15.3 13.5 VAC/L 17 
DAY 7 60.7 30.7 74.7 36.3 16.7 14.6 VAC/L 15 
DAY 14 60.3 32.6 88.4 58.4 18.1 15.6 VA C/L 17 
DAY 21 66.6 26.7 93.3 34.1 17.6 21.5 VA Cllj 20 
DAY 28 55.8 33.1 96.2 52.9 17.6 20.6 VA C/L 15 
DAY 60 73.6 26.3 84.5 41.4 16.9 23.4 VAC/L 18 
DAY 90 46.8 30.2 91.2 24.7 14.7 10.2 VACIL 17 
DAY 120 63.1 .24.7 67.1 43.3 13.9 24.7 VA C/LI18 I 
DAY 150 56.2 22.7 89.8 39.2 12.0 21.4 VA C/LI15 I 
CONTRAST SENSrTIVITYWffi-1 OONTACT LENSES 
Status I a_ I Pt# ~ [CJ I Q) I Age (EJ 
I PF lctL Rx .1&.... -_3._00 __ _....1 e.c.0 Dtal14.4 I Spec Rx 1-3.00 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 57.5 47.1 52.5 15.1 19.2 6.5 
DAY 7 51.3 27.8 70.3 20.6 19.1 6.5 
DAY 14 50.1 36.6 69.2 11.0 20.1 3.7 
DAY 21 43.0 29.1 67.1 18.5 16.9 11.4 
DAY 28 52.5 31.9 74.7 21.7 11.6 8.4 
DAY 60 56.2 28.0 81.3 11.1 19.1 7.6 
DAY 90 65.1 45.4 68.7 29.5 27.5 6.9 
DAY 120 63.1 37.7 64.1 13.8 23.8 10.9 















VA Ctlj 18 I 
VA C!L( 18 I 
Status ,l a_ I Pt# ~ [CJ I a> I Age (EJ 
I HCII lctL Rxl &..... -3_._oo __ ____.l B.C.~ Dtal14.5 J Spec Rx 1-3.00 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 66.6 32.4 74.1 12.7 18.6 9.9 
DAY 7 39.8 31.4 52.1 11.6 15.7 5.9 
DAY 14 40.1 30.0 57.1 19.8 22.7 10.5 
DAY 21 44.0 28.6 49.7 15.8 18.6 7.9 
DAY 28 46.4 21.4 41.7 16.2 11.4 8.4 
DAY 60 63.6 34.1 87.1 18.1 18.5 9.2 
DAY 90 44.7 34.4 90.5 18.9 28.4 10.7 
DAY 120 63.1 .42.7 90.5 28.2 20.7 10.3 
DAY 150 59.3 47.9 71.9 16.6 22.6 6.0 
VAC/L 18 
VAC/L 18 
VA C/L 18 
VAC/L 17 
VA C/L 17 
VA C/L 17 
20 VA Cll 
VAC/L~ 
VAC/L~ 
CONTRAST SENSITMTYWilH CONTACT LENSES 
Status I a. I Ptl# ~ ~ I rn I Age @I] 
I CSI-T lc/L Rx '-l -_4._oo __ __,l B.C.~ Dlal14.8 I Spec Rx 1-3.75 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 73.6 49.0 94.7 45.4 28.2 19.6 
DAY 7 58.4 68.1 87.1 52.9 31.6 16.0 
DAY 14 46.1 41.4 54.5 35.8 32.9 18.3 
DAY 21 20.4 48.6 44.3 12.5 38.9 6.4 
DAY 28 37.7 52.9 64.6 20.4 37.7 15.1 
DAY 60 38.3 45.0 54.5 15.1 37.7 15.4 
DAY 90 55.4 52.9 74.1 17.9 40.1 16.0 
DAY 120 68.7 55.8 98.5 24.2 38.6 12.4 















15 VA C/L 
VACIL.EJ 
VACIL~ 
Status I Q. f Ptl# ~ ~ f CS I Age @I] 
I HCII lc/L Rxl ..._ -_4._25 __ ___,1 B.c.[~] Dlal14.5 I Spec Rx j-4.00-0.50x180 j 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 75.3 46.1 90.9 53.3 33.1 22.6 
DAY 7 55.4 40.4 65.1 55.4 41.4 28.6 
DAY 14 45.4 40.4 71.3 23.3 40.4 14.7 
DAY 21 62.1 54.5 68.7 19.2 37.2 8.3 
DAY 28 49.7 35.5 58.0 21.9 30.9 13.9 
DAY 60 62.1 41.4 75.9 25.1 28.0 18.3 
DAY 90 44.0 40.7 55.3 30.2 40.4 19.8 
DAY 120 59.3 50.9 79.4 25.5 32.1 12.0 
DAY 150 56.7 38.6 55.0 20.7 21.4 15.5 
VA C/L 115 
VA C/L 14 




14 VA C/L 
VAC/L~ 
VAC/L~ 
CONTRAST SENSITIVIlYWITii CONTACT LENSES 
Status I a.. l Pt# ~ ~ I ro I Age [EJ 
I HCII JctL Rx .._1·_3._50 _ __.1 B.C.~ Dlal14.5 I Spec Rx l-3.50-0.75x180 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 40.4 28.8 62.1 25.3 22.9 22.7 
DAY 7 42.3 23.6 53.7 26.1 19.1 23.4 
DAY 14 30.9 24.2 30.0 15.4 19.3 15.1 
DAY 21 45.7 23.4 61.2 29.7 19.1 19.1 
DAY 28 42.7 24.0 52.5 30.2 22.4 20.9 
DAY 60 48.6 40.4 59.3 25.5 30.9 21.9 
DAY 90 68.7 38.0 63.6 26.3 20.6 14.3 
DAY 120 53.7 30.9 75.9 26.1 32.9 24.4 












VA C/LI 17 I 
VACtLITCJ 
VAC/L~ 
Status 11 a_ I Pt# ~ ~ r cs I Age [EJ 
I CSI-T Jc/L Rx .._1·_3._75 _ ___.1 B.C.~ Dlal14.8 I Spec Rx l-3.50-0.75x014 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 41.1 24.4 55.4 27.3 22.7 14.9 
DAY 7 40.1 19.5 66.1 38.6 24.9 17.1 
DAY 14 32.9 25.5 46.8 25.5 19.5 17.9 
DAY 21 45.7 24.7 45.7 29.5 21.9 22.6 
DAY 28 37.7 26.1 39.8 18.5 17.1 20.7 
DAY 60 49.0 28.6 44.7 24.0 37.2 15.8 
DAY 90 43.7 24.0 40.4 21.9 16.7 14.6 
DAY 120 60.3 34.1 73.0 28.4 21.4 13.4 















VA C/q 18 I 
VA C/L,18 I 
OONTRAST SENSITlVITYWTTH CONTACT LENSES 
Status r a.. I Pt#@U co fm I Age@D 










6.0 1.2 4.0 11.4 .7 16 
63.1 39.5 87.8 35.5 36.0 13.7 
46.8 44.0 98.0 88.4 23.4 24.5 
49.0 41.7 89.8 29.7 28.6 13.5 
73.0 56.2 103.1 63.6 45.7 16.5 
63.6 44.7 79.4 28.0 30.2 14.2 
63.1 43.3 95.5 45.0 31.6 18.5 
55.8 25.3 80.0 52.1 30.9 21.2 
64.6 43.7 67.1 40.7 20.1 13.9 













15 VA C/L 
VACtl '~ 
VACIL@=:J 
Status I a_ 11 Pt# @U CO f C6 I Age @D 
I PF !elL Rx .... 1-_6._5_0 __ __.1 e.c.0 Dlal14.4 I spec Rx j-7.00-0.50x015 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 67.1 41.1 89.8 34.4 31.6 22.2 
DAY 7 44.3 44.7 89.8 32.4 22.9 12.5 
DAY 14 58.9 50.9 85.1 39.8 32.4 17.6 
DAY 21 71.3 32.4 91.9 48.2 37.7 18.6 
DAY 28 63.1 25.3 70.8 34.1 25.5 15.0 
DAY 60 65.6 41.1 85.1 50.5 40.1 22.2 
DAY 90 50.1 32.4 92.6 44.3 25.9 19.2 
DAY 120 46.8 35.2 61.2 27.1 23.1 9.1 















VA C/LI 14 
?======'. 
VA C/LI ..... 1_7 _ __, 
CONTRASr SENSITM1Ywm; CONTACT LENSES 
Status fa... f Pt#~ ~ lm I Age~ 
I HCII lc/L Rx l.._-2_._75 __ ___,1 B.C.~ Dlaj14.5 I Spec Rx 1-2.75 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 60.7 40.3 77.0 33.0 22.6 17.5 
DAY 7 37.4 31.9 60.7 7.9 13.3 8.6 
DAY 14 42.7 30.9 47.1 15.8 16.9 7.8 
DAY 21 44.0 29.3 48.2 11.4 22.9 10.6 
DAY 28 30.4 22.7 45.4 6.9 13.1 4.6 
DAY 60 33.4 22.7 46.8 15.1 15.1 11.5 
DAY 90 50.9 22.0 48.6 16.5 20.7 5.1 
DAY 120 49.7 31.6 55.0 20.7 16.0 7.9 













18 VA Cll 
VAC!l~ 
VAC/L~ 
Status I 0... I Pt#~ ~ Ia> I Age~ 
I CSI-T lctL Rxl L-_2._50 __ ~1 e.c.0 Dla l 13.8 I Spec Rx 1-2.50 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 55.0 39.3 76.4 33.1 17.6 23.6 
DAY 7 60.3 31.1 68.7 31.9 16.2 21.4 
DAY 14 42.0 23.3 52.1 18.8 18.6 11.4 
DAY 21 50.1 34.9 52.5 24.9 18.1 16.5 
DAY 28 36.6 23.1 50.1 20.3 13.2 10.0 
DAY 60 32.6 22.6 46.8 19.8 10.8 16.7 
DAY 90 42.0 28.8 54.1 20.0 16.3 13.1 
DAY 120 55.4 24.0 76.4 29.7 15.5 18.8 
















VA C/q 17 I 
VA C/L,17 I 
CONTRAST SENSITIVITY WITH CONTACT LENSES 
Status I' 0.. I Pt# §] ~ f Q) I Age~ 
I HCII lc/L Rx .._1·_1._50 _ ____.1 e.c.~ Dlal14.5 I spec Rx l-1.25-0.50x070 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 52.1 38.9 69.2 34.4 29.7 14.3 
DAY 7 35.5 47.5 66.1 28.4 29.1 21.7 
DAY 14 24.7 . 21.9 31.1 8.0 10.8 4.4 
DAY 21 28.4 22.4 41.1 13.3 18.6 5.5 
DAY 28 31.1 32.1 46.1 16.9 20.3 6.2 
DAY 60 28.6 22.4 37.2 13.9 14.5 3.3 
DAY 90 34.1 40.7 55.0 16.9 31.1 9.0 
DAY 120 49.0 36.6 63.1 27.5 20.3 14.9 
DAY 150 45.0 28.6 52.9 29.3 28.8 13.1 
VAC/L 18 
VAC/L 17 
VA C/L 18 
VAC/L 18 
VA C/L 18 
VAC/L 18 
18 VA C/L 
VAC/L~ 
VAC/L~ 
status I 0.. J Pt#§J ~ ICE I Age~ 










6.0 1.2 4.0 11.4 .7 16 
41.1 43.3 83.2 20.6 24.5 4.8 
49.7 28.4 60.7 19.1 20.0 10.1 
28.4 17.6 35.5 17.0 12.8 9.5 
30.2 20.3 40.4 14.8 14.2 10.3 
37.2 25.7 46.1 16.7 22.6 9.8 
33.1 24.0 33.9 21.9 14.6 11.0 
52.5 31.4 62.1 20.3 24.2 9.0 
42.3 28.6 68.1 26.5 36.6 18.8 
59.8 35.2 63.1 42.3 28.0 17.2 
VA C/L 118 I 
VAC/L~ 
VAC/L~ 
VA ctlj 18 I 





CONTRAST SENSillVIlY WITH CONTACT LENSES 
Status I Q I Pt#~ [C) lm I Age~ 
J HCII l ctL Rxl ..._ -_3._25 __ ___,( B.C.~ Dlal14.5 I Spec Rx 1-3.25 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 58.4 40.4 73.0 47.9 27.3 22.3 
DAY 7 32.6 39.2 79.4 35.8 20.1 21.4 
DAY 14 51.3 31.4 73.6 30.4 20.3 13.1 
DAY 21 43.7 23.6 45.0 22.7 17.1 22.9 
DAY 28 41.4 30.9 58.0 17.4 16.0 17.6 
DAY 60 37.4 29.5 49.7 31.9 17.8 20.0 
DAY 90 38.3 24.5 54.1 25.3 16.7 20.9 
DAY 120 40.4 33.1 51.3 39.8 19.6 16.3 
















Status I Q I Pt#~ [C) jcs I Age~ 
I CSI-T l ctL Rx ..... l-_2._75 __ ___,1 B.c. @I] Dlaj13.8 { Spec Rx 1-2.75 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 55.3 52.9 94.8 33.9 19.6 13.0 
DAY 7 46.8 41.4 49.7 33.6 19.5 21.4 
DAY 14 36.3 26.1 63.1 23.6 14.5 12.9 
DAY 21 47.1 28.4 37.7 29.1 17.4 16.2 
DAY 28 24.9 19.6 25.5 22.0 13.4 14.9 
DAY 60 35.2 27.3 46.4 24.5 14.0 14.1 
DAY 90 30.9 21.2 39.5 29.7 16.7 20.4 
DAY 120 42.1 26.1 66.6 35.8 26.7 19.5 
DAY 150 35.5 30.7 40.7 17.6 13.7 14.0 
VA C/L 18 
~====-~ 
VA C/L 20 
====-===I 
VA C/L 17 
t===-=====\l 
VA C/L 18 
'=""==! VAC/L~ 
VAC/L~ 
VA CtLj22 I 
VAC/L~ 
VAC/L~ 
CONTRAST SENSillVIlYwm-1 CONTACT LENSES 
Status I 0... I Ptl @D [0 I CD 1j Age QIJ 
I HCII l c/L Rx 1'----1._25 __ ___,1 B.C.~ Dla l 14.5 I Spec Rx l-1.25 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 42.7 25.9 55.8 18.5 9.1 7.5 
DAY 7 35.5 19.6 41.7 22.6 11.2 13.1 
DAY 14 28.2 13.7 49.0 17.6 14.0 8.1 
DAY 21 32.8 11.4 44.3 13.8 12.6 10.2 
DAY 28 26.9 18.2 48.6 13.2 12.0 7.9 
DAY 60 34.4 17.2 53.7 18.5 12.3 14.2 
DAY 90 42.7 21.7 50.5 26.7 12.6 12.5 
DAY 120 46.1 20.6 58.0 19.1 18.2 11.0 
DAY 150 44.0 26.7 53.7 21.1 16.1 11.8 
VA C/L 18 
VA C/L 18 
I 
VA C/L 20 
VAC/L 18 









I CSI-T lc/L Rxl L--_1._50 __ ___,1 B.C.~ Dlal13.8 I Spec Rx l-1.50 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 43.3 16.7 46.8 26.5 8.4 14.2 
DAY 7 47.5 17.0 67.6 29.7 10.1 12.0 
DAY 14 47.1 14.0 63.6 13.8 21.7 9.1 
DAY 21 40.7 18.6 63.6 21.4 16.0 10.0 
DAY 28 33.9 13.7 44.0 12.7 9.5 8.0 
DAY 60 22.0 17.4 41.4 5.7 14.3 3.8 
DAY 90 50.5 15.8 62.1 15.8 14.7 17.0 
DAY 120 56.7 22.7 77.6 17.1 11.6 9.3 
DAY 150 55.8 25.3 72.4 26.1 20.4 17.0 
VA C/L 15 
VA C/L 17 
VA C/L 18 
VAC/L 17 
VA C/L 17 
VAC/L 17 
17 VA CIL 
VACtLECJ 
VACtLECJ 
CONTRAST SENSITlVIlY WITH CONTACT LENSES 
status (a_ I Pt#~ ~ jCD I Age~ 










6.0 1.2 4.0 11.4 .7 16 
30.9 25.7 56.2 27.5 21.2 15.3 
49.0 32.1 53.3 26.1 14.3 13.6 
43.0 20.4 54.5 18.1 13.2 12.5 
36.9 17.2 46.4 23.6 12.2 9.6 
18.9 14.8 30.9 18.1 9.8 15.0 
















status Ia.. I Pt#~ ~ lcs I Age~ 










6.0 1.2 4.0 11.4 .7 16 
45.4 26.1 60.3 22.0 22.2 11.0 
45.4 17.1 41.7 10.6 11.4 10.6 
34.9 17.0 38.6 21.5 12.6 9.1 
30.0 14.8 34.7 16.2 10.1 8.5 
27.1 13.4 31.1 21.4 6.9 8.8 
















CONTRAST SENSmVIlYWm-1 CONTACT LENSES 
Status I 0.. I Pt# ~ [=:] I Q) I Age ~ 
I HCII l c/L Rx l'---4_._25 ____ 1 B.C.~ Dlal14.5 I Spec Rx l-4.25-0.25x020 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 69.2 44.7 58.9 35.2 27.3 19.2 
DAY 7 64.6 34.7 42.0 27.1 14.5 19.1 
DAY 14 55.8 31.6 58.0 32.9 16.6 14.3 
DAY 21 37.7 18.9 46.1 22.4 14.5 18.9 
DAY 28 56.2 25.9 54.5 27.8 16.9 15.6 
DAY 60 42.3 28.8 58.9 31.6 24.7 17.8 
DAY 90 52.5 47.1 75.9 28.6 24.7 17.6 
DAY 120 69.1 49.4 83.1 59.3 25.7 22.4 
















Status I a.. I Pt#~ ~ joo f Age~ 
I CSI-T l c/L Rx 1'---3_._75 __ _.( B.C.~ Dlal14.8 I Spec Rx l-3.75-0.50x165 j 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 53.7 29.7 66.6 25.3 28.8 13.2 
DAY 7 26.7 24.0 21.2 12.9 13.1 11.6 
DAY 14 34.7 23.8 33.6 17.2 16.0 9.1 
DAY 21 37.2 21.7 46.1 18.2 14.7 11.0 
DAY 28 52.1 24.0 59.3 21.1 24.4 15.3 
DAY 60 44.7 40.4 54.5 26.1 21.5 18.9 
DAY 90 52.9 31.6 56.7 27.8 34.7 17.2 
DAY 120 40.1 49.0 67.1 31.1 43.3 15.7 















VA Ctlj 18 I 
VA ctlj 18 1 
CO"JTRAST SEJ\ISITIVITYWnH SPECTAa..E OORRECllON 
Status I Spec. I Pt# §] CO I Q) l Age ~ 










6.0 1.2 4.0 11.4 .7 16 
65.6 42.3 88.4 38.6 26.9 18.1 
51.7 33.4 67.1 26.9 20.3 28.2 
47.9 34.4 76.4 29.3 22.6 25.9 
64.1 43.0 91.9 32.9 28.0 14.0 
48.6 35.2 96.2 34.4 18.9 14.0 
VASpec. 18 
l====t 
VA Spec. 18 
F===9 
VA Spec. 17 
1=======4 




VASpec. I I 
VASpec. c=J 
VASpec. CJ 
Status I Spec. I Pt# §] CO J CS Age ~ 











6.0 1.2 4.0 11.4 .7 16 
68.1 30.9 113.9 68.7 33.4 27.1 
44.0 25.7 70.3 39.5 19.6 14.9 
61.7 28.0 86.4 27.5 18.9 15.8 
64.6 68.1 94.8 30.4 22.0 12.9 
46.4 22.6 63.1 13.4 21.7 12.7 
VASpec.(17 





VA Spec. 1,.----,1 
VASpec. c=J 
VASpec. CJ 
CONTRASTSENsmvrrYWilH SPECTAa..E CORRECllON 
Status I Spec. I Pt# ~ ~ I m I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
75.9 37.4 110.5 38.9 20.0 35.8 
46.4 27.3 45.7 19.3 14.8 15.1 
60.7 21.1 60.3 30.0 18.3 17.2 
74.1 28.6 64.1 31.9 14.7 17.9 
40.7 30.0 75.3 32.4 23.1 15.6 
87.1 48.2 106.2 58.0 19.2 31.1 
76.4 37.7 81.9 28.6 17.2 26.3 
71.3 48.6 84.5 43.3 24.4 18.1 












VA Spec. (F1~5 ~~ 
VASpec. ~ 
VASpec. ~ 
Status ( Spec. I Pt# ~ ~ 1( (1) I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
71.9 38.3 106.9 48.6 18.1 12.0 
39.5 18.9 46.8 18.9 15.4 9.9 
47.5 18.5 63.1 25.7 14.1 12.3 
46.8 31.6 78.2 28.0 16.2 10.6 
72.3 28.8 49.7 33.1 14.6 18.1 
70.8 38.0 97.0 48.6 17.0 20.0 
55.8 55.0 104.9 35.8 34.1 24.4 
69.7 50.9 66.6 30.9 32.9 21.2 







VA Spec. 15 
..._ _ __, 
VASpec. ~ 
VASpec. EJ 
VA Spec. (1 5 I 
VASpec. (14 f 
VA Spec. (1 4 ' 
CONTRAST SENSilMTYWITH SPECfAQ.E CORRECllON 
Status I Spec. I Pt# ~ [CJ I ro I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
46.8 43.3 75.9 34.7 24.4 35.8 
64.6 36.6 64.1 34.9 34.1 35.0 
42.3 21.7 44.3 32.4 28.4 21.9 
34.7 18.8 40.4 21.4 22.6 12.9 
33.4 26.9 51.7 18.1 25.9 17.5 
40.4 47.5 41.1 24.4 24.5 16.9 
30.4 32.6 53.3 31.1 27.8 17.8 
72.4 49.7 76.4 35.8 40.4 24.9 
43.0 38.6 74.7 31.6 32.6 19.5 
VASpec. 20 
...... -==\ 








VASpec. 117 I 
VASpec. ~ 
VASpec. [20 
Status I Spec. I Pt# ~ ~ I, CS I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
47.1 68.1 94.8 86.4 50.6 47.6 
41.1 41.4 57.5 41.7 46.8 38.0 
38.0 27.1 52.9 45.4 19.8 24.7 
27.3 24.2 38.6 21.4 15.7 11.9 
40.4 27.8 40.7 25.9 22.2 17.0 
26.3 31.1 31.1 23.4 22.7 14.3 
47.5 28.6 53.7 28.0 16.3 19.1 
75.9 39.8 71.3 43.3 35.2 34.1 
54.1 37.4 54.5 34.4 30.9 27.8 










VASpec. 118 I 
VASpec. (20 
VASpec. ~ 
CONTRAST SENSilMlYWITH SPECTAClE CORRECllON 
Status I Spec. I Ptt~ U lm I . Age ~ 










6.0 1.2 4.0 11.4 .7 16 
39.8 22.0 55.0 29.7 15.1 12.4 
58.4 39.8 70.3 33.4 27.3 19.6 
53.7 33.6 60.7 26.7 25.3 17.8 
59.8 41.1 85.1 42.7 29.1 26.5 
39.2 33.4 60.7 21.7 22.2 10.0 
45.4 31.6 55.8 24.0 23.6 11.4 
48.2 39.5 68.1 26.3 32.7 19.2 










VA Spec. 118 I 
VASpec. E] 
VA Spec. l==.J 
Status I Spec. I Pt# ~ U ICE I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
50.9 36.3 79.4 22.0 14.9 18.5 
55.0 31.6 62.6 34.4 29.5 14.1 
48.2 30.0 59.8 30.0 22.6 16.2 
47.1 34.4 65.1 33.4 .27.5 26.5 
37.2 27.8 61.2 24.2 16.9 14.0 
51.3 33.9 63.1 27.3 19.3 15.6 
51.7 36.0 50.1 26.9 22.6 15.6 







VA Spec. 15 
~=----' 
VASpec. ~. 17 
VA Spec. @=:J 
VA Spec. 1..---1-7 _,1 
VA Spec. 115 II 
VASpec. I I 
CONTRAST SENSITMlYwm-t SPECTACLE CORRECllON 
Status I Spec. I Pt# ~ U (CD Age ~ 










6.0 1.2 4.0 11.4 .7 16 
68.1 50.9 113.9 42.0 41.7 24.7 
65.1 33.6 1.0.5 24.9 13.0 9.9 
65.1 35.2 77.0 25.7 22.2 12.9 
62.1 29.7 69.7 26.5 22.9 16.0 
33.4 25.3 59.8= 25.3 17.5 14.3 
58.0 32.4 81.3 37.2 22.4 16.0 
56.2 43.3 76.4 36.9 32.9 14.8 
54.5 39.5 79.4 29.5 28.4 14.8 










VA Spec. 1=11==5==9 
VA Spec. 115 I 
VASpec. ~ 
VASpec. ~ 
Status I Spec. I Pt# [§] U I a> ,I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
64.1 52.5 105.9 35.5 26.9 14.5 
52.1 30.4 69.2 24.0 16.5 13.0 
52.5 27.5 62.6 24.9 21.4 11.8 
54.5 26.5 75.9 25.9 19.5 14.0 
51.3 26.9 69.7 23.1 22.2 11.0 
54.5 33.9 67.6 21.9 21.1 11.4 
57.5 47.9 79.4 23.1 41.4 17.5 
41.4 37.7 62.1 19.3 23.1 12.7 
56.2 46.4 73.0 22.9 25.1 12.4 






VASpec. 115 I 
VASpec. EJ 
VASpec. ~ 
VA Spec. ~~1 __;;7 ;..__,.,.1 
VA Spec. 115 I 
VA Spec. 115 I 
CONTRAST SENSITlVITYWm-i SPECTAa..E CORRECllON 
Status I Spec. I Pt# ~ ~ I m I Age ·@I] 










6.0 1.2 4.0 11.4 .7 16 
52.1 22.7 82.5 27.3 14.2 17.4 
52.9 28.8 76.4 32.9 14.5 15.8 
47.5 28.4 71.3 31.6 13.9 17.9 
41.7 21.7 66.6 21.4 9.5 14.2 
34.1 27.8 61.2 26.3 10.8 20.3 








~= ..... VASpec.~ 
VA Spec. @==:] 
VASpec. l I 
VASpec. CJ 
VASpec. CJ 
Status I Spec. ~ Pt# ~ ~ I CS I Age @I] 










6.0 1.2 4.0 11.4 .7 16 
54.1 27.8 69.7 42.7 13.1 20.4 
59.8 26.1 68.1 33.6 11.2 19.1 
60.3 23.1 78.2 35.5 13.3 21.2 
51.7 22.6 87.1 33.9 10.7 15.7 
50.9 29.3 65.6 35.5 13.0 21.4 
61.7 17.6 77.0 30.7 9.3 19.5 
VASpec. 15 
~-~ VASpec. 14 
1-====---4 








VASpec ...... I=~ 
VASpec. CJ 
VASpec. CJ 
ro..ITRAST SENSITMTYWITH SPECTAa..E OORRECllON 
Status r Spec. I Pt# ~ ~ [CD I Age @::] 










6.0 1.2 4.0 11.4 .7 16 
42.7 30.7 102.8 46.4 25.0 25.8 
41.1 21.9 60.3 26.9 14.7 18.8 
37.7 18.2 38.6 18.6 10.5 10.5 
27.3 16.7 59.3 10.4 12.8 8.2 
41.4 20.0 41.4 12.5 18.1 10.5 
42.0 20.0 31.4 23.3 25.7 12.6 
35.2 34.9 53.7 16.2 15.5 18.1 
40.1 26.3 61.7 30.9 10.9 9.1 










VA Spec. QI:=J 
VA Spec. r-~1-8 ;;;;_.....,1 
VASpec. ~ 
VASpec. ~ 
Status I Spec. I Pt# ~ ~ 1l CE Age ~ 
I HCII I C/L Rx 1-2.00 I B.C.~ Dla l 14.5 I Spec Rxj-2.00 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 41.4 36.0 91.2 30.4 18.5 10.9 
DAY 7 36.3 29.3 51.7 18.1 12.8 19.1 
DAY 14 33.6 20.9 32.1 11.3 12.5 14.8 
DAY 21 27.8 12.6 35.5 15.5 7.0 7.2 
DAY 28 25.1 11.7 60.3 14.8 13.5 13.3 
DAY 60 36.9 18.9 36.6 8.2 12.6 7.0 
DAY 90 29.3 22.0 50.5 24.2 17.1 11.6 
DAY 120 31.9 g7.5 77.0 16.5 12.3 9.6 












VA Spec. lr--1-8 ~~ 
VA Spec. f2o 11 
VA Spec. 118 I 
CONTRAST SENSillVIlYWTTH SPECTAClE CORRECTlON 
Status I Spec. I Ptt ~ ~ I Q) I Age @I] 










6.0 1.2 4.0 11.4 .7 16 
42.3 34.7 73.6 17.2 22.7 6.9 
43.3 23.8 52.9 22.4 24.4 7.4 
40.1 25.3 52.5 17.2 18.8 10.2 
47.9 24.0 59.3 24.7 19.5 17.6 
36.7 32.6 45.4 20.9 18.6 9.2 
34.7 31.1 41.1 29.7 13.1 6.4 
29.5 27.8 70.3 17.9 20.4 12.5 
33.3 27.8 51.7 15.8 13.1 5.7 
40.4 35.5 58.9 17.8 24.2 13.0 










VASpec. 117 I 
VASpec. ~ 
VASpec. ~ 
Status I Spec. I Pt# ~ ~ j ffi I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
80.0 44.3 108 26.7 24.7 8.7 
45.4 15.1 70.3 21.7 18.8 10.6 
49.7 25.7 56.2 25.1 18.3 9.9 
52.9 30.4 71.9 24.9 20.3 13.5 
38.6 17.8 55.0 30.7 12.2 10.5 
22.2 19.2 75.3 26.9 16.2 13.2 
40.7 38.8 61.2 37.2 11.9 15.8 
52.9 .19.6 54.5 36.0 15.4 14.0 





VA Spec. 18 
1===9 




VA Spec. r--~1-7 ____,, 
VASpec. ~ 
VASpec. ~ 
CONTRAST SENsmvnYWilH SPECTACLE CORRECTION 
Status I Spec. I Pt# ~ ~ I Q) I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
58.9 18.9 81.9 40.4 13.6 21.2 
58.0 31.9 77.6 23.8 20.4 14.8 
44.7 34.4 49.4 28.8 14.7 17.5 
46.8 24.4 59.8 27.3 14.3 15.3 
53.7 22.9 59.3 35.2 15.0 18.9 
55.0 26.9 55.8 35.8 14.7 13.5 
55.4 26.9 62.8 34.1 17.8 16.1 
52.9 30.2 58.4 36.9 16.6 21.9 











VA Spec. ,...;-11_;;;;;7 ~~ 
VA Spec. @=:J 
VASpec. (!0 
Status I Spec. I Pt# ~ ~ I ffi I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
64.1 26.3 71.3 38.9 13.3 20.6 
71.9 32.9 90.5 25.7 20.1 7.5 
43.3 32.9 55.4 22.0 11.7 7.9 
55.0 21.2 58.0 32.4 15.0 18.9 
42.0 22.7 63.1 20.7 17.6 7.1 
47.5 18.5 55.8 26.7 13.2 12.7 
47.5 25.1 56.7 24.9 19.5 15.5 
50.9 29.1 59.8 19.2 20.4 14.0 










VA Spec. .......,1-7 ___,, 
VASpec. ~ 
VASpec. ~ 
CONTRAST SENSITMTYWfTH SPECTAa..E CORRECllON 
Status I Spec. I Pt# §] ~ [ Q) I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
36.0 27.8 67.6 33.1 12.4 11.1 
31.6 16.9 41.1 26.1 15.8 17.5 
26.1 17.8 29.3 18.2 11.6 13.7 
14.6 11.7 21.9 13.3 8.4 9.3 
36.6 18.2 39.2 24.5 16.0 15.5 
35.5 20.0 38.9 23.1 22.7 12.4 











VA Spec.J,..... 1-7 -----., 
VASpec. B 
VA Spec. 
Status I Spec. I Pt# §] ~ I CS ] Age ~ 










6.0 1.2 4.0 11.4 . 7 16 
45.7 23.6 56.7 27.5 16.3 20.3 
29.5 19.2 42.7 17.0 21.4 13.9 
26.3 14.5 26.3 24.0 13.5 15.1 
17.0 13.5 18.5 14.1 11.3 11.8 
32.6 21.1 43.3 28.2 17.5 14.5 
28.2 19.6 39.2 19.3 19.2 12.8 











VA Spec. 117 I 
VASpec. c=J 
VASpec. C:=J 
CONTRASTSB\IsrnvnYWfTH SPECTAa.E CORRECllON 
Status I Spec. I Ptt Q2I] ~ I m I Age @!:] 










6.0 1.2 4.0 11.4 .7 16 
56.2 54.1 77.0 29.5 30.0 17.9 
52.9 33.4 76.4 36.0 24.4 17.5 
50.9 33.9 103.1 29.7 24.4 13.8 
62.1 29.1 66.6 18.6 24.2 13.4 
53.3 28.6 77.6 20.7 21.2 9.4 
55.4 32.6 101.5 19.8 31.9 15.0 
74.1 42.0 97.7 41.1 30.0 17.1 
48.2 33.4 73.6 25.1 28.8 12.6 











VA Spec. r--~1-8 ____,, 
VA Spec. m=:=l 
VASpec. EJ 
Status ~ Spec. I Pt# Q2IJ ~ .I CS I Age @!:] 










6.0 1.2 4.0 11.4 .7 16 
60.3 42.0 88.4 40.7 23.8 23.3 
59.8 31.9 73.6 33.9 19.3 24.5 
56.7 34.4 82.5 37.2 24.7 17.0 
55.0 28.2 70.8 24.7 26.3 14.5 
45.7 29.5 71.9 24.2 18.9 10.3 
44.3 29.7 59.3 20.4 18.3 9.5 
73.6 41.7 105.5 24.4 27.8 17.5 
77.0 35.5 77.6 40.1 20.4 13.8 











VA Spec. ..-,1.....;_;;8 ~~ 
VASpec. ~ 
VASpec. ~ 
CONTRAST SENSfTIVITYWfTH SPECTAa...E CORRECTION 
Status I Spec. I Pt# ~ u I m I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
I 
87.8 41.4 94.8 51.3 33.1 33.9 
45.7 44.3 107.2 18.1 36.6 13.9 
56.2 46.4 89.1 33.1 28.6 16.7 
57.5 42.3 68.7 27.8 22.0 20.7 
56.9 56.2 58.9 28.2 20.5 17.2 
40.7 39.2 88.4 32.1 26.7 18.3 
56.2 41.4 77.6 42.3 24.9 24.2 
60.7 42.0 103.9 38.9 29.5 12.9 
66.1 44.3 105.5 33.4 38.0 20.7 
VASpec. 17 




L........, ......... -... 
VASpec.~ 
VASpec. E) 
VA Spec. p;.;;;;11=5 =;;;;;;;,I 
VASpec. ~ 
VASpec. E) 
Status I Spec. I Pt# ~ U ( CS Age ~ 










6.0 1.2 4.0 11.4 .7 16 
85.8 54.1 111.3 59.8 26.3 28.6 
85.8 54.1 120.2 56.7 29.1 25.5 
88.4 38.0 131.8 54.1 24.4 28.4 
80.7 34.1 83.2 36.9 20.4 23.1 
65.3 38.5 126.E 45.7 32.9 23.7 
91.2 41.1 106.3 42.3 17.6 26.7 
68.1 30.9 81.9 47.1 29.3 26.9 
55.0 31.9 70.8 32.4 20.9 17.6 











VA Spec. 114 I 
VA Spec. 117 I 
VASpec. l15 I 
cx::>r-nRASr SENsmviTY WrTH SPECTACLE OORRECTION 
Status I Spec. I Pt# ~ ~ I CD Age ~ 











6.0 1.2 4.0 11.4 .7 16 
69.2 33.4 127.8 57.5 19.6 20.7 
56.2 38.0 73.0 32.9 21.4 24.4 
44.7 34.7 62.6 31.9 17.2 21.2 
41.1 33.1 75.3 29.7 30.4 24.2 
43.0 29.7 56.2 27.5 19.3 18.2 




VA Spec. 17 
t====~ 
VA Spec. 15 
......__  _., 
VASpec. EJ 




Status I Spec. I Pt# ~ [C) l CS I Age ~ 
I HCII I C/L Rx 1-2.00 I B.C.~ Dla 114.5 I Spec Rxj-2.00 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 55.0 35.8 103.1 44.3 21.5 23.8 
DAY 7 53.3 34.1 70.3 33.9 23.8 29.5 
DAY 14 46.1 31.4 68.7 27.3 20.9 18.8 
DAY 21 56.7 32.6 75.9 34.1 25.3 25.3 





VA Spec. 18 
VA Spec. 17 
VA Spec. 17 
VA Spec. 15 
VASpec. [IO 
VASpec. c=J 
VA Spec. r--~ ---,~ 
VASpec. CJ 
VASpec. c=J 
CONTRAST SENSlTIVITYWfTH SPECTAClE CORRECllON 
Status ~ Spec. ~ Pt# ~ ~ I CD I Age ~ 
I HCII I C/L Rx j-1.50 I B.C.~ Dlaj14.5 
1










6.0 1.2 4.0 11.4 .7 16 
71.9 38.0 1 88.4 47.9 17.1 29.7 
73.0 24.9 68.1 41.4 12.2 17.5 
45.7 14.0 144.3 31.4 10.8 20.0 
38.9 13.2 32.6 23.3 9.8 11.7 
40.4 12.5 43.3 25.9 10.7 11.3 
32.4 13.4 36.3 19.6 8.4 11.0 
37.4 11.8 28.4 24.7 7.9 9.7 
39.8 17.8 68.7 34.9 13.3 15.4 
58.0 26.5 163.6 35.5 18.2 17.1 










VASpec. j14 I 
VASpec. E) 
VASpec. ~ 
Status I Spec. I Pt# ~ ~ I ffi Age ~ 










6.0 1.2 4.0 11.4 .7 16 
72.4 27.3 75.9 36.6 17.6 17.1 
56.7 14.9 62.3 26.7 8.3 12.6 
49.7 12.5 50.5 23.6 9.5 12.4 
31.6 10.2 38.8 27.5 9.7 18.1 
36.3 11.7 37.4 33.6 10.3 14.1 
34.7 14.3 45.0 24.5 8.4 13.5 
26.1 10.6 32.1 19.5 8.3 6.5 
50.1 .20.1 75.3 18.1 15.6 5.4 





VA Spec. 17 
11===9 
VA Spec. 15 
~=~ VASpec.
VASpec. E1 
VA Spec. j14 ' 
VASpec. ~ 
VASpec. ~ 
CONTRASTSENSITlVITYWfTH SPECTAa..E CORRECTlON 
Status I Spec. I Pt## ~ ~ I CD I Age §] 










6.0 1.2 4.0 11.4 .7 16 
26.1 26.5 58.9 11.2 15.0 14.6 
31.4 21.7 31.1 7.8 15.3 7.0 
33.9 16.6 40.4 23.1 8.9 12.7 
21.1 14.0 27.5 9.8 8.6 4.8 
16.5 15.5 30.9 7.8 9.5 6.8 
32.4 17.0 41.1 22.2 13.6 12.8 
23.1 11.0 30.7 16.7 6.8 8.0 
23.8 24.0 36.0 25.5 22.4 14.6 











VA Spec. .....~ 1-8---.1 
VASpec. [20 
VASpec. ~ 
Status ~ Spec. I Pt# ~ ~ I CS I Age §] 










6.0 1.2 4.0 11.4 .7 16 
18.9 26.3 39.2 10.3 14.5 8.0 
18.2 16.5 21.4 9.6 11.1 6.1 
17.6 16.1 28.4 19.6 9.3 8.6 
15.0 12.6 33.6 7.8 10.8 6.3 
14.7 17.9 21.9 7.6 9.8 4.5 
22.2 17.0 34.9 12.4 10.7 8.1 
14.1 22.2 47.5 9.4 14.3 7.3 
21.5 21.7 34.1 17.1 18.1 10.0 
23.3 24.7 24.9 12.6 18.9 14.8 
VASpec. ~ 
VASpec. ~ 
VA Spec. r=l1=8====;, 
VA Spec. 118 I 
VASpec. ~ 
VASpec. ~· 
VA Spec. 11 8 I 
VA Spec. 11 8 I 
VA Spec. 118 I 
CONTRAST SB\JSrTIVfTYWffi-i SPECTAa..E CORRECTION 
Status I Spec. I Pt# ~ ~ l Q) I Age ~ 
I CSI-T I C/L Rx f-2 .25 I B.C.~ Dla f13.8 l Spec Rxl -2.25 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 95.5 36.6 112.2 47.5 21.7 29.5 
DAY 7 59.8 37.2 72.4 23.4 27.3 9.3 
DAY 14 50.5 36.3 111.3 44.3 25.3 14.9 
DAY 21 91.9 32.9 126.9 44.3 25.7 17.4 
DAY 28 88.4 42.0 110.5 36.9 30.2 17.1 
DAY 60 58.0 36.3 96.2 31.9 24.2 15.4 
DAY 90 52.5 37.7 78.2 27.5 18.8 12.0 
DAY 120 55.8 24.9 70.8 21.1 14.1 11.1 












VA Spec. ~,1=5 ==.1 
VASpec. ~ 
VASpec. (20 
Status J Spec. I Pt# ~ ~ I CS I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
92.6 36.0 139.1 33.1 20.0 24.5 
60.3 34.4 73.6 21.5 20.4 7.2 
45.0 32.9 68.1 18.3 23.3 10.6 
40.1 31.1 67.1 14.7 26.3 7.2 
45.0 26.1 80.0 17.8 18.9 6.7 
41.7 29.3 61.2 17.4 18.2 10.0 
50.9 23.1 65.1 19.2 15.3 9.8 
26.7 21.1 52.1 21.4 13.5 11.2 











VA Spec. .....,,-7-....,, 
VA Spec. f17 ~ 
VASpec. f18 I 
c:x.l'1TRAST SENSITIVITYWfTH SPECTAa..E CORRECllON 
Status I Spec. I Pt# ~ [CJ ~ Q) II Age ~ 










6.0 1.2 4.0 11.4 .7 16 
85.1 59.3 120.2 37.7 24.5 15.3 
41.1 30.2 70.3 29.3 19.2 14.7 
58.9 22.6 52.5 23.4 12.7 11.5 
50.5 20.3 65.6 24.5 13.7 11.0 
41.1 19.6 56.7 23.8 17.0 11.7 
51.7 25.9 67.1 23.4 16.6 13.1 
56.7 31.4 65.6 32.1 15.5 11.7 
48.6 28.2 65.6 16.2 20.6 6.9 











VA Spec. 118 I 
VASpec. ~ 
VASpec. ~ 
Status I Spec. I Pt# ~ [0 (a> Age ~ 










6.0 1.2 4.0 11.4 .7 16 
74.7 50.1 90.5 26.5 31.6 13.4 
54.5 30.0 74.7 18.5 17.0 13.8 
46.4 23.8 60.3 17.4 16.5 9.1 
42.0 14.8 41.1 11.4 17.0 7.6 
49.7 20.1 72.4 23.8 18.1 10.7 
53.7 29.1 77.0 25.5 15.5 14.0 
64.1 32.1 88.4 29.5 22.6 13.7 
47.1 30.2 67.6 17.0 24.4 8.4 
55.4 21.1 52.1 15.3 16.2 13.5 
VASpec. ~ 
VASpec. ~ 
VA Spec. 1;==1=8 ===;I 
VA Spec. 11 8 I 
VASpec. ~ 
VASpec. ~ 
VA Spec. 11 8 I 
VA Spec. 118 I 
VA Spec. 117 I 
CONTRAST SENSlTIVITYWfTH SPECTAa..E CORRECllON 
Status I Spec. I Pt# @I] ~ I <D Age ~ 










6.0 1.2 4.0 11.4 .7 16 
64.6 53.7 91.2 63.6 28.0 24.0 
62.6 39.2 81.3 58.0 27.1 22.0 
55.8 27.8 91.9 42.0 20.6 24.7 
87.8 30.2 97.7 31.1 17.4 12.5 
64.6 22.0 91.2 33.9 15.3 17.8 
62.6 29.3 74.6 49.4 18.8 29.7 
66.1 37.7 111.3 52.5 31.1 32.4 
78.2 36.6 109.6 52.5 28.8 26.9 











VA Spec. ,r-;11;;;;.;..5 =--.;;,1 
VASpec. (3D 
VASpec. EJ 
Status I Spec. I Pt# 1@3] ~ I CS Age ~ 










6.0 1.2 4.0 11.4 .7 16 
39.8 49.0 58.9 25.1 25.7 14.2 
78.2 34.7 105.5 52.9 23.6 24.2 
68.1 24.2 73.6 34.1 19.5 12.6 
85.8 26.5 102.3 41.4 19.6 22.7 
53.3 20.6 77.6 25.1 17.6 12.5 
58.9 28.4 86.4 36.6 19.2 17.0 
75.3 33.1 92.6 55.8 25.3 25.5 
70.3 34.7 101.5 45.4 30.4 23.6 
70.3 28.2 97.0 48.6 21.9 34.1 
VASpec. 18 
1-===='t 







VA Spec. r-,1-5 -----,1 
VASpec. (3D 
VASpec. EJ 
CONTRASTSENSITlVnYWilH SPECTAa..E CORRECTJON 
Status ~ Spec. I Pt# ~ II] I Q) I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
35.8 44.0 46.1 22.0 34.1 5.8 
34.4 27.1 50.1 17.8 16.3 12.4 
39.5 23.4 39.2 22.2 13.1 15.6 
52.5 31.4 50.5 24.5 16.6 8.4 
55.4 34.4 64.6 19.5 16.5 10.5 
68.1 61.2 93.3 31.9 25.1 7.4 
80.7 71.9 103.1 47.9 31.6 8.8 
73.0 53.7 99.2 17.1 24.7 5.8 












VASpec. j17 I 
VASpec. ~ 
VASpec. ~ 
Status I' Spec. I Pt# ~ II] I CS I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
47.5 38.9 59.3 21.1 25.5 11.9 
33.9 19.6 52.9 19.6 16.1 12.1 
41.1 22.9 51.3 18.9 13.2 6.5 
45.7 28.4 52.9 24.4 17.5 13.6 
42.0 31.1 54.1 23.3 18.6 10.6 
54.1 44.3 87.1 23.1 20.0 10.2 
75.9 78.2 81.3 37.4 32.4 14.6 
57.1 39.5 65.1 27.1 20.4 16.0 









VASpec. 115 I 
VASpec.l14 I 
VASpec. j17 I 
VASpec. ~ 
VASpec. ~ 
OONTRAST SENSITIVITYWfTH SPECTAa.E CORRECTION 
Status 1  Spec. ( Pt# ~ ~ li Q) I Age ~ 
I HCII t C/L Rx 1-2.00. J B.c.0 Dlal14.5 J Spec Rxl-1.25-0.25x090 ) 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 59.3 32.4 57.5 37.7 26.3 21.4 
DAY 7 38.9 26.3 54.5 13.2 13.1 6.9 
DAY 14 41.4 22.2 49.4 20.4 11.2 13.2 
DAY 21 33.1 24.5 48.2 18.3 12.3 9.8 
DAY 28 35.5 20.1 51.3 15.8 12.7 9.8 
DAY 60 32.4 28.8 66.1 25.7 17.1 16.5 
DAY 90 44.7 26.7 54.5 20.6 18.8 10.3 
DAY 120 47.5 32.9 79.4 35.2 31.9 21.9 











VA Spec. .....,1-7 ~~, 
VASpec. 120 
VASpec. ~ 
Status I Spec. I Pt# ~~  ( 03 ~ Age ~ 
I CSI-T I C/L Rx l-1.50 I B.C.~ Dla l 14.8 I Spec Rxl-1.50 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 42.7 34.4 57.5 20.9 23.3 11.4 
DAY 7 34.4 17.8 38.3 19.5 11.8 9.5 
DAY 14 32.4 17.5 50.5 11.5 13.0 10.9 
DAY 21 32.4 16.5 44.3 13.2 14.3 8.4 
DAY 28 27.9 18.8 41.7 16.0 14.2 10.9 
DAY 60 16.1 22.9 36.0 15.7 17.2 9.5 
DAY 90 39.5 24.4 53.3 18.1 16.1 8.9 
DAY 120 56.7 26.9 75.9 30.4 24.4 23.6 












VA Spec. 117 I 
VA Spec. [IC} 
VASpec. ~ 
(XX\J'l'RAST SENsmvrTYWITH SPECTAQE CORRECTION 
Status I Spec. I Pt# ~ ~ (CD I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
82.5 35.5 91.9 25.3 38.9 20.1 
17.9 29.3 37.2 9.5 17.2 8.6 
29.3 35.5 44.7 10.8 18.6 6.2 
22.9 16.5 31.6 11.7 11.5 6.8 
22.2 16.0 23.1 10.5 12.6 5.5 













VA Spec. ,r=-~=.~ 
VA Spec. C:=J 
VA Spec. C==:J 
Status I Spec. I Pt# ~ ~ I rn I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
51.7 24.2 58.0 34.7 17.9 16.2 
26.1 12.6 34.7 14.2 17.5 9.1 
34.1 19.8 40.7 17.0 12.1 12.1 
20.1 16.7 32.9 11.7 11.9 9.3 
17.5 14.6 19.5 6.8 10.5 4.7 











VA Spec. ~r.;...~=., 
VA Spec. C:=J 
VA Spec. C==:J 
CX)NTRAST SENSITlVIlYWITH SPECTAa..E OORRECTlON 
Status I Spec. I Ptt ~ ~ I CD II Age @I] 










6.0 1.2 4.0 11.4 .7 16 
52.1 30.4 81.3 33.4 21.5 20.3 
45.0 23.3 71.9 32.1 14.5 20.9 
50.5 23.4 70.3 36.0 15.0 16.9 
49.4 25.5 74.7 37.7 16.1 19.6 
48.6 26.5 63.1 38.3 17.0 17.5 











VA Spec. r--1 ---.~ 
VASpec. CJ 
VASpec. c=J 
Status I Spec. r Pt# ~ ~ I cs Age @I] 










6.0 1.2 4.0 11.4 .7 16 
61.7 30.9 77.6 25.7 15.4 11.4 
59.3 24.5 98.5 26.1 13.9 15.0 
63.6 26.5 60.7 36.6 18.3 14.0 
40.7 17.6 56.2 20.6 15.0 12.9 
45.4 23.6 60.3 34.4 14.6 17.0 











VASpec. r I 
VASpec. CJ 
VASpec. c=J 
CONTRAST SENSITMTYWfTH SPECTAClE OORRECllON 
Status I Spec. I Pt# ~ ~ l Q) I Age ~ 
I HCII I C/L Rx l-1.75 I B.C.~ Dlal14.5 I Spec Rxf-1.75 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 40.4 42.7 65.6 29.5 15.1 10.6 
DAY 7 36.6 26.7 57.5 25.7 14.0 13.6 
DAY 14 55.4 29.5 85.1 31.9 16.5 21.1 
DAY 21 38.3 24.7 65.1 24.4 16.0 11.0 
DAY 28 49.0 28.4 66.6 30.9 11.6 19.2 
DAY 60 54.5 22.4 64.1 36.0 12.6 17.5 
DAY 90 80.7 29.5 81.3 33.4 13.5 19.8 
DAY 120 56.7 29.1 88.4 23.1 14.6 12.4 











VA Spec. f15 I 
VA Spec. f18 I 
VA Spec. l 17 I 
Status l Spec. I Pt# ~ ~ I CS Age ~ 
! PF I C/L Rx 1-1.50 I B.c.@IJ Dla l 14.4 II Spec Rxl-1.50 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 54.1 41.4 67.1 31.6 12.4 18.3 
DAY 7 48.6 31.1 80.7 33.6 18.1 20.0 
DAY 14 50.9 27.5 74.1 27.3 14.7 13.9 
DAY 21 58.4 27.1 85.1 41.4 17.5 20.7 
DAY 28 55.8 30.0 80.7 44.0 12.0 22.7 
DAY 60 44.3 25.3 89.1 29.7 12.5 18.5 
DAY 90 59.8 23.1 90.5 32.1 13.2 18.5 
DAY 120 44.0 17.1 80.7 19.5 11.7 15.5 
DAY 150 45.4 17.1 46.4 29.3 10.0 17.5 
VA Spec. 18 
t=====. 
VA Spec. 15 
t==-==1 






VA Spec. ~~1;..._5 ....;;.,.=,1  
VA Spec. I. 1 7 I 
VA Spec. l17 11 
CO\ITRAST SENSITIVITY WITH SPECTACLE OORRECTION 
Status I Spec. I Pt# ~ U l CD I Age §] 
I PF I C/L Rx l -3.00 I e.c.@2J Dlal14.4 I Spec Rxl-3.00 sph 
DAY 0 








6.0 1 . 2 4.0 11.4 .7 16 
68.1 42.3 75.3 28.6 19.3 12.1 
55.8 35.5 75.9 26.3 15.6 13.0 
46.1 39.2 69.7 20.6 17.8 10.9 
35.5 35.8 49.4 25.5 13.7 15.5 
42.3 23.6 44.7 21.1 14.5 9.1 
39.2 36.0 48.6 26.7 21.4 14.5 
57.1 41.7 108.0 28.4 22.7 13.8 
42.7 35.2 45.7 27.1 17.2 14.6 
















1 Spec. ~ Pt# ~ U I CS I Age §] 
I HCII f C/L Rx 1-3.00 I B.C.~ Dla 114.5 I Spec Rx j -3.00 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 63.6 36.6 93.3 24.4 25.3 13.9 
DAY 7 42.0 30.4 78.2 23.8 16.1 8.9 
DAY 14 42.0 33.6 54.1 17.5 15.3 8.5 
DAY 21 37.7 26.3 46.1 15.4 13.7 8.6 
DAY 28 35.8 23.1 44.3 13.6 14.1 8.9 
DAY 60 49.4 33.1 72.4 23.4 17.1 8.5 
DAY 90 62.1 43.3 94.8 28.2 25.7 13.0 
DAY 120 68.1 41.1 71.9 36.3 21.4 19.6 













VA Spec. l18 I 
VASpec. ~ 
VASpec. ~ 
CONTRASTSENSfnVllYWilH SPECTACLE OORRECllON 
Status I Spec. I Pt# ~ ~ I Q) l Age @I] 
I CSJ-T I C/L Rx j-4.00 I B.C.~ Dlaj14.8 I Spec RxJ-3.75 sph 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 43.7 55.4 61.2 42.7 26.9 16.0 
DAY 7 47.1 48.2 65.6 34.7 26.9 21.7 
DAY 14 31.4 45.4 79.4 20.3 40.7 31.4 
DAY 21 45.7 55.8 45.4 24.4 38.6 31.1 
DAY 28 42.7 33.1 57.5 20.3 24.5 10.7 
DAY 60 57.5 39.8 55.0 24.0 27.3 14.6 
DAY 90 69.7 46.4 107.2 38.9 32.6 24.7 
DAY 120 74.1 49.7 105.5 34.4 29.7 16.0 












VA Spec. ~~1=4=-.;.;;,1 
VASpec. ~ 
VASpec. ~ 
Status I Spec. I Pt# ~ ~ I 03 ' Age @I] 










6.0 1.2 4.0 11.4 .7 16 
79.4 41.1 107.2 32.9 40.4 24.9 
42.7 55.4 71.3 24.2 30.4 16.7 
64.6 57.5 89.1 25.9 40.4 24.0 
52.9 45.0 50.5 30.0 39.2 14.1 
34.7 35.8 58.4 20.3 32.6 11.5 
53.3 32.1 61.2 26.7 32.9 15.1 
65.6 38.9 99.2 40.1 44.3 28.6 
81.9 37.2 84.1 34.4 39.8 13.2 













VA Spec. @:=J 
CONTRASTSENsmvtTYWffi-1 SPECTAQ.E OORRECTJON 
Status I Spec. r Pt# ~ ~ I Q) I Age ~ 










6.0 1.2 4.0 11.4 .7 ' 16 
42.0 33.4 63.1 29.7 24.4 15.3 
46.8 22.7 67.6 28.2 19.8 12.0 
50.5 28.0 49.0 27.5 17.9 17.5 
44.0 32.9 56.7 21.1 23.3 23.6 
56.7 30.4 58.9 24.5 15.8 17.8 
39.8 32.1 52.9 17.6 21.9 15.6 
28.0 33.1 43.0 17.2 27.1 7.6 
40.1 24.9 43.0 14.1 12.7 11.2 












VA Spec. (18 I 
VASpec. [20_ 
VASpec. ~ 
Status l Spec. I Pt# ~ ~ l CS I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
65.1 32.1 80.0 38.0 28.2 20.4 
46.4 26.1 52.1 28.0 23.4 26.9 
49.0 28.6 53.7 28.6 20.4 22.6 
45.0 30.0 46.4 26.3 17.1 18.8 
60.7 27.5 64.5 36.9 25.1 32.4 
63.6 27.5 80.7 27.8 20.1 20.0 
56.7 30.7 77.0 30.0 20.4 13.1 
67.6 32.1 66.1 27.3 24.5 25.1 











VA Spec. .,..;~1 ......... 8__;;,;;;;;;;;;;,1 
VASpec. QD 
VASpec. ~ 
CXJNTRASf SENSITMTYwm-1 SPECTAa...E CORRECTlON 
Status I Spec. I Pt# @D ~ I Q) Age ,§] 










6.0 1.2 4.0 11.4 .7 16 
46.1 44.0 74.7 22.6 21.1 14.0 
51.7 39.5 78.8 31.6 29.5 12.9 
46.4 41.1 94.0 34.1 29.5 15.1 
64.1 47.5 80.0 24.9 45.0 9.5 
29.5 38.6 50.5 15.4 27.8 7.0 
37.7 51.7 78.2 36.9 34.7 20.4 
24.0 37.7 60.7 16.6 20.0 3.7 
22.2 32.4 47.1 9.5 17.1 7.1 











VA Spec. ,.....,1-5 ___,, 
VASpec. ~.· 
VASpec. EJ 
Status ~ Spec. I Pt# @D [0 I C6 Age §] 










6.0 1.2 4.0 11.4 .7 16 
39.2 36.3 89.8 65.1 31.1 17.8 
48.6 49.4 67.6 43.3 40.7 17.5 
88.4 48.6 92.6 47.1 30.9 23.6 
48.2 33.1 79.4 28.8 40.7 9.8 
31.4 43.7 59.8 22.2 32.1 10.2 
66.6 48.6 91.9 41.1 28.4 18.9 
32.6 29.5 37.4 25.5 28.0 4.8 
40.4 31.6 55.8 26.9 19.8 16.1 
29.1 29.1 44.0 18.2 21.7 13.2 
VASpec.(18 
~=~ 








VA Spec. jr-1-8 ---.1 
VASpec. 114 I 
VA Spec. j14 j 
CCJ-JTRAST SEJ\IsmvrTYWITH SPECTAa..E CORRECTION 
Status I Spec. I Pt# @D ~ I m I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
60.7 66.6 83.8 37.2 11.2 22.2 
38.6 39.2 56.2 24.4 17.8 12.0 
53.7 33.1 61.2 23.8 20.6 13.4 
40.4 30.7 65.6 15.7 17.8 7.7 
33.9 26.1 47.1 7.6 18.2 6.6 
38.6 24.7 56.7 10.5 14.1 7.0 
46.8 22.7 69.2 24.4 16.5 12.2 
47.1 26.1 55.8 13.6 14.9 6.4 











VA Spec. o;;;;;;;;11=8 =;;;;;;;,I 
VASpec. l18 I 
VA Spec. 120 I 
Status I Spec. I Pt# @D ~ I CS I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
63.6 33.1 88.4 39.8 16.0 33.6 
79.4 28.8 80.0 27.5 18.2 20.1 
54.5 28.6 78.8 44.7 17.9 21.1 
57.5 32.6 63.1 28.6 15.8 18.6 
48.2 22.2 61.2 23.6 17.0 11.7 
45.4 27.8 54.5 22.2 13.8 13.9 
65.1 27.5 78.2 26.1 15.8 7.5 
61.2 g3.8 63.6 32.6 16.5 17.6 





VA Spec. 18 
I===~ 




VA Spec. r-~ 1-7---.l 
VASpec.QO 
VASpec. ~ 
OONTRASTSENSillVITYWrTH SPECTAa.E CORRECTION 
Status I Spec. 11 Pt# ~ ~ I CD I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
45.7 50.5 93.3 30.4 23.8 18.9 
30.9 33.1 39.8 12.5 20.6 6.6 
29.5 20.7 37.7 19.2 14.5 7.1 
27.3 19.6 39.8 21.4 14.7 10.6 
41.1 28.4 62.1 21.2 17.9 12.9 
15.4 20.0 28.8 11.4 20.7 4.0 
36.9 34.9 42.3 19.8 24.0 10.1 
40.4 36.9 64.1 28.2 28.6 16.2 










VA Spec. 118 I 
VASpec. ~ 
VASpec. ~ 
Status ~ Spec. I Pt# ~ ~ I C6 Age §] 










6.0 1.2 4.0 11.4 .7 16 
58.0 46.4 92.1 37.7 33.1 20.7 
30.9 34.7 46.8 20.3 22.7 9.8 
25.1 22.9 33.1 17.5 14.9 13.1 
30.0 21.1 33.9 24.7 16.5 13.4 
43.0 25.3 55.0 22.2 17.2 10.2 
35.2 26.7 45.7 21.4 20.9 11.0 
25.3 26.7 29.5 11.7 24.7 7.2 
40.1 37.4 55.0 32.6 19.6 16.2 











VA Spec. r-~1-8 ---,I 
VASpec. ~ 
VASpec. ~ 
CONTRASrSENSrTlVrTYWITH SPECTAQ.E cnRRECTJON 
Status I Spec. I Pt# ~ CO I CD ~ Age ~ 










6.0 1.2 4.0 11.4 .7 16 
66.1 30.4 108.8 39.5 17.9 14.7 
50.1 32.4 132.8 26.5 28.4 16.2 
35.5 27.5 55.4 19.5 14.3 9.0 
36.3 24.0 55.4 10.6 17.6 12.2 
36.3 24.4 62.1 13.2 13.7 9.3 
58.9 28.4 54.1 29.3 18.9 12.6 
62.6 29.3 78.8 34.4 19.3 28.2 
72.4 36.3 87.8 39.8 25.3 17.6 
51.7 39.5 78.2 33.9 15.6 16.2 
VASpec. 18 
~-=====~ 








VA Spec. lr 2=0 =tl 
VASpec. ,[20 
VASpec. ~ 
Status r Spec. I Pt# ~ co I C6 I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
72.4 46.1 93.3 49.7 22.2 29.5 
55.0 35.5 60.7 42.7 22.2 25.1 
49.7 24.4 47.5 25.7 15.6 25.9 
43.7 21.7 44.0 20.4 16.2 17.9 
39.2 21.9 61.2 21.9 16.5 12.7 
35.5 19.3 47.1 27.8 13.0 11.0 
45.4 32.6 63.1 35.2 21.2 23.7 
44.7 31.6 57.1 19.2 22.2 17.2 







VA Spec. 120 I 
VASpec. 118 I 
VASpec. j18 I 
<XX'.JTRAST SENSITIVITY WITH SPECTAa.E CORRECTlON 
Status I Spec. I Pt# @D co r m I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
56.7 22.0 73.6 36.0 20.9 18.2 
50.9 17.2 56.7 29.5 12.7 14.9 
40.4 28.0 47.1 31.9 12.9 18.1 
44.0 17.2 49.7 33.1 9.2 22.0 
37.4 18.5 55.8 25.1 14.3 9.8 
31.4 17.2 41.4 23.8 11.2 11.6 
39.2 18.8 53.7 16.0 14.0 7.8 
54.1 20.4 52.5 12.2 14.1 7.1 
55.4 28.2 75.9 46.8 20.4 26.1 
VASpec. 18 
~--4 
VASpec. 1 18 
1-=====-~ 
VASpec. 17 
----~ VASpec. 15 
~~= 
VASpec. (!0 
VA Spec. D2:=:J 
VA Spec. j;;;;;;;;1=7 =:=;;;;l 
VASpec. ~ 
VASpec. ~ 
Status I Spec. I Pt# @D CO I CS I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
45.4 24.9 54.5 33.1 14.1 19.2 
29.1 20.7 45.7 14.7 13.1 17.4 
66.6 26.1 66.6 29.5 12.2 16.3 
50.5 16.7 53.3 25.9 9.7 14.9 
52.1 17.9 56.7 30.2 12.4 16.0 
29.3 16.1 42.3 7.9 11.5 4.0 
49.0 20.0 66.1 25.9 12.8 14.2 
50.9 20.4 93.3 31.9 14.5 18.3 





VA Spec. 17 
?=====: 
VA Spec. 11 5 I 
VASpec.~ 
VASpec.@:] 
VASpec. j17 I 
VASpec. ~ 
VASpec. ~ 
C()f\fJ"RAST SEJ\JSilMTYWilH SPECTAa.E OORRECllON 
Status I Spec. 11 Pt#@!] ~ I CD I Age ~ 










6.0 1.2 4.0 11.4 .7 16 
56.7 29.7 76.4 37.4 20.1 17.5 
41.4 20.7 53.3 29.3 15.5 14.9 
38.0 21.2 52.1 24.4 11.0 12.8 
34.7 16.1 41.1 19.3 10.4 13.4 
21.5 13.5 36.6 21.4 10.6 11.5 








........... ~ ..... 
VASpec. (20 
VASpec. ~ 
VA Spec. r;;;;l ==.1 
VA Spec. c==J 
VA Spec. I=:=J 
Status ~ Spec. I Pt#@!] ~ I CS Age ~ 










6.0 1.2 4.0 11.4 .7 16 
54.1 25.7 70.3 34.1 14.3 17.1 
39.2 16.7 51.7 20.0 11.6 6.1 
37.7 18.3 39.5 21.7 10.0 6.5 
25.5 17.0 42.0 16.2 9.7 6.1 
23.3 10.0 41.7 11.0 7.1 6.9 











VA Spec. ~r----.1 
VA Spec. c==J 
VA Spec. I=:=J 
CONTRASTSENsmvnYWfTH SPECTAa.E CORRECTION 
Status I Spec. I Pt# ~ ~ I m Age @U 










6.0 1.2 4.0 11.4 .7 16 
' 
59.3 52.9 73.6 41.4 14.5 20.3 
29.7 31.6 32.1 13.7 14.0 6.6 
29.5 21.2 33.1 15.6 14.5 9.6 
24.4 26.5 31.1 20.1 9.5 15.3 
33.1 30.9 49.7 26.5 30.4 18.8 
46.8 37.7 63.6 31.6 24.4 21.5 
57.5 49.4 64.3 38.0 27.5 18.1 
46.8 51.7 58.0 21.4 25.5 11 .3 











VA Spec. l18 l 
VASpec. ~ 
VASpec. ~ 
Status I Spec. I Pt# ~ ~ I ffi I Age @U 










6.0 1.2 4.0 11.4 .7 16 
63.6 31.4 93.3 30.2 22.7 14.0 
24.2 30.4 28.2 14.6 15.1 11.7 
33.6 27.1 50.9 20.6 24.5 11.3 
33.6 22.6 45.4 18.2 11.7 11 .1 
31.4 30.7 42.7 21.1 21.9 10.1 
42.7 29.7 63.6 46.4 28.0 14.8 
40.4 39.8 51.7 21.7 28.2 11.4 
43.3 29.1 63.6 22.6 28.8 21.1 















VA Spec. 118 
VASpec. F11=8=~ 
OONTRQSUBJECTS 
Status I Spec. I Pt# D ~I L-m _ ____, 
Spec Rx I plano-1.25x091 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 73.2 58.4 105.9 46.4 36.9 17.2 
DAY 7 
DAY 14 70.3 64.1 108.8 52.5 49.0 21.5 
DAY 21 
DAY 28 65.2 60.5 85.6 50.7 38.4 19.7 
DAY 60 63.6 53.7 76.2 50.1 26.7 28.8 
DAY 90 49.0 52.1 78.2 31.1 59.3 23.4 
DAY 120 78.2 55.8 62.6 49.4 54.1 19.8 
DAY 150 81.9 68.1 87.8 34.7 46.8 25.1 
Status I Spec. I Pt# D ~ '-J cs_----1 
Spec Rx I plano-1.75x085 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 57.1 40.4 100.0 44.3 27.8 20.4 
DAY 7 
DAY 14 39.8 38.0 62.1 21.7 32.4 21.1 
DAY 21 
DAY 28 42.8 43.1 72.1 35.6 36.9 24.5 
DAY 60 54.5 47.9 71.3 49.0 45.6 27.4 
DAY 90 65.6 31.4 87.1 47.1 37.6 16.3 
DAY 120 47.5 46.8 70.3 32.9 32.4 25.5 
DAY 150 61.7 59.8 96.2 39.5 56.2 18.2 
Age~ 
VA Spec. 15 
VA Spec. 
VA Spec. 13 
VA Spec. I 
VA Spec. 13 I 
VA Spec. 14 I 
VA Spec. 14 I 
VA Spec. 14 I 
VA Spec. 14 I 
Age~ 
VA Spec.l14 
VA Spec. li=l l ===!, 
VA Spec.,14 
VA Spec. 11===9 
VASpec. ~ 
VASpec. ~ 
VA Spec. 11 5 I 
VA Spec. 11 4 I 
VA Spec. 114 I 
CD\ITRa..SUBJECTS 
Status I Spec. I Pt# [0 
Spec Rx ~ +0.50-0.25x180 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 48.2 24.5 81.9 29.1 12.0 14.3 
DAY 7 
DAY 14 73.0 32.9 85.8 30.4 21.1 8.1 
DAY 21 
DAY 28 54.1 36.6 72.4 34.1 19.3 17.8 
DAY 60 48.2 21.5 58.9 28.4 14.5 13.5 
DAY 90 58.0 20.3 64.6 24.0 14.6 11.4 
DAY 120 59.3 29.3 66.6 31.6 12.1 14.8 
DAY 150 49.0 35.5 58.9 25.3 15.3 9.1 
Status I Spec. I Pt# EJ ~ ~~--~----~ 
Spec Rx ~ +0.50 sph I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 42.0 33.1 73.0 24.0 20.9 7.6 
DAY 7 
DAY 14 48.2 26.7 78.2 25.7 13.7 8.9 
DAY 21 
DAY 28 47.5 21.9 70.3 31.6 21.9 14.1 
DAY 60 38.9 22.0 50.1 20.1 11.7 6.6 
DAY 90 46.1 21.2 58.0 26.1 11.7 7.3 
DAY 120 38.3 23.6 70.3 22.7 18.9 11.0 






VA Spec. 15 
VA Spec. li= ~ 






















...___ _ __, 
VASpec. EJ 
VASpec. 0::0 
VA Spec. 1;::::1=5==.1 
CONTRa... SUBJECTS 
Status I Spec. I Pt# ~ ~I._ m _ __, 
Spec Rx I +0.25 sph 11 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 57.5 47.1 112.2 27.1 20.3 7.6 
DAY 7 
DAY 14 68.1 49.4 110.6 37.5 35.8 16.1 
DAY 21 
DAY 28 48.2 56.7 90.5 32.4 29.1 9.6 
DAY 60 73.0 46.4 73.0 30.2 42.0 26.1 
DAY 90 62.1 50.1 107.2 58.9 54.5 21.4 
DAY 120 78.8 45.7 100.8 58.9 40.4 21.7 
DAY 150 80.0 62.1 96.4 38.3 54.1 16.6 
Status I Spec. I Pt# ~ ~( L-m _ _.~ 
Spec Rx I +0.25 sph I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 67.1 36.6 103.9 43.0 29.7 25.5 
DAY 7 
DAY 14 73.6 36.9 83.8 49.0 33.6 10.9 
DAY 21 
DAY 28 71.9 62.1 122.1 42.0 36.0 8.6 
DAY 60 87.8 32.4 104.7 42.0 26.3 24.2 
DAY 90 81.3 60.7 106.6 44.0 28.0 24.9 
DAY 120 77.6 38.9 103.1 46.1 22.0 17.4 
DAY 150 77.0 43.0 100.0 44.0 36.0 15.7 
Age~ 
VA Spec. 117 I 
VA Spec. [=:=1 
VASpec.~ 










VA Spec. 15 
L.-----1 
Age~ 
VA Spec. 17 
VA Spec. 
VA Spec. 17 
VA Spec. 
VA Spec. 15 
VA Spec. 17 
VA Spec. 17 
VA Spec. 15 
VA Spec. 15 
caiTROLSUBJECTS 
Status I Spec. I Pt# ~ Age @I] 
Spec Rx I plano-0.25x1 00 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 64.1 27.8 85.1 38.6 16.6 17.1 VA Spec. 14 
DAY 7 VA Spec. 
DAY 14 66.1 34.9 81.3 39.2 20.9 27.3 VA Spec. 14 
DAY 21 VA Spec. I 
DAY 28 65.1 36.6 65.1 34.9 26.7 16.6 VA Spec. 14 
DAY 60 74.1 55.0 108.0 45.4 27.1 23.1 VA Spec. 14 
DAY 90 69.7 56.7 102.3 37.2 31.4 12.5 VA Spec. 14 
DAY 120 71.3 48.2 80.7 45.4 34.1 18.6 VA Spec. 14 
DAY 150 68.7 46.1 98.5 45.0 28.8 17.9 VA Spec. 14 
Status I Spec. I Pt# ~ Age @I] 
Spec Rx I +0.25-0.75x060 I 
6.0 1.2 4.0 11.4 .7 16 
DAY 0 75.9 33.4 97.0 35.8 22.7 16.0 VASpec.j15 I 
DAY 7 VA Spec., I 
DAY 14 69.7 48.2 89.1 42.3 33.1 24.5 VA Spec. 14 li 
DAY 21 VA Spec. I 
DAY 28 69.7 40.4 107.2 40.1 21.4 18.5 VA Spec. 14 
DAY 60 62.6 56.2 108.8 43.3 34.4 20.0 VA Spec. 14 
DAY 90 68.7 43.0 87.1 39.2 27.8 21.9 VA Spec. 14 
DAY 120 65.1 42.7 94.0 41.1 33.9 22.0 VA Spec. 14 
DAY 150 69.7 44.3 91.2 38.9 32.9 21.4 VA Spec. 14 
